{ "@context" : { "@base" : "https://kodlistor.miljodatasamverkan.se/def/vocabulary/KemBioFys_PARAMETERNAMN/CH10/", "skos" : "http://www.w3.org/2004/02/skos/core#", "concepts" : "skos:Concept", "prefLabel" : "skos:prefLabel", "broader" : "skos:broader", "narrower" : "skos:narrower", "@language" : "sv", "VocabularyId" : "73", "ContinuityId" : "96337196-1622-375c-9a65-45f3a9b5ea0e", "Identifier" : "CH10", "Label" : "Läkemedel", "RegistrationStatus" : "Public draft", "IsWorkingCopy" : "false", "CheckedOutCopyId" : "0", "WorkingUser" : null, "DateModified" : "2026-04-04 16:20:21.0", "UserModified" : "staffan", "IsNumericConceptIdentifiers" : "true", "VocabularyType" : "Common", "FolderId" : "4", "FolderName" : "KemBioFys_PARAMETERNAMN", "FolderLabel" : "Kemiska, biologiska, fysikaliska parameternamn", "IsNotationsEqualIdentifiers" : "false", "Definition" : null, "Version" : null }, "concepts" : [ { "@id" : "1", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "17-α-Östradiol", "@language" : "sv" } ], "VocabularyConceptId" : "349163", "VocabularyId" : "73", "Identifier" : "1", "Label" : "17-α-Östradiol", "Definition" : null, "Notation" : "CH10/1", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "17-alpha-Estradiol; Alfatradiol" ], "Synonym_1" : [ "Alfatradiol" ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(17α)-17-Hydroxyestra-1,3,5(10)-trien-3-yl β-D-glucopyranosiduronate" ], "CAS-Nr" : [ "57-91-0" ], "EC-Nr" : [ "200-354-8" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Steroidhormoner/Östrogena hormoner" ], "Anvandningsomrade-Egenskaper" : [ "Mot: Alopeci" ] }, { "@id" : "2", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "7-Aminoflunitrazepam", "@language" : "sv" } ], "VocabularyConceptId" : "349164", "VocabularyId" : "73", "Identifier" : "2", "Label" : "7-Aminoflunitrazepam", "Definition" : null, "Notation" : "CH10/2", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "7-Aminoflunitrazepam" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "7-Amino-5-(2-fluorophenyl)-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one" ], "CAS-Nr" : [ "34084-50-9" ], "EC-Nr" : [ "saknas" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Bensodiazepiner" ], "Anvandningsomrade-Egenskaper" : [ "Sömnmedel/Sedativa/Muskelavslappnande/Flunitrazepam-metabolit" ] }, { "@id" : "3", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Acebutolol", "@language" : "sv" } ], "VocabularyConceptId" : "349165", "VocabularyId" : "73", "Identifier" : "3", "Label" : "Acebutolol", "Definition" : null, "Notation" : "CH10/3", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Acebutolol" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(RS)-N-{3-Acetyl-4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl}butanamide" ], "CAS-Nr" : [ "37517-30-9" ], "EC-Nr" : [ "253-539-0" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Amider/Aminer/Alkoholer" ], "Anvandningsomrade-Egenskaper" : [ "Mot: Hjärtarytmi, Högt blodtryck/Beta-blockerare" ] }, { "@id" : "4", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Acekarbromal", "@language" : "sv" } ], "VocabularyConceptId" : "349166", "VocabularyId" : "73", "Identifier" : "4", "Label" : "Acekarbromal", "Definition" : null, "Notation" : "CH10/4", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Acecarbromal" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "N-(Acetylcarbamoyl)-2-bromo-2-ethyl-butanamide" ], "CAS-Nr" : [ "77-66-7" ], "EC-Nr" : [ "201-047-1" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Bromorganiska ämnen/Ureater" ], "Anvandningsomrade-Egenskaper" : [ "Sedativa/Sömnmedel" ] }, { "@id" : "5", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Aceklofenak", "@language" : "sv" } ], "VocabularyConceptId" : "349167", "VocabularyId" : "73", "Identifier" : "5", "Label" : "Aceklofenak", "Definition" : null, "Notation" : "CH10/5", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Aceclofenac" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "2-[2-[2-[(2,6-Dichlorophenyl)amino]phenyl]acetyl]oxyacetic acid" ], "CAS-Nr" : [ "89796-99-6" ], "EC-Nr" : [ "920-224-0" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Klorerade aromater/Aniliner/Karboxylsyror/Karboxylatestrar" ], "Anvandningsomrade-Egenskaper" : [ "Antiinflammatoriska medel/Analgetika/Antipyretika/NSAID (Non-steroidal anti-inflammatory drugs)" ] }, { "@id" : "6", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Acemetacin", "@language" : "sv" } ], "VocabularyConceptId" : "349168", "VocabularyId" : "73", "Identifier" : "6", "Label" : "Acemetacin", "Definition" : null, "Notation" : "CH10/6", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Acemetacin" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "2-[2-[1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-indol-3-yl]acetyl]oxyacetic acid" ], "CAS-Nr" : [ "53164-05-9" ], "EC-Nr" : [ "258-403-4" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Klorerade aromater/Indoler/Acetater" ], "Anvandningsomrade-Egenskaper" : [ "Mot: Reumatism/Analgetika/NSAID (Non-steroidal anti-inflammatory drugs)" ] }, { "@id" : "7", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Acetazolamid", "@language" : "sv" } ], "VocabularyConceptId" : "349169", "VocabularyId" : "73", "Identifier" : "7", "Label" : "Acetazolamid", "Definition" : null, "Notation" : "CH10/7", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Acetazolamide" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "N-(5-Sulfamoyl-1,3,4-thiadiazol-2-yl)acetamide" ], "CAS-Nr" : [ "59-66-5" ], "EC-Nr" : [ "200-440-5" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Sulfonamider/Tiadiazoler" ], "Anvandningsomrade-Egenskaper" : [ "Antidiuretika/Mot: Glaukom, Höjdsjuka/Antiepileptika" ] }, { "@id" : "8", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Acetylsalicylsyra", "@language" : "sv" } ], "VocabularyConceptId" : "349170", "VocabularyId" : "73", "Identifier" : "8", "Label" : "Acetylsalicylsyra", "Definition" : null, "Notation" : "CH10/8", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Acetylsalicylic acid" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "2-Acetoxybenzoic acid" ], "CAS-Nr" : [ "50-78-2" ], "EC-Nr" : [ "200-064-1" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Salicylater" ], "Anvandningsomrade-Egenskaper" : [ "Analgetika/Antipyretika/Antiinflammatoriska medel" ] }, { "@id" : "9", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Aciklovir", "@language" : "sv" } ], "VocabularyConceptId" : "349171", "VocabularyId" : "73", "Identifier" : "9", "Label" : "Aciklovir", "Definition" : null, "Notation" : "CH10/9", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Aciclovir; Acyclovir" ], "Synonym_1" : [ "Acyklovir" ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "2-Amino-9-[(2-hydroxyethoxy)methyl]-1,9-dihydro-6H-purin-6-one" ], "CAS-Nr" : [ "59277-89-3" ], "EC-Nr" : [ "261-685-1" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Guanosin-analoger" ], "Anvandningsomrade-Egenskaper" : [ "Anti-virala medel/ Mot: Herpesvirus, m.fl." ] }, { "@id" : "10", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Albendazol", "@language" : "sv" } ], "VocabularyConceptId" : "349172", "VocabularyId" : "73", "Identifier" : "10", "Label" : "Albendazol", "Definition" : null, "Notation" : "CH10/10", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Albendazole" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "Methyl [5-(propylthio)-1H-benzoimidazol-2-yl]carbamate" ], "CAS-Nr" : [ "54965-21-8" ], "EC-Nr" : [ "259-414-7" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Bensimidazoler/Karbamater" ], "Anvandningsomrade-Egenskaper" : [ "Antiparasitika/Helminticider, \"maskmedel\"" ] }, { "@id" : "11", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Albuterol", "@language" : "sv" } ], "VocabularyConceptId" : "349173", "VocabularyId" : "73", "Identifier" : "11", "Label" : "Albuterol", "Definition" : null, "Notation" : "CH10/11", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Albuterol; Salbutamol; Ventolin" ], "Synonym_1" : [ "Salbutamol" ], "Synonym_2" : [ "Ventolin" ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(RS)-4-[2-(tert-Butylamino)-1-hydroxyethyl]-2-(hydroxymethyl)phenol" ], "CAS-Nr" : [ "18559-94-9" ], "EC-Nr" : [ "242-424-0" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Fenoler/Aminer" ], "Anvandningsomrade-Egenskaper" : [ "Astmamediciner/Bronkialvidgande/Selektiva beta-2-stimulerare (β2-stimulerare), eller beta-2-agonister" ] }, { "@id" : "12", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Albuterolsulfat", "@language" : "sv" } ], "VocabularyConceptId" : "349174", "VocabularyId" : "73", "Identifier" : "12", "Label" : "Albuterolsulfat", "Definition" : null, "Notation" : "CH10/12", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Albuterol sulfate; Salbutamol sulfate; Ventolin HFA" ], "Synonym_1" : [ "Salbutamolsulfat" ], "Synonym_2" : [ "VentolinHFA" ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "2-(Hydroxymethyl)-4-{1-hydroxy-2-[(2-methyl-2-propanyl)amino]ethyl}phenol sulfate (2:1)" ], "CAS-Nr" : [ "51022-70-9" ], "EC-Nr" : [ "256-916-8" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Fenoler/Aminer" ], "Anvandningsomrade-Egenskaper" : [ "Astmamediciner/Bronkialvidgande/Selektiva beta-2-stimulerare (β2-stimulerare), eller beta-2-agonister" ] }, { "@id" : "13", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Alfuzosin", "@language" : "sv" } ], "VocabularyConceptId" : "349175", "VocabularyId" : "73", "Identifier" : "13", "Label" : "Alfuzosin", "Definition" : null, "Notation" : "CH10/13", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Alfuzosin; Uroxatral" ], "Synonym_1" : [ "Xatral" ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "N-[3-[(4-Amino-6,7-dimethoxy-quinazolin-2-yl)- methyl-amino]propyl] tetrahydrofuran- 2-carboxamide" ], "CAS-Nr" : [ "81403-80-7" ], "EC-Nr" : [ "617-230-8" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Kinazoliner/Fenoletrar/Amider/Tetrahydrofuraner" ], "Anvandningsomrade-Egenskaper" : [ "Muskelavslappnande i prostata och urinblåsa/Mot Prostataförstoring (BPH)/Alfareceptor-blockerare" ] }, { "@id" : "14", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Alklofenak", "@language" : "sv" } ], "VocabularyConceptId" : "349176", "VocabularyId" : "73", "Identifier" : "14", "Label" : "Alklofenak", "Definition" : null, "Notation" : "CH10/14", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Alclofenac" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "2-(3-Chloro-4-prop-2-enoxyphenyl)acetic acid" ], "CAS-Nr" : [ "22131-79-9" ], "EC-Nr" : [ "244-795-4" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Klorerade aromater/Karboxylsyror" ], "Anvandningsomrade-Egenskaper" : [ "Antiinflammatoriska medel/Analgetika/Antipyretika/NSAID (Non-steroidal anti-inflammatory drugs)" ] }, { "@id" : "15", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Allobarbital", "@language" : "sv" } ], "VocabularyConceptId" : "349177", "VocabularyId" : "73", "Identifier" : "15", "Label" : "Allobarbital", "Definition" : null, "Notation" : "CH10/15", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Allobarbital" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "5,5-Diprop-2-enyl-1,3-diazinane-2,4,6-trione" ], "CAS-Nr" : [ "52-43-7" ], "EC-Nr" : [ "200-140-4" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Barbiturater" ], "Anvandningsomrade-Egenskaper" : [ "Sedativa/Antikonvulsiva" ] }, { "@id" : "16", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Alprazolam", "@language" : "sv" } ], "VocabularyConceptId" : "349178", "VocabularyId" : "73", "Identifier" : "16", "Label" : "Alprazolam", "Definition" : null, "Notation" : "CH10/16", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Alprazolam; Xanax" ], "Synonym_1" : [ "Xanax" ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "8-Chloro-1-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine" ], "CAS-Nr" : [ "28981-97-7" ], "EC-Nr" : [ "249-349-2" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Klororganiska ämnen/Diazepiner" ], "Anvandningsomrade-Egenskaper" : [ "Ångestdämpande/Sedativa/Narkotikaklassad" ] }, { "@id" : "17", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Amiodaron", "@language" : "sv" } ], "VocabularyConceptId" : "349179", "VocabularyId" : "73", "Identifier" : "17", "Label" : "Amiodaron", "Definition" : null, "Notation" : "CH10/17", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Amiodarone" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(2-{4-[(2-Butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}ethyl)diethylamine" ], "CAS-Nr" : [ "1951-25-3" ], "EC-Nr" : [ "217-772-1" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Jodfenyler/Bensofuraner/Aminer" ], "Anvandningsomrade-Egenskaper" : [ "Mot: Hjärtarytmi/Vid hjärtoperationer" ] }, { "@id" : "18", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Amitriptilin", "@language" : "sv" } ], "VocabularyConceptId" : "349180", "VocabularyId" : "73", "Identifier" : "18", "Label" : "Amitriptilin", "Definition" : "2026-04-01 Ändrat stavfel från Amitryptilin till Amitriptilin - ChSp/PubCh/ECHA/WIKI", "Notation" : "CH10/18", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Amitriptyline; Amitryptiline" ], "Synonym_1" : [ "Amitryptilin" ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "N,N-Dimethyl-3-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,11,13-hexaenylidene)propan-1-amine; 3-(10,11-Dihydro-5H-dibenzo[a,d]cycloheptene-5-ylidene)-N,N-dimethylpropan-1-amine" ], "CAS-Nr" : [ "50-48-6" ], "EC-Nr" : [ "200-041-6" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Dibensocykloheptener/Aminer" ], "Anvandningsomrade-Egenskaper" : [ "Antidepressiva/Sedativa/Neuroleptika/TCA: Tri-Cykliska Antidepressiva" ] }, { "@id" : "19", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Amobarbital", "@language" : "sv" } ], "VocabularyConceptId" : "349181", "VocabularyId" : "73", "Identifier" : "19", "Label" : "Amobarbital", "Definition" : null, "Notation" : "CH10/19", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Amobarbital" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "5-Ethyl-5-(3-methylbutyl)-1,3-diazinane-2,4,6-trione" ], "CAS-Nr" : [ "57-43-2" ], "EC-Nr" : [ "200-330-7" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Barbiturater" ], "Anvandningsomrade-Egenskaper" : [ "Sömnmedel/Sedativa" ] }, { "@id" : "20", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Amoxicillin", "@language" : "sv" } ], "VocabularyConceptId" : "349182", "VocabularyId" : "73", "Identifier" : "20", "Label" : "Amoxicillin", "Definition" : null, "Notation" : "CH10/20", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Amoxicillin" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(2S,5R,6R)-6-{[(2R)-2-Amino-2-(4-hydroxyphenyl)-acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-24-carboxylic acid" ], "CAS-Nr" : [ "26787-78-0" ], "EC-Nr" : [ "248-003-8" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Beta-laktamer" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika" ] }, { "@id" : "21", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Ampicillin", "@language" : "sv" } ], "VocabularyConceptId" : "349183", "VocabularyId" : "73", "Identifier" : "21", "Label" : "Ampicillin", "Definition" : null, "Notation" : "CH10/21", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Ampicillin" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(2S,5R,6R)-6-([(2R)-2-Amino-2-phenylacetyl]amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid" ], "CAS-Nr" : [ "69-53-4" ], "EC-Nr" : [ "200-709-7" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Beta-laktamer/Aminopenicilliner" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika" ] }, { "@id" : "22", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Antracen-1,4-dion", "@language" : "sv" } ], "VocabularyConceptId" : "349184", "VocabularyId" : "73", "Identifier" : "22", "Label" : "Antracen-1,4-dion", "Definition" : null, "Notation" : "CH10/22", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Anthracene-1,4-dione" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "Anthracene-1,4-dione" ], "CAS-Nr" : [ "635-12-1" ], "EC-Nr" : [ "211-228-7" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Antrakinoner" ], "Anvandningsomrade-Egenskaper" : [ "Antineoplastiska läkemedel/Cytostatika" ] }, { "@id" : "23", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Apramycin", "@language" : "sv" } ], "VocabularyConceptId" : "349185", "VocabularyId" : "73", "Identifier" : "23", "Label" : "Apramycin", "Definition" : null, "Notation" : "CH10/23", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Apramycin" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(2R,3R,4R,5S,6R)-5-Amino-2- [((1R,2R,3R,4R,6R,8R)-8-amino-9- [(1R,2S,3R,4R,6R)-4,6-diamino-2,3- dihydroxy-cyclohexyl]oxy-2-hydroxy- 3-methylamino-5,10- dioxabicyclo[4.4.0]dec-4-yl)oxy]-6- (hydroxymethyl)oxane-3,4-diol" ], "CAS-Nr" : [ "37321-09-8" ], "EC-Nr" : [ "253-460-1" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Aminoglykosider" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika" ] }, { "@id" : "24", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Aprobarbital", "@language" : "sv" } ], "VocabularyConceptId" : "349186", "VocabularyId" : "73", "Identifier" : "24", "Label" : "Aprobarbital", "Definition" : null, "Notation" : "CH10/24", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Aprobarbital" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "5-Propan-2-yl-5-prop-2-enyl-1,3-diazinane-2,4,6-trione" ], "CAS-Nr" : [ "77-02-1" ], "EC-Nr" : [ "200-997-4" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Barbiturater" ], "Anvandningsomrade-Egenskaper" : [ "Sedativa/Sömnmedel/Antikonvulsiva/Narkotikaklassad" ] }, { "@id" : "25", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Atenolol", "@language" : "sv" } ], "VocabularyConceptId" : "349187", "VocabularyId" : "73", "Identifier" : "25", "Label" : "Atenolol", "Definition" : null, "Notation" : "CH10/25", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Atenolol" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(RS)-2-{4-[2-Hydroxy-3-(propan-2-ylamino)propoxy]phenyl}acetamide" ], "CAS-Nr" : [ "29122-68-7" ], "EC-Nr" : [ "249-451-7" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Aminer/Amider" ], "Anvandningsomrade-Egenskaper" : [ "Mot: Hypertoni, Angina, Hjärtarytmi/Beta-blockerare" ] }, { "@id" : "26", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Atorvastatin", "@language" : "sv" } ], "VocabularyConceptId" : "349188", "VocabularyId" : "73", "Identifier" : "26", "Label" : "Atorvastatin", "Definition" : null, "Notation" : "CH10/26", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Atorvastatin" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(3R,5R)-7-[2-(4-Fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid" ], "CAS-Nr" : [ "134523-00-5" ], "EC-Nr" : [ "saknas" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Fluorfenyler/Fenylkarbamoyler/Pyrroler" ], "Anvandningsomrade-Egenskaper" : [ "Blodfettssänkande mediciner/Statiner" ] }, { "@id" : "27", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Atrakuriumbesylat", "@language" : "sv" } ], "VocabularyConceptId" : "349189", "VocabularyId" : "73", "Identifier" : "27", "Label" : "Atrakuriumbesylat", "Definition" : "ChSp/PubCh/ECHA/WIKI", "Notation" : "CH10/27", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Atracurium besylate; Atracurium besilate" ], "Synonym_1" : [ "Atrakuriumbesilat" ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "2,2'-{1,5-Pentanediylbis[oxy(3-oxo-3,1-propanediyl)]}bis[1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolinium] bisbenzenesulfonate" ], "CAS-Nr" : [ "64228-81-5" ], "EC-Nr" : [ "264-743-4" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Tetrahydroisokinoliner/Kvarternära ammoniumföreningar/Fenoletrar/Propionater" ], "Anvandningsomrade-Egenskaper" : [ "Muskelavslappnande medel/Anestetika" ] }, { "@id" : "28", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Azelastin", "@language" : "sv" } ], "VocabularyConceptId" : "349190", "VocabularyId" : "73", "Identifier" : "28", "Label" : "Azelastin", "Definition" : null, "Notation" : "CH10/28", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Azelastine" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "4-(4-Chlorobenzyl)-2-(1-methyl-4-azepanyl)-1(2H)-phthalazinone" ], "CAS-Nr" : [ "58581-89-8" ], "EC-Nr" : [ "611-699-2" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Ftalazinoner" ], "Anvandningsomrade-Egenskaper" : [ "Antihistaminer/Antiinflammatoriska medel" ] }, { "@id" : "29", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Azitromycin", "@language" : "sv" } ], "VocabularyConceptId" : "349191", "VocabularyId" : "73", "Identifier" : "29", "Label" : "Azitromycin", "Definition" : null, "Notation" : "CH10/29", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Azithromycin" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-2-Ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-15-oxo- 11-{[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy}-1-oxa-6-azacyclopentadec-13-yl 2,6-dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranoside" ], "CAS-Nr" : [ "83905-01-5" ], "EC-Nr" : [ "617-500-5" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Makrolider/Azalider" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika" ] }, { "@id" : "30", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Baklofen", "@language" : "sv" } ], "VocabularyConceptId" : "349192", "VocabularyId" : "73", "Identifier" : "30", "Label" : "Baklofen", "Definition" : null, "Notation" : "CH10/30", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Baclofen" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(RS)-4-Amino-3-(4-chlorophenyl)butanoic acid" ], "CAS-Nr" : [ "1134-47-0" ], "EC-Nr" : [ "214-486-9" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Klorfenyler/Aminer" ], "Anvandningsomrade-Egenskaper" : [ "Antispasmolytika/Muskelavslappnande/Derivat av gamma-amino-smörsyra, GABA " ] }, { "@id" : "31", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Beklometason", "@language" : "sv" } ], "VocabularyConceptId" : "349193", "VocabularyId" : "73", "Identifier" : "31", "Label" : "Beklometason", "Definition" : null, "Notation" : "CH10/31", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Beclomethasone" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(11β,16β)-9-Chloro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione" ], "CAS-Nr" : [ "4419-39-0" ], "EC-Nr" : [ "224-585-9" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Kortikosteroider" ], "Anvandningsomrade-Egenskaper" : [ "Astmamediciner/Antiinflammatorisk lungmedicin" ] }, { "@id" : "32", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Betametason", "@language" : "sv" } ], "VocabularyConceptId" : "349194", "VocabularyId" : "73", "Identifier" : "32", "Label" : "Betametason", "Definition" : null, "Notation" : "CH10/32", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Betamethasone" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(8S,9R,10S,11S,13S,14S,16S,17R)-9-Fluoro- 11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl- 6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro- 3H-cyclopenta[a]phenanthren-3-one" ], "CAS-Nr" : [ "378-44-9" ], "EC-Nr" : [ "206-825-4" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Glukokortikoider" ], "Anvandningsomrade-Egenskaper" : [ "Antiinflammatoriska medel/Immunosuppressiva" ] }, { "@id" : "33", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "beta-Sitosterol", "@language" : "sv" } ], "VocabularyConceptId" : "349195", "VocabularyId" : "73", "Identifier" : "33", "Label" : "beta-Sitosterol", "Definition" : null, "Notation" : "CH10/33", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "beta-Sitosterol" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "17-(5-Ethyl-6-methylheptan-2-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol; (24α-Ethylcholesterol)" ], "CAS-Nr" : [ "83-46-5" ], "EC-Nr" : [ "201-480-6" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Fytosteroler (Växtsteroler)" ], "Anvandningsomrade-Egenskaper" : [ "Potentiellt kolesterolsänkande medel samt hämmande medel vid prostataförstoring (BPH)/Potentiell prekursor till androgener, möjlig \"Anabol steroid\"" ] }, { "@id" : "34", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Betaxolol", "@language" : "sv" } ], "VocabularyConceptId" : "349196", "VocabularyId" : "73", "Identifier" : "34", "Label" : "Betaxolol", "Definition" : null, "Notation" : "CH10/34", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Betaxolol" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(RS)-1-{4-[2-(Cyclopropylmethoxy)ethyl]-phenoxy}-3-(isopropylamino)propan-2-ol" ], "CAS-Nr" : [ "63659-18-7" ], "EC-Nr" : [ "613-310-1" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Aryloxyalkylaminer/Alkoholer" ], "Anvandningsomrade-Egenskaper" : [ "Blodtrycksmediciner/Mot: Glaukom/Beta-blockerare" ] }, { "@id" : "35", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Bezafibrat", "@language" : "sv" } ], "VocabularyConceptId" : "349197", "VocabularyId" : "73", "Identifier" : "35", "Label" : "Bezafibrat", "Definition" : null, "Notation" : "CH10/35", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Bezafibrate" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "2-(4-{2-[(4-Chlorobenzoyl)amino]ethyl}phenoxy)-2-methylpropanoic acid" ], "CAS-Nr" : [ "41859-67-0" ], "EC-Nr" : [ "255-567-9" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Klorfenyler/Karboxylsyror" ], "Anvandningsomrade-Egenskaper" : [ "Blodfettssänkande mediciner/Fibrater: Amfipatiska karboxylsyror" ] }, { "@id" : "36", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Biperiden", "@language" : "sv" } ], "VocabularyConceptId" : "349198", "VocabularyId" : "73", "Identifier" : "36", "Label" : "Biperiden", "Definition" : null, "Notation" : "CH10/36", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Biperiden" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "1RS,2SR,4RS)-1-(Bicyclo[2.2.1]hept-5-en-2-yl)-1-phenyl-3-(piperidin- 1-yl)propan-1-ol" ], "CAS-Nr" : [ "514-65-8" ], "EC-Nr" : [ "208-184-6" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Piperidiner/Fenyler/Bicykloheptener" ], "Anvandningsomrade-Egenskaper" : [ "Anti-Parkinson-läkemedel/Antikolinerg verkan" ] }, { "@id" : "37", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Bisoprolol", "@language" : "sv" } ], "VocabularyConceptId" : "349199", "VocabularyId" : "73", "Identifier" : "37", "Label" : "Bisoprolol", "Definition" : null, "Notation" : "CH10/37", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Bisoprolol" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(RS)-1-{4-[(2-Isopropoxyethoxy)methyl]phenoxy}-3-(isopropylamino)propan-2-ol" ], "CAS-Nr" : [ "66722-44-9" ], "EC-Nr" : [ "613-980-5" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Etrar/Fenoletrar/Alkoholer/Aminer" ], "Anvandningsomrade-Egenskaper" : [ "Mot: Högt blodtryck, Hjärtproblem (Angina, Arytmi, Hjärtsvikt, efter Hjärtattack)/Beta-blockerare" ] }, { "@id" : "38", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Bromazepam", "@language" : "sv" } ], "VocabularyConceptId" : "349200", "VocabularyId" : "73", "Identifier" : "38", "Label" : "Bromazepam", "Definition" : null, "Notation" : "CH10/38", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Bromazepam" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "7-Bromo-5-(2-pyridinyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one" ], "CAS-Nr" : [ "1812-30-2" ], "EC-Nr" : [ "217-322-4" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Bensodiazepiner" ], "Anvandningsomrade-Egenskaper" : [ "Ångestdämpande/Sedativa" ] }, { "@id" : "39", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Bromokriptin", "@language" : "sv" } ], "VocabularyConceptId" : "349201", "VocabularyId" : "73", "Identifier" : "39", "Label" : "Bromokriptin", "Definition" : null, "Notation" : "CH10/39", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Bromocriptine" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(5′α)-2-Bromo-12′-hydroxy-5′-(2-methylpropyl)-3′,6′,18-trioxo-2′-(propan-2-yl)ergotaman" ], "CAS-Nr" : [ "25614-03-3" ], "EC-Nr" : [ "247-128-5" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Ergot-alkaloider/Ergotaminer/Ergo-peptider/Cykloler/Amider" ], "Anvandningsomrade-Egenskaper" : [ "Anti-Parkinson-läkemedel/Mot: Sköldkörteltumörer/Dopamin-agonister" ] }, { "@id" : "40", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Budesonid", "@language" : "sv" } ], "VocabularyConceptId" : "349202", "VocabularyId" : "73", "Identifier" : "40", "Label" : "Budesonid", "Definition" : null, "Notation" : "CH10/40", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Budesonide" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "16,17-(Butylidenebis(oxy))-11,21-dihydroxy-, (11-β,16-α)-pregna-1,4-diene-3,20-dione" ], "CAS-Nr" : [ "51333-22-3" ], "EC-Nr" : [ "257-139-7" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Glukokortikoider" ], "Anvandningsomrade-Egenskaper" : [ "Astmamediciner/Antirhinita medel/Antiinflammatoriska medel - i luftvägar och lungor" ] }, { "@id" : "41", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Buprenorfin", "@language" : "sv" } ], "VocabularyConceptId" : "349203", "VocabularyId" : "73", "Identifier" : "41", "Label" : "Buprenorfin", "Definition" : null, "Notation" : "CH10/41", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Buprenorphine" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(2S)-2-[(5R,6R,7R,14S)-9α-Cyclopropylmethyl-4,5-epoxy-6,14-ethano-3-hydroxy-6-methoxymorphinan-7-yl]-3,3-dimethylbutan-2-ol" ], "CAS-Nr" : [ "52485-79-7" ], "EC-Nr" : [ "257-950-6" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Opioider/Alkaloider" ], "Anvandningsomrade-Egenskaper" : [ "Mot: Effekterna av opioidöverdosering/Analgetika/Narkotikaklassad" ] }, { "@id" : "42", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Bupropion", "@language" : "sv" } ], "VocabularyConceptId" : "349204", "VocabularyId" : "73", "Identifier" : "42", "Label" : "Bupropion", "Definition" : null, "Notation" : "CH10/42", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Bupropion" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(±)-2-(tert-Butylamino)-1-(3-chlorophenyl)propan-1-one" ], "CAS-Nr" : [ "34911-55-2" ], "EC-Nr" : [ "250-759-9" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Klororganiska ämnen/Aminoketoner" ], "Anvandningsomrade-Egenskaper" : [ "Antidepressiva/ADHD-medicin" ] }, { "@id" : "43", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Butalbarbital", "@language" : "sv" } ], "VocabularyConceptId" : "349205", "VocabularyId" : "73", "Identifier" : "43", "Label" : "Butalbarbital", "Definition" : null, "Notation" : "CH10/43", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Butalbarbital; Butalbital" ], "Synonym_1" : [ "Butalbital" ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "5-(2-Methylpropyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione" ], "CAS-Nr" : [ "77-26-9" ], "EC-Nr" : [ "201-017-8" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Barbiturater" ], "Anvandningsomrade-Egenskaper" : [ "Sedativa/Sömnmedel/Analgetika/Mot: Spänningshuvudvärk" ] }, { "@id" : "44", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Cefacetril", "@language" : "sv" } ], "VocabularyConceptId" : "349206", "VocabularyId" : "73", "Identifier" : "44", "Label" : "Cefacetril", "Definition" : null, "Notation" : "CH10/44", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Cefacetrile" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(6R,7R)-3-(Acetyloxymethyl)-7-[(2-cyanoacetyl)amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid" ], "CAS-Nr" : [ "10206-21-0" ], "EC-Nr" : [ "233-508-8" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Heterocykler/Cefalosporiner/Beta-laktamer/Nitriler" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika" ] }, { "@id" : "45", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Cefalexin", "@language" : "sv" } ], "VocabularyConceptId" : "349207", "VocabularyId" : "73", "Identifier" : "45", "Label" : "Cefalexin", "Definition" : null, "Notation" : "CH10/45", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Cefalexin" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(6R,7R)-7-{[(2R)-2-Amino-2-phenylacetyl]amino}- 3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene- 2-carboxylic acid" ], "CAS-Nr" : [ "15686-71-2" ], "EC-Nr" : [ "239-773-6" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Beta-laktamer" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika" ] }, { "@id" : "46", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Cefalonium", "@language" : "sv" } ], "VocabularyConceptId" : "349208", "VocabularyId" : "73", "Identifier" : "46", "Label" : "Cefalonium", "Definition" : null, "Notation" : "CH10/46", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Cefalonium" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(6R,7R)-3-[(4-Carbamoylpyridin-1-ium-1-yl)methyl]-8-oxo-7-[(2-thiophen-2-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate" ], "CAS-Nr" : [ "5575-21-3" ], "EC-Nr" : [ "226-948-7" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Cefalosporiner" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika" ] }, { "@id" : "47", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Cefapirin", "@language" : "sv" } ], "VocabularyConceptId" : "349209", "VocabularyId" : "73", "Identifier" : "47", "Label" : "Cefapirin", "Definition" : null, "Notation" : "CH10/47", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Cephapirin" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(6R,7R)-3-(Acetoxymethyl)-8-oxo-7-{[(4-pyridinylsulfanyl)acetyl]amino}-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid" ], "CAS-Nr" : [ "21593-23-7" ], "EC-Nr" : [ "244-466-5" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Beta-laktamer/Cefalosporiner" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika/Veterinärmedicin" ] }, { "@id" : "48", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Cefazolin", "@language" : "sv" } ], "VocabularyConceptId" : "349210", "VocabularyId" : "73", "Identifier" : "48", "Label" : "Cefazolin", "Definition" : null, "Notation" : "CH10/48", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Cefazolin" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(6R,7R)-3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)thio]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid" ], "CAS-Nr" : [ "25953-19-9" ], "EC-Nr" : [ "247-362-8" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Beta-laktamer/Cefalosporiner" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika" ] }, { "@id" : "49", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Cefoperazon", "@language" : "sv" } ], "VocabularyConceptId" : "349211", "VocabularyId" : "73", "Identifier" : "49", "Label" : "Cefoperazon", "Definition" : null, "Notation" : "CH10/49", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Cefoperazone" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(6R,7R)-7-[(2R)-2-{[(4-Ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}-2-(4-hydroxyphenyl)acetamido]-3-{[(1-methyl-1H-1,2,3,4-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid" ], "CAS-Nr" : [ "62893-19-0" ], "EC-Nr" : [ "263-749-4" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Cefalosporiner" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika" ] }, { "@id" : "50", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Cilazapril", "@language" : "sv" } ], "VocabularyConceptId" : "349212", "VocabularyId" : "73", "Identifier" : "50", "Label" : "Cilazapril", "Definition" : null, "Notation" : "CH10/50", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Cilazapril" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(1S,9S)-9-[(2S)-(1-Ethoxy-1-oxo-4-phenylbutan-2-yl)amino]-10-oxo-octahydro-1H-pyridazino[1,2-a][1,2]diazepine-1-carboxylic acid" ], "CAS-Nr" : [ "88768-40-5" ], "EC-Nr" : [ "saknas" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Karboxylsyror/Laktamer/Etylestrar" ], "Anvandningsomrade-Egenskaper" : [ "Blodtrycksmediciner/Mot: Hjärtsvikt/ACE-hämmare" ] }, { "@id" : "51", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Ciprofloxacin", "@language" : "sv" } ], "VocabularyConceptId" : "349213", "VocabularyId" : "73", "Identifier" : "51", "Label" : "Ciprofloxacin", "Definition" : null, "Notation" : "CH10/51", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Ciprofloxacin" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "1-Cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-quinoline-3-carboxylic acid" ], "CAS-Nr" : [ "85721-33-1" ], "EC-Nr" : [ "617-751-0" ], "WFD" : [ "SFÄ" ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Fluorkinoloner/Piperaziner/Karboxylsyror" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika" ] }, { "@id" : "52", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Citalopram", "@language" : "sv" } ], "VocabularyConceptId" : "349214", "VocabularyId" : "73", "Identifier" : "52", "Label" : "Citalopram", "Definition" : null, "Notation" : "CH10/52", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Citalopram" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(RS)-1-[3-(Dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile" ], "CAS-Nr" : [ "59729-33-8" ], "EC-Nr" : [ "261-891-1" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Fluorerade aromater/Aminer/Bensofuraner/Karbonitriler" ], "Anvandningsomrade-Egenskaper" : [ "Antidepressiva/Mot: PDS, OCD, PMDD, m.fl./SSRI: Selektiva Serotoninåterupptagshämmare" ] }, { "@id" : "53", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Cyklofosfamid", "@language" : "sv" } ], "VocabularyConceptId" : "349215", "VocabularyId" : "73", "Identifier" : "53", "Label" : "Cyklofosfamid", "Definition" : "ChSp/PubCh/ECHA/WIKI", "Notation" : "CH10/53", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Cyclophosphamide; Cyclophosphamide-anhydrous; Ciclophosphamide" ], "Synonym_1" : [ "Cyklofosfamid-anhydrat" ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "N,N-Bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide" ], "CAS-Nr" : [ "50-18-0" ], "EC-Nr" : [ "200-015-4" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Klororganiska ämnen/Oxazafosfinaner/Fosforamid-senapsföreningar/Organofosfater" ], "Anvandningsomrade-Egenskaper" : [ "Cytostatika vid maligna tumörer/Immunosuppressiva/Mot: Reumatism" ] }, { "@id" : "54", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Cyproheptadin", "@language" : "sv" } ], "VocabularyConceptId" : "349216", "VocabularyId" : "73", "Identifier" : "54", "Label" : "Cyproheptadin", "Definition" : null, "Notation" : "CH10/54", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Cyproheptadine" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "4-(5H-Dibenzo(a,d)cyclohepten-5-ylidene)-1-methylpiperidine" ], "CAS-Nr" : [ "129-03-3" ], "EC-Nr" : [ "204-928-9" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Aromater/Piperidiner" ], "Anvandningsomrade-Egenskaper" : [ "Antihistaminer" ] }, { "@id" : "55", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Danofloxacin", "@language" : "sv" } ], "VocabularyConceptId" : "349217", "VocabularyId" : "73", "Identifier" : "55", "Label" : "Danofloxacin", "Definition" : null, "Notation" : "CH10/55", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Danofloxacin" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "1-Cyclopropyl-6-fluoro-7-(5-methyl-2,5-diazabicyclo[2.2.1]hept-2-yl)-4-oxo-quinoline-3-carboxylic acid" ], "CAS-Nr" : [ "112398-08-0" ], "EC-Nr" : [ "saknas" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Fluorkinoloner" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika/Veterinärmedicin" ] }, { "@id" : "56", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Dantrolen", "@language" : "sv" } ], "VocabularyConceptId" : "349218", "VocabularyId" : "73", "Identifier" : "56", "Label" : "Dantrolen", "Definition" : null, "Notation" : "CH10/56", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Dantrolene" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "1-{[5-(4-Nitrophenyl)-2-furyl]methylideneamino}imidazolidine-2,4-dione" ], "CAS-Nr" : [ "7261-97-4" ], "EC-Nr" : [ "230-684-8" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Hydantoiner/Furaner/Nitrobensener" ], "Anvandningsomrade-Egenskaper" : [ "Muskelavslappnande medel" ] }, { "@id" : "57", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Dapson", "@language" : "sv" } ], "VocabularyConceptId" : "349219", "VocabularyId" : "73", "Identifier" : "57", "Label" : "Dapson", "Definition" : null, "Notation" : "CH10/57", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Dapsone" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "4,4'-Sulfonyldianiline" ], "CAS-Nr" : [ "80-08-0" ], "EC-Nr" : [ "201-248-4" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Aniliner/Sulfoner" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika/Mot: Lepra, Lunginflammation, Toxoplasmos, Akne, m.fl." ] }, { "@id" : "58", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Daunorubicin", "@language" : "sv" } ], "VocabularyConceptId" : "349220", "VocabularyId" : "73", "Identifier" : "58", "Label" : "Daunorubicin", "Definition" : null, "Notation" : "CH10/58", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Daunorubicin" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(8S,10S)-8-Acetyl-10-[(2S,4S,5S,6S)- 4-amino-5-hydroxy-6-methyl-oxan-2-yl]oxy-6,8,11-trihydroxy-1-methoxy- 9,10-dihydro-7H-tetracene-5,12-dione" ], "CAS-Nr" : [ "20830-81-3" ], "EC-Nr" : [ "244-069-7" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Aminoglykosider/Antracykliner" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika/Cancer-terapeutika (leukemier)" ] }, { "@id" : "59", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Demeklocyklin", "@language" : "sv" } ], "VocabularyConceptId" : "349221", "VocabularyId" : "73", "Identifier" : "59", "Label" : "Demeklocyklin", "Definition" : null, "Notation" : "CH10/59", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Demeclocycline" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(2E,4S,4aS,5aS,6S,12aS)-2-[Amino(hydroxy)methylidene]-7-chloro-4-(dimethylamino)-6,10,11,12a-tetrahydroxy-1,2,3,4,4a,5,5a,6,12,12a-decahydrotetracene-1,3,12-trione" ], "CAS-Nr" : [ "127-33-3" ], "EC-Nr" : [ "204-834-8" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Tetracykliner" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika" ] }, { "@id" : "60", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Desloratadin", "@language" : "sv" } ], "VocabularyConceptId" : "349222", "VocabularyId" : "73", "Identifier" : "60", "Label" : "Desloratadin", "Definition" : null, "Notation" : "CH10/60", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Desloratadine; Aerius" ], "Synonym_1" : [ "Aerius" ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "8-Chloro-6,11-dihydro-11-(4-piperdinylidene)- 5H-benzo[5,6]cyclohepta[1,2-b]pyridine" ], "CAS-Nr" : [ "100643-71-8" ], "EC-Nr" : [ "saknas" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Organiska kolföreningar" ], "Anvandningsomrade-Egenskaper" : [ "Antihistaminer/Antiallergika" ] }, { "@id" : "61", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Desmetyldiazepam", "@language" : "sv" } ], "VocabularyConceptId" : "349223", "VocabularyId" : "73", "Identifier" : "61", "Label" : "Desmetyldiazepam", "Definition" : null, "Notation" : "CH10/61", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Desmethyldiazepam; Nordiazepam" ], "Synonym_1" : [ "Nordiazepam" ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ " 7-Chloro-1,3-dihydro-5-phenyl-2H-1,4-Benzodiazepin-2-one" ], "CAS-Nr" : [ "1088-11-5" ], "EC-Nr" : [ "214-123-4" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Bensodiazepiner" ], "Anvandningsomrade-Egenskaper" : [ "Ångestdämpande/Sedativa/En intermediär i metabolismen av DIAZEPAM till OXAZEPAM" ] }, { "@id" : "62", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Dexametason", "@language" : "sv" } ], "VocabularyConceptId" : "349224", "VocabularyId" : "73", "Identifier" : "62", "Label" : "Dexametason", "Definition" : null, "Notation" : "CH10/62", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Dexamethasone" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(8S,9R,10S,11S,13S,14S,16R,17R)-9- Fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,9,10,11,12,13,14,15,16,17- dodecahydro-3H-cyclopenta[a]phenanthren-3-one" ], "CAS-Nr" : [ "50-02-2" ], "EC-Nr" : [ "200-003-9" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Glukokortikoider" ], "Anvandningsomrade-Egenskaper" : [ "Antiinflammatoriska medel/Immunosuppressiva/Mot: Reumatism, Allergier, Astma, KOL, TBC" ] }, { "@id" : "63", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Dextropropoxifen", "@language" : "sv" } ], "VocabularyConceptId" : "349225", "VocabularyId" : "73", "Identifier" : "63", "Label" : "Dextropropoxifen", "Definition" : "2026-04-01 Ändrat stavning från propoxy till propoxi - ChSp/PubCh/ECHA/WIKI", "Notation" : "CH10/63", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Dextropropoxyphene" ], "Synonym_1" : [ "Dextropropoxyfen" ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(1S,2R)-1-Benzyl-3-(dimethylamino)-2-methyl-1-phenylpropyl propionate" ], "CAS-Nr" : [ "469-62-5" ], "EC-Nr" : [ "207-420-5" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Opioider/Alkaloider" ], "Anvandningsomrade-Egenskaper" : [ "Analgetika/Anestetika" ] }, { "@id" : "64", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Diatrizoinsyra", "@language" : "sv" } ], "VocabularyConceptId" : "349226", "VocabularyId" : "73", "Identifier" : "64", "Label" : "Diatrizoinsyra", "Definition" : "Dubblett med CH10/370", "Notation" : "CH10/64", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Diatrizoic acid; Amidotrizoic acid; Diatrizoate" ], "Synonym_1" : [ "Amidotrizoinsyra" ], "Synonym_2" : [ "Diatrizoat" ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "3,5-Diacetamido-2,4,6-triiodobenzoic acid" ], "CAS-Nr" : [ "117-96-4" ], "EC-Nr" : [ "204-223-6" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Joderade bensoesyror/Acetamider" ], "Anvandningsomrade-Egenskaper" : [ "Röntgen-kontrastmedia/Ett vanligt röntgenkontrastmedium. I form av Na- el. meglumin-diatrizoat används det vid gastrointestinala studier, angiografi och urografi." ] }, { "@id" : "65", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Diazepam", "@language" : "sv" } ], "VocabularyConceptId" : "349227", "VocabularyId" : "73", "Identifier" : "65", "Label" : "Diazepam", "Definition" : null, "Notation" : "CH10/65", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Diazepam; Valium; Stesolid" ], "Synonym_1" : [ "Valium" ], "Synonym_2" : [ "Stesolid" ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "5-Phenyl-1,3-dihydro-7-chloro-1-methyl-1,4-benzodiazepin-2(2H)-one" ], "CAS-Nr" : [ "439-14-5" ], "EC-Nr" : [ "207-122-5" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Bensodiazepiner" ], "Anvandningsomrade-Egenskaper" : [ "Ångestdämpande/Sedativa" ] }, { "@id" : "66", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Dicykloverin", "@language" : "sv" } ], "VocabularyConceptId" : "349228", "VocabularyId" : "73", "Identifier" : "66", "Label" : "Dicykloverin", "Definition" : null, "Notation" : "CH10/66", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Dicycloverine; Dicyclomine" ], "Synonym_1" : [ "Dicyklomin" ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "2-(Diethylamino)ethyl 1-cyclohexylcyclohexane-1-carboxylate" ], "CAS-Nr" : [ "77-19-0" ], "EC-Nr" : [ "201-009-4" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Aminer/Karboxylestrar" ], "Anvandningsomrade-Egenskaper" : [ "Antispasmolytika/Mot: Spädbarnskolik, IBS/Muskarin-antagonister" ] }, { "@id" : "67", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Dietylstilbestrol", "@language" : "sv" } ], "VocabularyConceptId" : "349229", "VocabularyId" : "73", "Identifier" : "67", "Label" : "Dietylstilbestrol", "Definition" : null, "Notation" : "CH10/67", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Diethylstilbestrol" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "4,4'-(3E)-Hex-3-ene-3,4-diyldiphenol; (E)-11,12-Diethyl-4,13-stilbenediol" ], "CAS-Nr" : [ "56-53-1" ], "EC-Nr" : [ "200-278-5" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Stilbendioler" ], "Anvandningsomrade-Egenskaper" : [ "Xeno-östrogen/Hormonstörande ämnen/F.d. läkemedel, nu förbjudet" ] }, { "@id" : "68", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Difenhydramin", "@language" : "sv" } ], "VocabularyConceptId" : "349230", "VocabularyId" : "73", "Identifier" : "68", "Label" : "Difenhydramin", "Definition" : null, "Notation" : "CH10/68", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Diphenhydramine" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "2-(Diphenylmethoxy)-N,N-dimethylethanamine" ], "CAS-Nr" : [ "58-73-1" ], "EC-Nr" : [ "200-396-7" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Difenyler/Etrar/Aminer/Etanolaminderivat" ], "Anvandningsomrade-Egenskaper" : [ "Antihistaminer/Mot: Allergi, Hosta/Sedativa/Anti-Parkinson-läkemedel/Antiemetika" ] }, { "@id" : "69", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Difloxacin", "@language" : "sv" } ], "VocabularyConceptId" : "349231", "VocabularyId" : "73", "Identifier" : "69", "Label" : "Difloxacin", "Definition" : null, "Notation" : "CH10/69", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Difloxacin" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "6-Fluoro-1-(4-fluorophenyl)-7-(4-methylpiperazin-1-yl)- 4-oxoquinoline-3-carboxylic acid" ], "CAS-Nr" : [ "98106-17-3" ], "EC-Nr" : [ "saknas" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Fluorerade aromater/Fluorkinoloner/Piperaziner" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika/Veterinärmedicin" ] }, { "@id" : "70", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Dihydroergotamin", "@language" : "sv" } ], "VocabularyConceptId" : "349232", "VocabularyId" : "73", "Identifier" : "70", "Label" : "Dihydroergotamin", "Definition" : null, "Notation" : "CH10/70", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Dihydroergotamine" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(2R,4R,7R)-N-[(1S,2S,4R,7S)-7-Benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.02,7.012,16]hexadeca-1(16),9,12,14-tetraene-4-carboxamide" ], "CAS-Nr" : [ "511-12-6" ], "EC-Nr" : [ "208-123-3" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Ergot-alkaloider/Ergotaminer" ], "Anvandningsomrade-Egenskaper" : [ "Migränmedicin/Dopamin+Serotonin+Adrenerg-antagonister/partiella agonister" ] }, { "@id" : "71", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Dihydrokodein", "@language" : "sv" } ], "VocabularyConceptId" : "349233", "VocabularyId" : "73", "Identifier" : "71", "Label" : "Dihydrokodein", "Definition" : null, "Notation" : "CH10/71", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Dihydrocodeine" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "4,5-alpha-Epoxy-3-methoxy-17-methylmorphinan-6-ol" ], "CAS-Nr" : [ "125-28-0" ], "EC-Nr" : [ "204-732-3" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Opioider/Alkaloider" ], "Anvandningsomrade-Egenskaper" : [ "Analgetika/Narkotikaklassad" ] }, { "@id" : "72", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Dihydrostreptomycinsulfat", "@language" : "sv" } ], "VocabularyConceptId" : "349234", "VocabularyId" : "73", "Identifier" : "72", "Label" : "Dihydrostreptomycinsulfat", "Definition" : null, "Notation" : "CH10/72", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Dihydrostreptomycin sulfate" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "2-[(1R,2R,3S,4R,5R,6S)-3-(Diaminomethylideneamino)-4-[(2R,3R,4R,5S)-3-[(2S,3S,4S,5R,6S)-4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy-4-hydroxy-4-(hydroxymethyl)-5-methyloxolan-2-yl]oxy-2,5,6-trihydroxycyclohexyl]guanidine;sulfuric acid" ], "CAS-Nr" : [ "5490-27-7" ], "EC-Nr" : [ "226-823-7" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Aminoglykosider" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika" ] }, { "@id" : "73", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Diklofenak", "@language" : "sv" } ], "VocabularyConceptId" : "349235", "VocabularyId" : "73", "Identifier" : "73", "Label" : "Diklofenak", "Definition" : null, "Notation" : "CH10/73", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Diclofenac" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "2-[2-(2,6-Dichlorophenyl)aminophenyl]acetic acid" ], "CAS-Nr" : [ "15307-86-5" ], "EC-Nr" : [ "239-348-5" ], "WFD" : [ "SFÄ" ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Klorerade aromater/Aniliner/Karboxylsyror" ], "Anvandningsomrade-Egenskaper" : [ "Antiinflammatoriska medel/Analgetika/Antipyretika/NSAID (Non-steroidal anti-inflammatory drugs)" ] }, { "@id" : "74", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Dikloxacillin", "@language" : "sv" } ], "VocabularyConceptId" : "349236", "VocabularyId" : "73", "Identifier" : "74", "Label" : "Dikloxacillin", "Definition" : null, "Notation" : "CH10/74", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Dicloxacillin" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(2S,5R,6R)-6-({[3-(2,6-Dichlorophenyl)-5-methyl-1,2-oxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid" ], "CAS-Nr" : [ "3116-76-5" ], "EC-Nr" : [ "221-488-3" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Beta-laktamer" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika" ] }, { "@id" : "75", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Diltiazem", "@language" : "sv" } ], "VocabularyConceptId" : "349237", "VocabularyId" : "73", "Identifier" : "75", "Label" : "Diltiazem", "Definition" : null, "Notation" : "CH10/75", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Diltiazem" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "cis-(+)-[2-(2-Dimethylaminoethyl)-5-(4-methoxyphenyl)-3-oxo-6-thia-2-azabicyclo[5.4.0]undeca-7,9,11-trien-4-yl]ethanoate" ], "CAS-Nr" : [ "42399-41-7" ], "EC-Nr" : [ "255-796-4" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Bensodiazepiner" ], "Anvandningsomrade-Egenskaper" : [ "Mot: Hjärtproblem (Angina, arytmi), Högt blodtryck, Migrän/Kalcium-antagonister" ] }, { "@id" : "76", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Dipyridamol", "@language" : "sv" } ], "VocabularyConceptId" : "349238", "VocabularyId" : "73", "Identifier" : "76", "Label" : "Dipyridamol", "Definition" : null, "Notation" : "CH10/76", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Dipyridamole" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "2,2',2'',2'''-{[4,8-Di(1-piperidinyl)pyrimido[5,4-d]pyrimidine-2,6-diyl]dinitrilo}tetraethanol" ], "CAS-Nr" : [ "58-32-2" ], "EC-Nr" : [ "200-374-7" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Pyrimidiner/Piperidiner" ], "Anvandningsomrade-Egenskaper" : [ "Blodproppshämmare/Vasodilativa" ] }, { "@id" : "77", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Domperidon", "@language" : "sv" } ], "VocabularyConceptId" : "349239", "VocabularyId" : "73", "Identifier" : "77", "Label" : "Domperidon", "Definition" : null, "Notation" : "CH10/77", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Domperidone" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "5-Chloro-1-(1-[3-(2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)propyl]piperidin-4-yl)-1H-benzo[d]imidazol-2(3H)-one" ], "CAS-Nr" : [ "57808-66-9" ], "EC-Nr" : [ "260-968-7" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Bensimidazoler/Piperidiner" ], "Anvandningsomrade-Egenskaper" : [ "Antiemetika/Ökar: Tarm-peristaltik + Amning/Dopamin-antagonister" ] }, { "@id" : "78", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Donepezil", "@language" : "sv" } ], "VocabularyConceptId" : "349240", "VocabularyId" : "73", "Identifier" : "78", "Label" : "Donepezil", "Definition" : null, "Notation" : "CH10/78", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Donepezil" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(RS)-2-[(1-Benzyl-4-piperidyl)methyl]- 5,6-dimethoxy-2,3-dihydroinden-1-one" ], "CAS-Nr" : [ "120014-06-4" ], "EC-Nr" : [ "601-651-9" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Aromater/Indenoner/Piperidiner" ], "Anvandningsomrade-Egenskaper" : [ "Lindrar olika demenssjukdomar, bland annat Alzheimers sjukdom" ] }, { "@id" : "79", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Doramektin", "@language" : "sv" } ], "VocabularyConceptId" : "349241", "VocabularyId" : "73", "Identifier" : "79", "Label" : "Doramektin", "Definition" : null, "Notation" : "CH10/79", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Doramectin" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(1'R,2S,4'S,5S,6R,8'R,10'E,12'R,13'S,14'E,20'R,21'R,24'S)-6-Cyclohexyl-21',24'-dihydroxy-12'-{[(2R,4S,5S,6S)-5-{[(2S,4S,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-4-methoxy-6-methyloxan-2-yl]oxy}-5,11',13',22'-tetramethyl-5,6-dihydro-3',7',19'-trioxaspiro[pyran-2,6'-tetracyclo[15.6.1.14,8.020,24]pentacosane]-10',14',16',22'-tetraen-2'-one" ], "CAS-Nr" : [ "117704-25-3" ], "EC-Nr" : [ "601-490-4" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Makrocykliska laktoner/Glykosider" ], "Anvandningsomrade-Egenskaper" : [ "Antiparasitika/Veterinärmedicin" ] }, { "@id" : "80", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Doxepin", "@language" : "sv" } ], "VocabularyConceptId" : "349242", "VocabularyId" : "73", "Identifier" : "80", "Label" : "Doxepin", "Definition" : null, "Notation" : "CH10/80", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Doxepin" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(E/Z)-3-(Dibenzo[b,e]oxepin-11(6H)-ylidene)-N,N-dimethylpropan-1-amine" ], "CAS-Nr" : [ "1668-19-5" ], "EC-Nr" : [ "saknas" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Dibensoxepiner/Tricykliska föreningar" ], "Anvandningsomrade-Egenskaper" : [ "Antidepressiva/TCA: Tri-Cykliska Antidepressiva" ] }, { "@id" : "81", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Doxicyklin-monohydrat", "@language" : "sv" } ], "VocabularyConceptId" : "349243", "VocabularyId" : "73", "Identifier" : "81", "Label" : "Doxicyklin-monohydrat", "Definition" : null, "Notation" : "CH10/81", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Doxycycline-monohydrate" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(4S,4aR,5S,5aR,6R,12aS)-4-(Dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-2-tetracenecarboxamide hydrate (1:1)" ], "CAS-Nr" : [ "17086-28-1" ], "EC-Nr" : [ "605-591-4" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Tetracykliner" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika" ] }, { "@id" : "82", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Doxorubicin", "@language" : "sv" } ], "VocabularyConceptId" : "349244", "VocabularyId" : "73", "Identifier" : "82", "Label" : "Doxorubicin", "Definition" : null, "Notation" : "CH10/82", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Doxorubicin" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(7S,9S)-7-[(2R,4S,5S,6S)-4-Amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione" ], "CAS-Nr" : [ "23214-92-8" ], "EC-Nr" : [ "245-495-6" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Antracykliner" ], "Anvandningsomrade-Egenskaper" : [ "Antitumör-antibiotika/Kemoterapeutika" ] }, { "@id" : "83", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Doxycyklin", "@language" : "sv" } ], "VocabularyConceptId" : "349245", "VocabularyId" : "73", "Identifier" : "83", "Label" : "Doxycyklin", "Definition" : null, "Notation" : "CH10/83", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Doxycycline; Doxycycline-anhydrous; Vibramycin" ], "Synonym_1" : [ "Doxycyklin-anhydrid" ], "Synonym_2" : [ "Vibramycin" ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(4S,4aR,5S,5aR,6R,12aS)-4-(Dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-2-tetracenecarboxamide" ], "CAS-Nr" : [ "564-25-0" ], "EC-Nr" : [ "209-271-1" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Tetracykliner" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika" ] }, { "@id" : "84", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Duloxetin", "@language" : "sv" } ], "VocabularyConceptId" : "349246", "VocabularyId" : "73", "Identifier" : "84", "Label" : "Duloxetin", "Definition" : null, "Notation" : "CH10/84", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Duloxetine" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(+)-(S)-N-Methyl-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propan-1-amine" ], "CAS-Nr" : [ "116539-59-4" ], "EC-Nr" : [ "601-438-0" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Naftalener/Tiofener/Aminer" ], "Anvandningsomrade-Egenskaper" : [ "Antidepressiva/SSRI: Selektiva Serotoninåterupptagshämmare" ] }, { "@id" : "85", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Enoxacin", "@language" : "sv" } ], "VocabularyConceptId" : "349247", "VocabularyId" : "73", "Identifier" : "85", "Label" : "Enoxacin", "Definition" : null, "Notation" : "CH10/85", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Enoxacin" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "1-Ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-[1,8]naphthyridine-3-carboxylic acid" ], "CAS-Nr" : [ "74011-58-8" ], "EC-Nr" : [ "saknas" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Fluorkinoloner/Piperaziner/Naftyridiner" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika" ] }, { "@id" : "86", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Enrofloxacin", "@language" : "sv" } ], "VocabularyConceptId" : "349248", "VocabularyId" : "73", "Identifier" : "86", "Label" : "Enrofloxacin", "Definition" : null, "Notation" : "CH10/86", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Enrofloxacin" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "1-Cyclopropyl-7-(4-ethylpiperazin-1-yl)-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid" ], "CAS-Nr" : [ "93106-60-6" ], "EC-Nr" : [ "618-911-2" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Fluorkinoloner/Piperaziner/Cyklopropaner" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika" ] }, { "@id" : "87", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Epirubicin", "@language" : "sv" } ], "VocabularyConceptId" : "349249", "VocabularyId" : "73", "Identifier" : "87", "Label" : "Epirubicin", "Definition" : null, "Notation" : "CH10/87", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Epirubicin" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(8R,10S)-10-((2S,4S,5R,6S)-4-Amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione" ], "CAS-Nr" : [ "56420-45-2" ], "EC-Nr" : [ "Epirubicin HCl: 260-145-2" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Antracykliner" ], "Anvandningsomrade-Egenskaper" : [ "Kemoterapeutisk antibiotika" ] }, { "@id" : "88", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Eprinomektin", "@language" : "sv" } ], "VocabularyConceptId" : "349250", "VocabularyId" : "73", "Identifier" : "88", "Label" : "Eprinomektin", "Definition" : null, "Notation" : "CH10/88", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Eprinomectin" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "Mixture of: (10E,14E,16E)-(1R,4S,5′S,6S,6′R,8R,12S,13S,20R,21R,24S)-6′-[(S)-sec-Butyl]-21,24-dihydroxy-5′,11,13,22-tetramethyl-2-oxo-(3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene)-6-spiro-2′-(5′,6′-dihydro-2′H-pyran)-12-yl 4-O-(4-acetamido-2,4,6-trideoxy-3-O-methyl-α-L-lyxo-hexopyranosyl)-2,6-dideoxy-3-O-methyl-α-L-arabino-hexopyranoside (major component) and (10E,14E,16E)-(1R,4S,5′S,6S,6′R,8R,12S,13S,20R,21R,24S)-21,24-Dihydroxy-6′-isopropyl-5′,11,13,22-tetramethyl-2-oxo-(3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene)-6-spiro-2′-(5′,6′-dihydro-2′H-pyran)-12-yl 4-O-(4-acetamido-2,4,6-trideoxy-3-O-methyl-α-L-lyxo-hexopyranosyl)-2,6-dideoxy-3-O-methyl-α-L-arabino-hexopyranoside (minor component)" ], "CAS-Nr" : [ "123997-26-2 (eprinomectin B1a is 133305-88-1, eprinomectin B1b is 133305-89-2)" ], "EC-Nr" : [ "saknas" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Makrocykliska laktoner/Avermektiner" ], "Anvandningsomrade-Egenskaper" : [ "Ekto-/Endo-parasiticider/Veterinärmedicin/Insekticider/Akaricider" ] }, { "@id" : "89", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Eprosartan", "@language" : "sv" } ], "VocabularyConceptId" : "349251", "VocabularyId" : "73", "Identifier" : "89", "Label" : "Eprosartan", "Definition" : null, "Notation" : "CH10/89", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Eprosartan" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "4-({2-Butyl-5-[2-carboxy-2-(thiophen-2-ylmethyl)eth-1-en-1-yl]-1H-imidazol-1-yl}methyl)benzoic acid" ], "CAS-Nr" : [ "133040-01-4" ], "EC-Nr" : [ "saknas" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Imidazoler/Tiofener/Bensoesyror" ], "Anvandningsomrade-Egenskaper" : [ "Blodtrycksmediciner/Angiotensin-II-receptor-antagonister" ] }, { "@id" : "90", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Erytromycin", "@language" : "sv" } ], "VocabularyConceptId" : "349252", "VocabularyId" : "73", "Identifier" : "90", "Label" : "Erytromycin", "Definition" : null, "Notation" : "CH10/90", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Erythromycin" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy}-3,5,7,9,11,13-hexamethyl-1-oxacyclotetradecane-2,10-dione" ], "CAS-Nr" : [ "114-07-8" ], "EC-Nr" : [ "204-040-1" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Makrolider/Alkoholer/Aminer/Etrar/Ketoner" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika" ] }, { "@id" : "91", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Escitalopram", "@language" : "sv" } ], "VocabularyConceptId" : "349253", "VocabularyId" : "73", "Identifier" : "91", "Label" : "Escitalopram", "Definition" : null, "Notation" : "CH10/91", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Escitalopram" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(S)-1-[3-(Dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile" ], "CAS-Nr" : [ "128196-01-0" ], "EC-Nr" : [ "saknas" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Karbonitriler/Furaner" ], "Anvandningsomrade-Egenskaper" : [ "Antidepressiva/SSRI: Selektiva Serotoninåterupptagshämmare" ] }, { "@id" : "92", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Esomeprazol", "@language" : "sv" } ], "VocabularyConceptId" : "349254", "VocabularyId" : "73", "Identifier" : "92", "Label" : "Esomeprazol", "Definition" : null, "Notation" : "CH10/92", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Esomeprazole" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(S)-5-Methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]-3H-benzoimidazole" ], "CAS-Nr" : [ "119141-88-7" ], "EC-Nr" : [ "201-212-8" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Bensimidazoler/Sulfinyler/Pyridiner" ], "Anvandningsomrade-Egenskaper" : [ "Protonpumpshämmare/Magsårsmediciner" ] }, { "@id" : "93", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Etinylöstradiol", "@language" : "sv" } ], "VocabularyConceptId" : "349255", "VocabularyId" : "73", "Identifier" : "93", "Label" : "Etinylöstradiol", "Definition" : null, "Notation" : "CH10/93", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Ethinyl estradiol; 17-alfa-Ethinyl estradiol; 17α-Ethinyl estradiol" ], "Synonym_1" : [ "17-alfa-Etinylöstradiol" ], "Synonym_2" : [ "17α-Etinylöstradiol" ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(8S,9S,13S,14S,17S)-17-Ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol" ], "CAS-Nr" : [ "57-63-6" ], "EC-Nr" : [ "200-342-2" ], "WFD" : [ "SFÄ" ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Hydroxisteroider/Semisyntetiska östrogener" ], "Anvandningsomrade-Egenskaper" : [ "Hormonella preventivmedel/Mot: Klimakteriebesvär, Hypogonadism, Bröstcancer, m.fl." ] }, { "@id" : "94", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Etofibrat", "@language" : "sv" } ], "VocabularyConceptId" : "349256", "VocabularyId" : "73", "Identifier" : "94", "Label" : "Etofibrat", "Definition" : null, "Notation" : "CH10/94", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Etofibrate" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "2-{[2-(4-Chlorophenoxy)-2-methylpropanoyl]oxy}ethyl nicotinate; 2-{[2-(4-chlorophenoxy)-2-methylpropanoyl]oxy}ethyl pyridine-3-carboxylate" ], "CAS-Nr" : [ "31637-97-5" ], "EC-Nr" : [ "250-743-1" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Klofibrater/Niaciner" ], "Anvandningsomrade-Egenskaper" : [ "Blodfettssänkande mediciner" ] }, { "@id" : "95", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Etonogestrel", "@language" : "sv" } ], "VocabularyConceptId" : "349257", "VocabularyId" : "73", "Identifier" : "95", "Label" : "Etonogestrel", "Definition" : null, "Notation" : "CH10/95", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Etonogestrel" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(8S,9R,10S,13S,14S,17R)-13-Ethyl-17-ethynyl-17-hydroxy-11-methylidene-2,6,7,8,9,10,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one" ], "CAS-Nr" : [ "54048-10-1" ], "EC-Nr" : [ "258-936-2" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Syntetiska steroidhormoner/Syntetiska progestagener" ], "Anvandningsomrade-Egenskaper" : [ "Hormonella preventivmedel/Desogestrel-metabolit (aktiv)" ] }, { "@id" : "96", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Etosuximid", "@language" : "sv" } ], "VocabularyConceptId" : "349258", "VocabularyId" : "73", "Identifier" : "96", "Label" : "Etosuximid", "Definition" : null, "Notation" : "CH10/96", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Ethosuximide" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(RS)-3-Ethyl-3-methyl-pyrrolidine-2,5-dione" ], "CAS-Nr" : [ "77-67-8" ], "EC-Nr" : [ "201-048-7" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Pyrrolidindioner/Succinimider" ], "Anvandningsomrade-Egenskaper" : [ "Antiepileptika/Kramplösande" ] }, { "@id" : "97", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Ezetimib", "@language" : "sv" } ], "VocabularyConceptId" : "349259", "VocabularyId" : "73", "Identifier" : "97", "Label" : "Ezetimib", "Definition" : null, "Notation" : "CH10/97", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Ezetimibe" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(3R,4S)-1-(4-Fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)azetidin-2-one" ], "CAS-Nr" : [ "163222-33-1" ], "EC-Nr" : [ "saknas" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Fluorfenyler/Azetidinoner" ], "Anvandningsomrade-Egenskaper" : [ "Kolesterolsänkande" ] }, { "@id" : "98", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Famotidin", "@language" : "sv" } ], "VocabularyConceptId" : "349260", "VocabularyId" : "73", "Identifier" : "98", "Label" : "Famotidin", "Definition" : null, "Notation" : "CH10/98", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Famotidine" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "3-[({2-[(Diaminomethylidene)amino]-1,3-thiazol-4-yl}methyl)sulfanyl]-N'-sulfamoylpropanimidamide" ], "CAS-Nr" : [ "76824-35-6" ], "EC-Nr" : [ "616-396-9" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Sulfonamider/Guanidiner/Tiazoler/Tioetrar/Amidiner" ], "Anvandningsomrade-Egenskaper" : [ "Mot: Dyspepsi, Halsbränna, Refluxsjukdom, Magsår/Histamin-2-receptor-antagonister" ] }, { "@id" : "99", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Febantel", "@language" : "sv" } ], "VocabularyConceptId" : "349261", "VocabularyId" : "73", "Identifier" : "99", "Label" : "Febantel", "Definition" : null, "Notation" : "CH10/99", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Febantel" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "Dimethyl [({2-[(methoxyacetyl)amino]-4-(phenylsulfanyl)phenyl}amino)methylylidene]biscarbamate" ], "CAS-Nr" : [ "58306-30-2" ], "EC-Nr" : [ "261-205-0" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Bensimidazoler" ], "Anvandningsomrade-Egenskaper" : [ "Antiparasitika/Helminticider, \"maskmedel\"/Veterinärmedicin" ] }, { "@id" : "100", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Felodipin", "@language" : "sv" } ], "VocabularyConceptId" : "349262", "VocabularyId" : "73", "Identifier" : "100", "Label" : "Felodipin", "Definition" : null, "Notation" : "CH10/100", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Felodipine; Plendil" ], "Synonym_1" : [ "Plendil" ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(RS)-3-Ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate" ], "CAS-Nr" : [ "72509-76-3" ], "EC-Nr" : [ "saknas" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Klorerade aromater/Hydropyridiner/Dikarboxylater" ], "Anvandningsomrade-Egenskaper" : [ "Vasodilativa/Blodtrycksmedicin/Kalcium-antagonister" ] }, { "@id" : "101", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Fenazon", "@language" : "sv" } ], "VocabularyConceptId" : "349263", "VocabularyId" : "73", "Identifier" : "101", "Label" : "Fenazon", "Definition" : null, "Notation" : "CH10/101", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Phenazone" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "1,2-Dihydro-1,5-dimethyl-2-phenyl-3H-pyrazol-3-one" ], "CAS-Nr" : [ "60-80-0" ], "EC-Nr" : [ "200-486-6" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Fenylpyrazoloner" ], "Anvandningsomrade-Egenskaper" : [ "Analgetika/Antipyretika/NSAID (Non-steroidal anti-inflammatory drugs)" ] }, { "@id" : "102", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Fenbendazol", "@language" : "sv" } ], "VocabularyConceptId" : "349264", "VocabularyId" : "73", "Identifier" : "102", "Label" : "Fenbendazol", "Definition" : null, "Notation" : "CH10/102", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Fenbendazole" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "Methyl- N-(6-phenylsulfanyl-1H-benzoimidazol-2-yl)carbamate" ], "CAS-Nr" : [ "43210-67-9" ], "EC-Nr" : [ "256-145-7" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Bensimidazoler/Karbamater" ], "Anvandningsomrade-Egenskaper" : [ "Antiparasitika/Helminticider, \"maskmedel\"/Veterinärmedicin" ] }, { "@id" : "103", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Fenfluramin", "@language" : "sv" } ], "VocabularyConceptId" : "349265", "VocabularyId" : "73", "Identifier" : "103", "Label" : "Fenfluramin", "Definition" : null, "Notation" : "CH10/103", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Fenfluramine; 3-Trifluoromethyl-N-ethylamphetamine" ], "Synonym_1" : [ "3-Trifluorometyl-N-etylamfetamin" ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(RS)-N-Ethyl- 1-[3-(trifluoromethyl)phenyl]propan- 2-amine" ], "CAS-Nr" : [ "458-24-2" ], "EC-Nr" : [ "207-276-3" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Substituerade amfetaminer" ], "Anvandningsomrade-Egenskaper" : [ "Serotonin-höjande medicin/Viktreduceringspreparat" ] }, { "@id" : "104", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Fenobarbital", "@language" : "sv" } ], "VocabularyConceptId" : "349266", "VocabularyId" : "73", "Identifier" : "104", "Label" : "Fenobarbital", "Definition" : null, "Notation" : "CH10/104", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Phenobarbital" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "5-Ethyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione" ], "CAS-Nr" : [ "50-06-6" ], "EC-Nr" : [ "200-007-0" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Barbiturater" ], "Anvandningsomrade-Egenskaper" : [ "Antiepileptika/Sedativa/Mot: Alkoholabstinens/Narkotikaklassad" ] }, { "@id" : "105", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Fenofibrat", "@language" : "sv" } ], "VocabularyConceptId" : "349267", "VocabularyId" : "73", "Identifier" : "105", "Label" : "Fenofibrat", "Definition" : null, "Notation" : "CH10/105", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Fenofibrate" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "1-Methylethyl-2-{4-[(4-chlorphenyl)carbonyl]phenoxy}-2-methylpropanoat" ], "CAS-Nr" : [ "49562-28-9" ], "EC-Nr" : [ "256-376-3" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Klorfenyler/Ketoner/Acetater" ], "Anvandningsomrade-Egenskaper" : [ "Blodfettssänkande mediciner/Fibrater: Amfipatiska karboxylsyror" ] }, { "@id" : "106", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Fenofibrinsyra", "@language" : "sv" } ], "VocabularyConceptId" : "349268", "VocabularyId" : "73", "Identifier" : "106", "Label" : "Fenofibrinsyra", "Definition" : null, "Notation" : "CH10/106", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Fenofibric acid; Clofop" ], "Synonym_1" : [ "Clofop" ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "2-[4-(4-Chlorophenoxy)phenoxy]propanoic acid" ], "CAS-Nr" : [ "26129-32-8" ], "EC-Nr" : [ "saknas" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Fenoxisyror" ], "Anvandningsomrade-Egenskaper" : [ "Blodfettssänkande mediciner/Herbicider" ] }, { "@id" : "107", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Fenoprofen", "@language" : "sv" } ], "VocabularyConceptId" : "349269", "VocabularyId" : "73", "Identifier" : "107", "Label" : "Fenoprofen", "Definition" : null, "Notation" : "CH10/107", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Fenoprofen" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "2-(3-Phenoxyphenyl)propanoic acid" ], "CAS-Nr" : [ "31879-05-7" ], "EC-Nr" : [ "250-850-3" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Fenoxisyror" ], "Anvandningsomrade-Egenskaper" : [ "Antiinflammatoriska medel/Analgetika/Antipyretika/NSAID (Non-steroidal anti-inflammatory drugs)" ] }, { "@id" : "108", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Fenoprofen-kalciumsaltdihydrat", "@language" : "sv" } ], "VocabularyConceptId" : "349270", "VocabularyId" : "73", "Identifier" : "108", "Label" : "Fenoprofen-kalciumsaltdihydrat", "Definition" : null, "Notation" : "CH10/108", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Fenoprofen calcium salt dihydrate" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "Calcium (2S)-2-(3-phenoxyphenyl)propanoate hydrate (1:2:2)" ], "CAS-Nr" : [ "53746-45-5" ], "EC-Nr" : [ "Anhydriden: 252-107-9 = fenoprofen calcium" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Fenoxisyror" ], "Anvandningsomrade-Egenskaper" : [ "Antiinflammatoriska medel/Analgetika/Antipyretika/NSAID (Non-steroidal anti-inflammatory drugs)" ] }, { "@id" : "109", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Fenoterol", "@language" : "sv" } ], "VocabularyConceptId" : "349271", "VocabularyId" : "73", "Identifier" : "109", "Label" : "Fenoterol", "Definition" : null, "Notation" : "CH10/109", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Fenoterol" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "5-[1-Hydroxy-2-[1-(4-hydroxyphenyl)propan-2-ylamino]ethyl]benzene-1,3-diol" ], "CAS-Nr" : [ "13392-18-2" ], "EC-Nr" : [ "saknas" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Hydroxifenyler/Aminer" ], "Anvandningsomrade-Egenskaper" : [ "Astmamediciner/Bronkialvidgande/Selektiva beta-2-stimulerare (β2-stimulerare), eller beta-2-agonister" ] }, { "@id" : "110", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Fentanyl", "@language" : "sv" } ], "VocabularyConceptId" : "349272", "VocabularyId" : "73", "Identifier" : "110", "Label" : "Fentanyl", "Definition" : null, "Notation" : "CH10/110", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Fentanyl" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "N-(1-(2-Phenylethyl)-4-piperidinyl)-N-phenylpropanamide" ], "CAS-Nr" : [ "437-38-7" ], "EC-Nr" : [ "207-113-6" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Opioider/Alkaloider" ], "Anvandningsomrade-Egenskaper" : [ "Analgetika/Anestetika/Narkotikaklassad" ] }, { "@id" : "111", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Fenylbutazon", "@language" : "sv" } ], "VocabularyConceptId" : "349273", "VocabularyId" : "73", "Identifier" : "111", "Label" : "Fenylbutazon", "Definition" : null, "Notation" : "CH10/111", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Phenylbutazone" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "4-Butyl-1,2-diphenyl-pyrazolidine-3,5-dione" ], "CAS-Nr" : [ "50-33-9" ], "EC-Nr" : [ "200-029-0" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Pyrazolidiner" ], "Anvandningsomrade-Egenskaper" : [ "Antiinflammatoriska medel/Analgetika/Antipyretika/Veterinärmediciner/NSAID (Non-steroidal anti-inflammatory drugs)" ] }, { "@id" : "112", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Fenytoin", "@language" : "sv" } ], "VocabularyConceptId" : "349274", "VocabularyId" : "73", "Identifier" : "112", "Label" : "Fenytoin", "Definition" : null, "Notation" : "CH10/112", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Phenytoine" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "5,5-Diphenylimidazolidine-2,4-dione" ], "CAS-Nr" : [ "57-41-0" ], "EC-Nr" : [ "200-328-6" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Imidazolidiner" ], "Anvandningsomrade-Egenskaper" : [ "Antiepileptika/Antikonvulsiva/Mot: Hjärtarytmi" ] }, { "@id" : "113", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Fexofenadin", "@language" : "sv" } ], "VocabularyConceptId" : "349275", "VocabularyId" : "73", "Identifier" : "113", "Label" : "Fexofenadin", "Definition" : null, "Notation" : "CH10/113", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Fexofenadine; Allegra" ], "Synonym_1" : [ "Allegra" ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "2-[4-(1-Hydroxy-4-{4-[hydroxy(diphenyl)methyl]-1-piperidinyl}butyl)phenyl]-2-methylpropanoic acid" ], "CAS-Nr" : [ "83799-24-0" ], "EC-Nr" : [ "801-893-7" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Karboxylsyror/Piperidiner/Alkoholer" ], "Anvandningsomrade-Egenskaper" : [ "Antihistaminer/Antiallergika" ] }, { "@id" : "114", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Finasterid", "@language" : "sv" } ], "VocabularyConceptId" : "349276", "VocabularyId" : "73", "Identifier" : "114", "Label" : "Finasterid", "Definition" : null, "Notation" : "CH10/114", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Finasteride; Proscar; Propecia" ], "Synonym_1" : [ "Proscar" ], "Synonym_2" : [ "Propecia" ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-tert-Butyl-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide" ], "CAS-Nr" : [ "98319-26-7" ], "EC-Nr" : [ "saknas" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Aza-steroider/Laktamer" ], "Anvandningsomrade-Egenskaper" : [ "Mot: Prostataförstoring (BPH), Manligt håravfall/5-Alfareduktashämmare" ] }, { "@id" : "115", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Flekainid", "@language" : "sv" } ], "VocabularyConceptId" : "349277", "VocabularyId" : "73", "Identifier" : "115", "Label" : "Flekainid", "Definition" : null, "Notation" : "CH10/115", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Flecainide" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(RS)-N-(Piperidin-2-ylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide" ], "CAS-Nr" : [ "54143-55-4" ], "EC-Nr" : [ "923-247-4" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Bensamider/Piperidiner" ], "Anvandningsomrade-Egenskaper" : [ "Mot: Hjärtarytmi/Natriumkanal-blockerare" ] }, { "@id" : "116", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Flubendazol", "@language" : "sv" } ], "VocabularyConceptId" : "349278", "VocabularyId" : "73", "Identifier" : "116", "Label" : "Flubendazol", "Definition" : null, "Notation" : "CH10/116", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Flubendazol" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "Methyl N-[6-(4-fluorobenzoyl)-1H-benzimidazol-2-yl]carbamate" ], "CAS-Nr" : [ "31430-15-6" ], "EC-Nr" : [ "250-624-4" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Fluororganiska ämnen/Bensimidazoler/Karbamater" ], "Anvandningsomrade-Egenskaper" : [ "Antiparasitika/Helminticider, \"maskmedel\"" ] }, { "@id" : "117", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Flufenazin", "@language" : "sv" } ], "VocabularyConceptId" : "349279", "VocabularyId" : "73", "Identifier" : "117", "Label" : "Flufenazin", "Definition" : null, "Notation" : "CH10/117", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Fluphenazine" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "2-[4-[3-[2-(Trifluoromethyl)-10H-phenothiazin-10-yl]propyl]piperazin-1-yl]ethanol" ], "CAS-Nr" : [ "69-23-8" ], "EC-Nr" : [ "200-702-9" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Fluororganiska ämnen/Fenotiaziner/Piperaziner" ], "Anvandningsomrade-Egenskaper" : [ "Antipsykotika/Mot: Schizofreni" ] }, { "@id" : "118", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Flukloxacillin", "@language" : "sv" } ], "VocabularyConceptId" : "349280", "VocabularyId" : "73", "Identifier" : "118", "Label" : "Flukloxacillin", "Definition" : null, "Notation" : "CH10/118", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Flucloxacillin" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(2S,5R,6R)-6-({[3-(2-Chloro-5-fluorophenyl)-5-methylisoxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid" ], "CAS-Nr" : [ "5250-39-5" ], "EC-Nr" : [ "226-051-0" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Beta-laktamer" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika" ] }, { "@id" : "119", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Flukonazol", "@language" : "sv" } ], "VocabularyConceptId" : "349281", "VocabularyId" : "73", "Identifier" : "119", "Label" : "Flukonazol", "Definition" : null, "Notation" : "CH10/119", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Fluconazole" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "2-(2,4-Difluorophenyl)-1,3-bis(1H-1,2,4-triazol-1-yl)propan-2-ol" ], "CAS-Nr" : [ "86386-73-4" ], "EC-Nr" : [ "saknas" ], "WFD" : [ "Watch" ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Fluorerade aromater/Triazoler/Alkoholer" ], "Anvandningsomrade-Egenskaper" : [ "Fungicider/Mot: Candidiasis" ] }, { "@id" : "120", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Flumekvin", "@language" : "sv" } ], "VocabularyConceptId" : "349282", "VocabularyId" : "73", "Identifier" : "120", "Label" : "Flumekvin", "Definition" : null, "Notation" : "CH10/120", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Flumequine" ], "Synonym_1" : [ "Flumekin" ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "7-Fluoro-12-methyl-4-oxo-1-azatricyclo[7.3.1.05,13]trideca-2,5,7,9(13)-tetraene-3-carboxylic acid" ], "CAS-Nr" : [ "42835-25-6" ], "EC-Nr" : [ "255-962-6" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Fluorkinoloner" ], "Anvandningsomrade-Egenskaper" : [ "Kemoterapeutisk antibiotika" ] }, { "@id" : "121", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Flunitrazepam", "@language" : "sv" } ], "VocabularyConceptId" : "349283", "VocabularyId" : "73", "Identifier" : "121", "Label" : "Flunitrazepam", "Definition" : null, "Notation" : "CH10/121", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Flunitrazepam; former Rohypnol" ], "Synonym_1" : [ "f.d.Rohypnol" ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "5-(2-Fluorophenyl)-1-methyl-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one" ], "CAS-Nr" : [ "1622-62-4" ], "EC-Nr" : [ "216-597-8" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Bensodiazepiner" ], "Anvandningsomrade-Egenskaper" : [ "Sömnmedel/Sedativa/Muskelavslappnande/Narkotikaklassad" ] }, { "@id" : "122", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Fluorouracil", "@language" : "sv" } ], "VocabularyConceptId" : "349284", "VocabularyId" : "73", "Identifier" : "122", "Label" : "Fluorouracil", "Definition" : null, "Notation" : "CH10/122", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Fluorouracil" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "5-Fluoro-1H,3H-pyrimidine-2,4-dione" ], "CAS-Nr" : [ "51-21-8" ], "EC-Nr" : [ "200-085-6" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Fluorpyrimidiner" ], "Anvandningsomrade-Egenskaper" : [ "Cytostatika/Kemoterapeutika" ] }, { "@id" : "123", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Fluoxetin", "@language" : "sv" } ], "VocabularyConceptId" : "349285", "VocabularyId" : "73", "Identifier" : "123", "Label" : "Fluoxetin", "Definition" : null, "Notation" : "CH10/123", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Fluoxetine; Prozac" ], "Synonym_1" : [ "Prozac" ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(RS)-N-Methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine" ], "CAS-Nr" : [ "54910-89-3" ], "EC-Nr" : [ "611-209-7" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Fluororganiska aromater/Aminer" ], "Anvandningsomrade-Egenskaper" : [ "Antidepressiva - Mot: MDD, OCD, Bulimia m.fl./SSRI: Selektiva Serotoninåterupptagshämmare" ] }, { "@id" : "124", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Flupentixol", "@language" : "sv" } ], "VocabularyConceptId" : "349286", "VocabularyId" : "73", "Identifier" : "124", "Label" : "Flupentixol", "Definition" : null, "Notation" : "CH10/124", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Flupentixol" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(EZ)-2-[4-[3-[2-(Trifluoromethyl)thioxanthen-9-ylidene]propyl]piperazin-1-yl]ethanol" ], "CAS-Nr" : [ "2709-56-0" ], "EC-Nr" : [ "220-304-9" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Tioxantener" ], "Anvandningsomrade-Egenskaper" : [ "Neuroleptika/Antipsykotika" ] }, { "@id" : "125", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Flutamid", "@language" : "sv" } ], "VocabularyConceptId" : "349287", "VocabularyId" : "73", "Identifier" : "125", "Label" : "Flutamid", "Definition" : null, "Notation" : "CH10/125", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Flutamide" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "2-Methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]-propanamide" ], "CAS-Nr" : [ "13311-84-7" ], "EC-Nr" : [ "236-341-9" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Fluorerade kolväten/Amider" ], "Anvandningsomrade-Egenskaper" : [ "Prostatacancerbehandling/Antiandrogent läkemedel" ] }, { "@id" : "126", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Fluvoxamin", "@language" : "sv" } ], "VocabularyConceptId" : "349288", "VocabularyId" : "73", "Identifier" : "126", "Label" : "Fluvoxamin", "Definition" : null, "Notation" : "CH10/126", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Fluvoxamine" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "2-{[(E)-{5-Methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene}amino]oxy}ethanamine" ], "CAS-Nr" : [ "54739-18-3" ], "EC-Nr" : [ "611-193-1" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Fluororganiska aromater/Aminer" ], "Anvandningsomrade-Egenskaper" : [ "Antidepressiva - Mot: OCD, MDD, PTSD, m.fl./SSRI: Selektiva Serotoninåterupptagshämmare" ] }, { "@id" : "127", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Fulvestrant", "@language" : "sv" } ], "VocabularyConceptId" : "349289", "VocabularyId" : "73", "Identifier" : "127", "Label" : "Fulvestrant", "Definition" : null, "Notation" : "CH10/127", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Fulvestrant" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(7α,17β)-7-{9-[(4,4,5,5,5-Pentafluoropentyl)sulfinyl]nonyl}estra-1,3,5(10)-triene-3,17-diol" ], "CAS-Nr" : [ "129453-61-8" ], "EC-Nr" : [ "saknas" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Fluorerade kolväten/Sulfinyler" ], "Anvandningsomrade-Egenskaper" : [ "Bröstcancerbehandling/Östrogenreceptor-antagonister" ] }, { "@id" : "128", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Furosemid", "@language" : "sv" } ], "VocabularyConceptId" : "349290", "VocabularyId" : "73", "Identifier" : "128", "Label" : "Furosemid", "Definition" : null, "Notation" : "CH10/128", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Furosemide" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "4-Chloro-2-(2-furylmethylamino)-5-sulfamoyl-benzoic acid" ], "CAS-Nr" : [ "54-31-9" ], "EC-Nr" : [ "200-203-6" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Klorerade aromater/Furaner/Sulfamoyler/Bensoesyror" ], "Anvandningsomrade-Egenskaper" : [ "Diuretika/Vätskedrivande medel mot: Hjärtsvikt, Ödem" ] }, { "@id" : "129", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Gemfibrozil", "@language" : "sv" } ], "VocabularyConceptId" : "349291", "VocabularyId" : "73", "Identifier" : "129", "Label" : "Gemfibrozil", "Definition" : null, "Notation" : "CH10/129", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Gemfibrozil" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "5-(2,5-Dimethylphenoxy)-2,2-dimethyl-pentanoic acid" ], "CAS-Nr" : [ "25812-30-0" ], "EC-Nr" : [ "247-280-2" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Fenoler/Karboxylsyror" ], "Anvandningsomrade-Egenskaper" : [ "Blodfettssänkande mediciner/Fibrater: Amfipatiska karboxylsyror" ] }, { "@id" : "130", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Gentamicin", "@language" : "sv" } ], "VocabularyConceptId" : "349292", "VocabularyId" : "73", "Identifier" : "130", "Label" : "Gentamicin", "Definition" : null, "Notation" : "CH10/130", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Gentamicin" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "General formula: (3R,4R,5R)-2-{[(1S,2S,3R,4S,6R)-4,6-Diamino-3-{[(2R,3R,6S)-3-amino-6-[(1R)-1-(methylamino)ethyl]oxan-2-yl]oxy}-2-hydroxycyclohexyl]oxy}-5-methyl-4-(methylamino)oxane-3,5-diol; Gentamycin C1: (1R,2S,3S,4R,6S)-4,6-diamino-3-[3-deoxy-4-C-methyl-3-(methylamino)-β-L-arabinopyranosyloxy]-2-hydroxycyclohexyl 2-amino-2,3,4,6,7-pentadeoxy-6-(methylamino)-β-L-lyxo-heptopyranoside; Gentamycin C1a: (1R,2S,3S,4R,6S)-4,6-diamino-3-[3-deoxy-4-C-methyl-3-(methylamino)-β-L-arabinopyranosyloxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,4,6-tetradeoxy-α-D-erythro-hexopyranoside; Gentamycin C2: (1R,2S,3R,4R,6S)-4,6-diamino-3-[3-deoxy-4-C-methyl-3-(methylamino)-β-L-arabinopyranosyloxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,4,6,7-pentadeoxy-α-D-ribo-heptopyranoside" ], "CAS-Nr" : [ "1403-66-3" ], "EC-Nr" : [ "215-765-8" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Aminoglykosider" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika/\"A complex of three different closely related aminoglycoside sulfates, Gentamicins C1, C2, and C1(subA), obtained from Micromonospora purpurea and related species.\" (Toxnet) \"Gentamicin is composed of a number of related gentamicin components and fractions which have varying degrees of antimicrobial potency. The main components of gentamicin include members of the gentamicin C complex: gentamicin C1, gentamicin C1a, and gentamicin C2 which compose approximately 80% of gentamicin and have been found to have the highest antibacterial activity. Gentamicin A, B, X, and a few others make up the remaining 20% of gentamicin.\" (Wikipedia)" ] }, { "@id" : "131", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Glimepirid", "@language" : "sv" } ], "VocabularyConceptId" : "349293", "VocabularyId" : "73", "Identifier" : "131", "Label" : "Glimepirid", "Definition" : null, "Notation" : "CH10/131", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Glimepiride" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "3-Ethyl-4-methyl-N-(4-[N-((1r,4r)-4-methylcyclohexylcarbamoyl)sulfamoyl]phenethyl)-2-oxo-2,5-dihydro-1H-pyrrole-1-carboxamide" ], "CAS-Nr" : [ "93479-97-1" ], "EC-Nr" : [ "saknas" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Sylfonylureor/Karboxamider/Pyrroliner" ], "Anvandningsomrade-Egenskaper" : [ "Antidiabetika" ] }, { "@id" : "132", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Glyburide", "@language" : "sv" } ], "VocabularyConceptId" : "349294", "VocabularyId" : "73", "Identifier" : "132", "Label" : "Glyburide", "Definition" : null, "Notation" : "CH10/132", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Glyburide ; Glibenclamide; Glybenzcyclamide" ], "Synonym_1" : [ "Glibenklamid" ], "Synonym_2" : [ "Glybenzcyclamid" ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "5-Chloro-N-(4-[N-(cyclohexylcarbamoyl)sulfamoyl]phenethyl)-2-methoxybenzamide" ], "CAS-Nr" : [ "10238-21-8" ], "EC-Nr" : [ "233-570-6" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Sulfanylureor" ], "Anvandningsomrade-Egenskaper" : [ "Antidiabetika" ] }, { "@id" : "133", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Haloperidol", "@language" : "sv" } ], "VocabularyConceptId" : "349295", "VocabularyId" : "73", "Identifier" : "133", "Label" : "Haloperidol", "Definition" : null, "Notation" : "CH10/133", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Haloperidol; Haldol" ], "Synonym_1" : [ "Haldol" ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one" ], "CAS-Nr" : [ "52-86-8" ], "EC-Nr" : [ "200-155-6" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Halogenerade aromater/Butyrofenoner/Piperidiner" ], "Anvandningsomrade-Egenskaper" : [ "Antipsykotika/Antiemetika" ] }, { "@id" : "134", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Heroin", "@language" : "sv" } ], "VocabularyConceptId" : "349296", "VocabularyId" : "73", "Identifier" : "134", "Label" : "Heroin", "Definition" : null, "Notation" : "CH10/134", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Heroin" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(5α,6α)-17-Methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diyl diacetate" ], "CAS-Nr" : [ "561-27-3" ], "EC-Nr" : [ "209-217-7" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Opiater/Fenoletrar/Acetatestrar" ], "Anvandningsomrade-Egenskaper" : [ "Droger/Analgetika/Narkotikaklassad" ] }, { "@id" : "135", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Hexobarbital", "@language" : "sv" } ], "VocabularyConceptId" : "349297", "VocabularyId" : "73", "Identifier" : "135", "Label" : "Hexobarbital", "Definition" : null, "Notation" : "CH10/135", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Hexobarbital" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(RS)-5-(Cyclohex-1-en-1-yl)-1,5-dimethyl-1,3-diazinane-2,4,6-trione" ], "CAS-Nr" : [ "56-29-1" ], "EC-Nr" : [ "200-264-9" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Barbiturater" ], "Anvandningsomrade-Egenskaper" : [ "Sömnmedel/Sedativa/Anestetika" ] }, { "@id" : "136", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Hydroklortiazid", "@language" : "sv" } ], "VocabularyConceptId" : "349298", "VocabularyId" : "73", "Identifier" : "136", "Label" : "Hydroklortiazid", "Definition" : null, "Notation" : "CH10/136", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Hydrochlorothiazide" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "6-Chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide" ], "CAS-Nr" : [ "58-93-5" ], "EC-Nr" : [ "200-403-3" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Bensotiadiaziner/Sulfonamider" ], "Anvandningsomrade-Egenskaper" : [ "Diuretika/Blodtrycksmedicin" ] }, { "@id" : "137", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Hydrokodon", "@language" : "sv" } ], "VocabularyConceptId" : "349299", "VocabularyId" : "73", "Identifier" : "137", "Label" : "Hydrokodon", "Definition" : null, "Notation" : "CH10/137", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Hydrocodone" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "4,5-alpha-Epoxy-3-methoxy-17-methylmorphinan-6-one" ], "CAS-Nr" : [ "125-29-1" ], "EC-Nr" : [ "204-733-9" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Opioider/Alkaloider" ], "Anvandningsomrade-Egenskaper" : [ "Analgetika/Narkotikaklassad" ] }, { "@id" : "138", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Hydroxizin", "@language" : "sv" } ], "VocabularyConceptId" : "349300", "VocabularyId" : "73", "Identifier" : "138", "Label" : "Hydroxizin", "Definition" : null, "Notation" : "CH10/138", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Hydroxyzine; Atarax" ], "Synonym_1" : [ "Atarax" ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(±)-2-(2-{4-[(4-Chlorophenyl)-phenylmethyl]piperazin-1-yl}ethoxy)ethanol" ], "CAS-Nr" : [ "68-88-2" ], "EC-Nr" : [ "200-693-1" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Klorerade aromater/Piperaziner/Difenylmetaner/Etrar/Alkoholer" ], "Anvandningsomrade-Egenskaper" : [ "Antihistaminer/Klådstillande/Sedativa/Sömnmedel/Antiemetika/Ångestdämpande" ] }, { "@id" : "139", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Ibuprofen", "@language" : "sv" } ], "VocabularyConceptId" : "349301", "VocabularyId" : "73", "Identifier" : "139", "Label" : "Ibuprofen", "Definition" : null, "Notation" : "CH10/139", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Ibuprofen" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(RS)-2-(4-(2-Methylpropyl)phenyl)propanoic acid" ], "CAS-Nr" : [ "15687-27-1" ], "EC-Nr" : [ "239-784-6" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Arylpropionsyror" ], "Anvandningsomrade-Egenskaper" : [ "Antiinflammatoriska medel/Analgetika/Antipyretika/NSAID (Non-steroidal anti-inflammatory drugs)" ] }, { "@id" : "140", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Ibuprofen-1-hydroxy", "@language" : "sv" } ], "VocabularyConceptId" : "349302", "VocabularyId" : "73", "Identifier" : "140", "Label" : "Ibuprofen-1-hydroxy", "Definition" : null, "Notation" : "CH10/140", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Ibuprofen-1-hydroxy" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "2-[4-(1-Hydroxy-2-methylpropyl)phenyl]propionic acid " ], "CAS-Nr" : [ "53949-53-4" ], "EC-Nr" : [ "saknas" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Arylpropionsyror" ], "Anvandningsomrade-Egenskaper" : [ "Antiinflammatoriska medel-NSAID (Non-steroidal anti-inflammatory drugs)/Analgetika/Antipyretika/Ibuprofen-metabolit" ] }, { "@id" : "141", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Ibuprofen-2-hydroxy", "@language" : "sv" } ], "VocabularyConceptId" : "349303", "VocabularyId" : "73", "Identifier" : "141", "Label" : "Ibuprofen-2-hydroxy", "Definition" : null, "Notation" : "CH10/141", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Ibuprofen-2-hydroxy" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "3-[4-(2-Hydroxy-2-methylpropyl)-phenyl]propionic acid" ], "CAS-Nr" : [ "51146-55-5" ], "EC-Nr" : [ "saknas" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Arylpropionsyror" ], "Anvandningsomrade-Egenskaper" : [ "Antiinflammatoriska medel-NSAID (Non-steroidal anti-inflammatory drugs)/Analgetika/Antipyretika/Ibuprofen-metabolit" ] }, { "@id" : "142", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Ibuprofen-COOH", "@language" : "sv" } ], "VocabularyConceptId" : "349304", "VocabularyId" : "73", "Identifier" : "142", "Label" : "Ibuprofen-COOH", "Definition" : null, "Notation" : "CH10/142", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Ibuprofen-COOH; Carboxy-ibuprofen" ], "Synonym_1" : [ "Karboxy-ibuprofen" ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "2-(4-(2-Carboxypropyl)phenyl)propionic acid" ], "CAS-Nr" : [ "15935-54-3" ], "EC-Nr" : [ "239-784-6" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Arylpropionsyror" ], "Anvandningsomrade-Egenskaper" : [ "Antiinflammatoriska medel-NSAID (Non-steroidal anti-inflammatory drugs)/Analgetika/Antipyretika/Ibuprofen-metabolit" ] }, { "@id" : "143", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Ifosfamid", "@language" : "sv" } ], "VocabularyConceptId" : "349305", "VocabularyId" : "73", "Identifier" : "143", "Label" : "Ifosfamid", "Definition" : null, "Notation" : "CH10/143", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Ifosfamide" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "N-3-bis(2-Chloroethyl)-1,3,2-oxazaphosphinan-2-amide-2-oxide" ], "CAS-Nr" : [ "3778-73-2" ], "EC-Nr" : [ "223-237-3" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Oxazafosfinaner/Fosforamid-senapsföreningar" ], "Anvandningsomrade-Egenskaper" : [ "Cytostatika vid maligna tumörer" ] }, { "@id" : "144", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Iminostilben", "@language" : "sv" } ], "VocabularyConceptId" : "349306", "VocabularyId" : "73", "Identifier" : "144", "Label" : "Iminostilben", "Definition" : null, "Notation" : "CH10/144", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Iminostilbene; Dibenzazepine" ], "Synonym_1" : [ "Dibensazepin" ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "5H-Dibenzo[b,f]azepine" ], "CAS-Nr" : [ "256-96-2; 1189918-57-7" ], "EC-Nr" : [ "205-970-0" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Dibensazepiner" ], "Anvandningsomrade-Egenskaper" : [ "Antidepressiva/Antikonvulsiva/TCA: Tri-Cykliska Antidepressiva" ] }, { "@id" : "145", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Imipramin", "@language" : "sv" } ], "VocabularyConceptId" : "349307", "VocabularyId" : "73", "Identifier" : "145", "Label" : "Imipramin", "Definition" : null, "Notation" : "CH10/145", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Imipramine" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "3-(10,11-Dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine" ], "CAS-Nr" : [ "50-49-7" ], "EC-Nr" : [ "200-042-1" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Dibensazepiner" ], "Anvandningsomrade-Egenskaper" : [ "Antidepressiva/Ångestdämpande/Mot: Inkontinens/TCA: Tri-Cykliska Antidepressiva" ] }, { "@id" : "146", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Indometacin", "@language" : "sv" } ], "VocabularyConceptId" : "349308", "VocabularyId" : "73", "Identifier" : "146", "Label" : "Indometacin", "Definition" : null, "Notation" : "CH10/146", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Indomethacin" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "2-{1-[(4-Chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetic acid" ], "CAS-Nr" : [ "53-86-1" ], "EC-Nr" : [ "200-186-5" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Klorerade aromater/Indoler/Fenoletrar/Amider" ], "Anvandningsomrade-Egenskaper" : [ "Antiinflammatoriska medel/Analgetika/Antipyretika/Veterinärmediciner/NSAID (Non-steroidal anti-inflammatory drugs)" ] }, { "@id" : "147", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Irbesartan", "@language" : "sv" } ], "VocabularyConceptId" : "349309", "VocabularyId" : "73", "Identifier" : "147", "Label" : "Irbesartan", "Definition" : null, "Notation" : "CH10/147", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Irbesartan" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "2-Butyl-3-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1,3-diazaspiro[4.4]non-1-en-4-one" ], "CAS-Nr" : [ "138402-11-6" ], "EC-Nr" : [ "604-078-2" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Aromater/Tetrazoler" ], "Anvandningsomrade-Egenskaper" : [ "Blodtrycksmediciner/Angiotensin-II-receptor-antagonister" ] }, { "@id" : "148", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Isradipin", "@language" : "sv" } ], "VocabularyConceptId" : "349310", "VocabularyId" : "73", "Identifier" : "148", "Label" : "Isradipin", "Definition" : null, "Notation" : "CH10/148", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Isradipine" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "3-Methyl 5-propan-2-yl 4-(2,1,3-benzoxadiazol-4-yl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate" ], "CAS-Nr" : [ "75695-93-1" ], "EC-Nr" : [ "saknas" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Bensoxadiazoler/Dihydropyridiner/Karboxylatestrar" ], "Anvandningsomrade-Egenskaper" : [ "Blodtrycksmediciner/Vasodilativa/Kalcium-kanal-blockerare" ] }, { "@id" : "149", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Ivermektin", "@language" : "sv" } ], "VocabularyConceptId" : "349311", "VocabularyId" : "73", "Identifier" : "149", "Label" : "Ivermektin", "Definition" : null, "Notation" : "CH10/149", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Ivermectin" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "22,23-Dihydroavermectin B1a + 22,23-Dihydroavermectin B1b: (1'R,2R,4'S,5S,6R,8'R,10'E,12'S,13'S,14'E,16'E,20'R,21'R,24'S)-21',24'-Dihydroxy-12'-{[(2R,4S,5S,6S)-5-{[(2S,4S,5S,6S)-5-hydroxy-4-methoxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-4-methoxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-5,11',13',22'-tetramethyl-6-[(1S)-1-methylpropyl]-3,4,5,6-tetrahydro-2'H-spiro[pyran-2,6' [3,7,19]trioxatetracyclo[15.6.1.14,8.020,24]pentacosa[10,14,16,22]tetraen]-2'-one" ], "CAS-Nr" : [ "70288-86-7" ], "EC-Nr" : [ "274-536-0" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Avermektiner" ], "Anvandningsomrade-Egenskaper" : [ "Antiparastika/Nematicider/Särskilt mot: Flodblindhet/Insekticider/Akaricider/Nematicider" ] }, { "@id" : "150", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Johexol", "@language" : "sv" } ], "VocabularyConceptId" : "349312", "VocabularyId" : "73", "Identifier" : "150", "Label" : "Johexol", "Definition" : null, "Notation" : "CH10/150", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Iohexol" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "1-N,3-N-bis(2,3-Dihydroxypropyl)-5-[N-(2,3-dihydroxypropyl)acetamido]-2,4,6-triiodobenzene-1,3-dicarboxamide" ], "CAS-Nr" : [ "66108-95-0" ], "EC-Nr" : [ "266-164-2" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Joderade aromater/Karboxamider/Alkoholer" ], "Anvandningsomrade-Egenskaper" : [ "Röntgen-kontrastmedia/Vid: Angiografi" ] }, { "@id" : "151", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Jomeprol", "@language" : "sv" } ], "VocabularyConceptId" : "349313", "VocabularyId" : "73", "Identifier" : "151", "Label" : "Jomeprol", "Definition" : null, "Notation" : "CH10/151", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Iomeprol" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "1-N,3-N-bis(2,3-Dihydroxypropyl)-5-(2-hydroxy-N-methylacetamido)-2,4,6-triiodobenzene-1,3-dicarboxamide" ], "CAS-Nr" : [ "78649-41-9" ], "EC-Nr" : [ "saknas" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Jodorganiska ämnen/Bensamider/Acetanilider/Alkoholer" ], "Anvandningsomrade-Egenskaper" : [ "Röntgen-kontrastmedia/Vid: Angiografi, Hjärn-CT, Urografi" ] }, { "@id" : "152", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Jopamidol", "@language" : "sv" } ], "VocabularyConceptId" : "349314", "VocabularyId" : "73", "Identifier" : "152", "Label" : "Jopamidol", "Definition" : "ChSp/PubCh/ECHA/WIKI", "Notation" : "CH10/152", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Iopamidol" ], "Synonym_1" : [ "Iopamidol" ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "1-N,3-N-Bis(1,3-dihydroxypropan-2-yl)-5-[[(2S)-2-hydroxypropanoyl]amino]-2,4,6-triiodobenzene-1,3-dicarboxamide; N,N'-Bis(1,3-dihydroxy-2-propanyl)-2,4,6-triiodo-5-(lactoylamino)isophthalamide" ], "CAS-Nr" : [ "60166-93-0" ], "EC-Nr" : [ "262-093-6" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Joderade aromater/Karboxamider" ], "Anvandningsomrade-Egenskaper" : [ "Röntgen-kontrastmedia/Vid: Angiografi, Urografi, Datortomografi" ] }, { "@id" : "153", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Jopromid", "@language" : "sv" } ], "VocabularyConceptId" : "349315", "VocabularyId" : "73", "Identifier" : "153", "Label" : "Jopromid", "Definition" : "ChSp/PubCh/ECHA/WIKI", "Notation" : "CH10/153", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Iopromide" ], "Synonym_1" : [ "Iopromid" ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "1-N,3-N-Bis(2,3-Dihydroxypropyl)-2,4,6-triiodo-5-(2-methoxyacetamido)-1-N-methylbenzene-1,3-dicarboxamide; N,N′-Bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-[(methoxyacetyl)amino]-N-methylisophthalamide" ], "CAS-Nr" : [ "73334-07-3" ], "EC-Nr" : [ "277-385-9" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Joderade aromater/Bensamider/Acetanilider" ], "Anvandningsomrade-Egenskaper" : [ "Röntgen-kontrastmedia/Vid: Lungangiografi, Hjärn-CT, Urografi" ] }, { "@id" : "154", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Josamycin", "@language" : "sv" } ], "VocabularyConceptId" : "349316", "VocabularyId" : "73", "Identifier" : "154", "Label" : "Josamycin", "Definition" : null, "Notation" : "CH10/154", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Josamycin" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(2S,3S,4R,6S) -6- {[(2R,3S,4R,5R,6S) -6- {[(4R,5S,6S,7R,9R,10R,11E,13E,16R) -4- (Acetyloxy)-10-hydroxy-5-methoxy-9, 16-dimethyl-2-oxo-7-(2-oxoethyl)-1-oxacyclohexadeca-11, 13-dien-6-yl]oxy}-4-(dimethylamino)-5-hydroxy-2-methyloxan-3-yl]oxy}-4-hydroxy-2, 4-dimethyloxan-3-yl 3-methylbutanoate" ], "CAS-Nr" : [ "16846-24-5" ], "EC-Nr" : [ "240-871-6" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Makrolider" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika" ] }, { "@id" : "155", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Joxitalamsyra", "@language" : "sv" } ], "VocabularyConceptId" : "349317", "VocabularyId" : "73", "Identifier" : "155", "Label" : "Joxitalamsyra", "Definition" : null, "Notation" : "CH10/155", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Ioxitalamic acid" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "3-Acetamido-5-(2-hydroxyethylcarbamoyl)-2,4,6-triiodobenzoic acid" ], "CAS-Nr" : [ "28179-44-4" ], "EC-Nr" : [ "248-887-5" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Joderade aromater/Bensoater/Ftalamsyror/Acetamider" ], "Anvandningsomrade-Egenskaper" : [ "Röntgen-kontrastmedia" ] }, { "@id" : "156", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Kanamycinsulfat", "@language" : "sv" } ], "VocabularyConceptId" : "349318", "VocabularyId" : "73", "Identifier" : "156", "Label" : "Kanamycinsulfat", "Definition" : null, "Notation" : "CH10/156", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Kanamycin sulfate" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(1S,2R,3R,4S,6R)-4,6-Diamino-3-[(6-amino-6-deoxy-α-D-glucopyranosyl)oxy]-2-hydroxycyclohexyl 3-amino-3-deoxy-α-D-glucopyranoside sulfate (1:1)" ], "CAS-Nr" : [ "25389-94-0" ], "EC-Nr" : [ "223-347-1" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Aminoglykosider" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika" ] }, { "@id" : "157", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Karazolol", "@language" : "sv" } ], "VocabularyConceptId" : "349319", "VocabularyId" : "73", "Identifier" : "157", "Label" : "Karazolol", "Definition" : null, "Notation" : "CH10/157", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Carazolol" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "1-(9H-Carbazol-4-yloxy)-3-(propan-2-ylamino)propan-2-ol" ], "CAS-Nr" : [ "57775-29-8" ], "EC-Nr" : [ "260-945-1" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Karbazoler" ], "Anvandningsomrade-Egenskaper" : [ "Blodtrycksmediciner/Mot: Hjärtarytmi/Sedativa/Fr.a. Veterinärmedicin/Beta-blockerare" ] }, { "@id" : "158", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Karbamazepin", "@language" : "sv" } ], "VocabularyConceptId" : "349320", "VocabularyId" : "73", "Identifier" : "158", "Label" : "Karbamazepin", "Definition" : null, "Notation" : "CH10/158", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Carbamazepine" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "5H-Dibenzo[b,f]azepine-5-carboxamide" ], "CAS-Nr" : [ "298-46-4" ], "EC-Nr" : [ "206-062-7" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Dibensoazepiner/Karboxamider" ], "Anvandningsomrade-Egenskaper" : [ "Antiepileptika/Neuroleptika/Mot: Neuropati" ] }, { "@id" : "159", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Ketokonazol", "@language" : "sv" } ], "VocabularyConceptId" : "349321", "VocabularyId" : "73", "Identifier" : "159", "Label" : "Ketokonazol", "Definition" : null, "Notation" : "CH10/159", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Ketoconazole" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "1-[4-(4-{[(2R,4S)-2-(2,4-Dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]ethan-1-one" ], "CAS-Nr" : [ "65277-42-1" ], "EC-Nr" : [ "265-667-4" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Klorerade aromater/Imidazoler/Piperaziner" ], "Anvandningsomrade-Egenskaper" : [ "Fungicider/Mot: Fotsvamp, Candidiasis, m.fl." ] }, { "@id" : "160", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Ketoprofen", "@language" : "sv" } ], "VocabularyConceptId" : "349322", "VocabularyId" : "73", "Identifier" : "160", "Label" : "Ketoprofen", "Definition" : null, "Notation" : "CH10/160", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Ketoprofen" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(RS)-2-(3-Benzoylphenyl)propanoic acid" ], "CAS-Nr" : [ "22071-15-4" ], "EC-Nr" : [ "244-759-8" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Bensoylfenyler/Propionsyror" ], "Anvandningsomrade-Egenskaper" : [ "Antiinflammatoriska medel/Analgetika/Antipyretika/NSAID (Non-steroidal anti-inflammatory drugs)" ] }, { "@id" : "161", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Klaritromycin", "@language" : "sv" } ], "VocabularyConceptId" : "349323", "VocabularyId" : "73", "Identifier" : "161", "Label" : "Klaritromycin", "Definition" : null, "Notation" : "CH10/161", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Clarithromycin" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(3R,4S,5S,6R,7R,9R,11S,12R,13S,14S)-6-{[(2S,3R,4S,6R) -4-(Dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy} -14-ethyl-12,13-dihydroxy-4-{[(2R,4S,5S,6S)-5-hydroxy -4-methoxy-4,6-dimethyloxan-2-yl]oxy}-7 -methoxy-3,5,7,9,11,13-hexamethyl -1-oxacyclotetradecane-2,10-dione; 6-O-Methyl-erythromycin " ], "CAS-Nr" : [ "81103-11-9" ], "EC-Nr" : [ "617-200-4" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Makrolider/Laktoner/Oximer" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika" ] }, { "@id" : "162", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Klemastin", "@language" : "sv" } ], "VocabularyConceptId" : "349324", "VocabularyId" : "73", "Identifier" : "162", "Label" : "Klemastin", "Definition" : "ChSp/PubCh/ECHA/WIKI", "Notation" : "CH10/162", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Clemastine" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(2R)-2-{2-[(1R)-1-(4-Chlorophenyl)-1-phenylethoxy]ethyl}-1-methylpyrrolidine; (2R)-2-{2-[1-(4-Chlorophenyl)-1-phenylethoxy]ethyl}-1-methylpyrrolidine" ], "CAS-Nr" : [ "15686-51-8" ], "EC-Nr" : [ "239-055-2" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Klorfenyler/Pyrrolidiner" ], "Anvandningsomrade-Egenskaper" : [ "Antihistaminer/Antikolinergika/Sedativa" ] }, { "@id" : "163", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Klenbuterol", "@language" : "sv" } ], "VocabularyConceptId" : "349325", "VocabularyId" : "73", "Identifier" : "163", "Label" : "Klenbuterol", "Definition" : null, "Notation" : "CH10/163", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Clenbuterol" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(RS)-1-(4-Amino-3,5-dichlorophenyl)-2-(tert-butylamino)ethanol" ], "CAS-Nr" : [ "37148-27-9" ], "EC-Nr" : [ "253-366-0" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Klorerade aromater/Sympatomimetiska aminer" ], "Anvandningsomrade-Egenskaper" : [ "Astmamediciner/Bronkialvidgande/β2-agonist" ] }, { "@id" : "164", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Klindamycin", "@language" : "sv" } ], "VocabularyConceptId" : "349326", "VocabularyId" : "73", "Identifier" : "164", "Label" : "Klindamycin", "Definition" : null, "Notation" : "CH10/164", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Clindamycin" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "Methyl (5R)-5-[(1S,2S)-2-chloro-1-{[(4R)-1-methyl-4-propyl-L-prolyl]amino}propyl]-1-thio-β-L-arabinopyranoside" ], "CAS-Nr" : [ "18323-44-9" ], "EC-Nr" : [ "242-209-1" ], "WFD" : [ "Watch" ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Linkosamider" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika" ] }, { "@id" : "165", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Klomipramin", "@language" : "sv" } ], "VocabularyConceptId" : "349327", "VocabularyId" : "73", "Identifier" : "165", "Label" : "Klomipramin", "Definition" : null, "Notation" : "CH10/165", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Clomipramine" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "3-(3-Chloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine" ], "CAS-Nr" : [ "303-49-1" ], "EC-Nr" : [ "206-144-2" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Dibensazepiner" ], "Anvandningsomrade-Egenskaper" : [ "Antidepressiva/TCA: Tri-Cykliska Antidepressiva" ] }, { "@id" : "166", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Klonazepam", "@language" : "sv" } ], "VocabularyConceptId" : "349328", "VocabularyId" : "73", "Identifier" : "166", "Label" : "Klonazepam", "Definition" : null, "Notation" : "CH10/166", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Clonazepam" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "5-(2-Chlorophenyl)-7-nitro-2,3-dihydro-1,4-benzodiazepin-2-one" ], "CAS-Nr" : [ "1622-61-3" ], "EC-Nr" : [ "216-596-2" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Bensodiazepiner" ], "Anvandningsomrade-Egenskaper" : [ "Antiepileptika/Antipsykotika/Narkotikaklassad" ] }, { "@id" : "167", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Kloralhydrat", "@language" : "sv" } ], "VocabularyConceptId" : "349329", "VocabularyId" : "73", "Identifier" : "167", "Label" : "Kloralhydrat", "Definition" : null, "Notation" : "CH10/167", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Chloral hydrate" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "2,2,2-Trichloroethane-1,1-diol" ], "CAS-Nr" : [ "302-17-0" ], "EC-Nr" : [ "206-117-5" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Klororganiska ämnen" ], "Anvandningsomrade-Egenskaper" : [ "Sömnmedel/Sedativa/Narkotikaklassad" ] }, { "@id" : "168", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Kloramfenikol", "@language" : "sv" } ], "VocabularyConceptId" : "349330", "VocabularyId" : "73", "Identifier" : "168", "Label" : "Kloramfenikol", "Definition" : null, "Notation" : "CH10/168", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Chloramphenicol" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "2,2-Dichloro-N-[(1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)-2-propanyl]acetamide" ], "CAS-Nr" : [ "56-75-7" ], "EC-Nr" : [ "200-287-4" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Tetracykliner" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika" ] }, { "@id" : "169", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Klorbutanol", "@language" : "sv" } ], "VocabularyConceptId" : "349331", "VocabularyId" : "73", "Identifier" : "169", "Label" : "Klorbutanol", "Definition" : null, "Notation" : "CH10/169", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Chlorobutanol" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "1,1,1-Trichloro-2-methylpropan-2-ol" ], "CAS-Nr" : [ "57-15-8" ], "EC-Nr" : [ "200-317-6" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Klororganiska ämnen/Alkoholer" ], "Anvandningsomrade-Egenskaper" : [ "Sömnmedel/Sedativa/Anestetika/Baktericider" ] }, { "@id" : "170", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Klorhexidin", "@language" : "sv" } ], "VocabularyConceptId" : "349332", "VocabularyId" : "73", "Identifier" : "170", "Label" : "Klorhexidin", "Definition" : null, "Notation" : "CH10/170", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Chlorhexidine" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "N,N''''-1,6-Hexanediylbis[N'-(4-chlorophenyl)(imidodicarbonimidic diamide)]" ], "CAS-Nr" : [ "55-56-1" ], "EC-Nr" : [ "200-238-7" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Klororganiska ämnen/Biguanider" ], "Anvandningsomrade-Egenskaper" : [ "Antiseptika/Desinfektionsmedel" ] }, { "@id" : "171", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Klorpromazin", "@language" : "sv" } ], "VocabularyConceptId" : "349333", "VocabularyId" : "73", "Identifier" : "171", "Label" : "Klorpromazin", "Definition" : null, "Notation" : "CH10/171", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Chlorpromazine" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "3-(2-Chloro-10H-phenothiazin-10-yl)-N,N-dimethyl-propan-1-amine" ], "CAS-Nr" : [ "50-53-3" ], "EC-Nr" : [ "200-045-8" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Klororganiska ämnen/Aminer/Klorfenotiaziner" ], "Anvandningsomrade-Egenskaper" : [ "Antidepressiva/Antipsykotika/Dopamin-antagonister" ] }, { "@id" : "172", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Klorprotixen", "@language" : "sv" } ], "VocabularyConceptId" : "349334", "VocabularyId" : "73", "Identifier" : "172", "Label" : "Klorprotixen", "Definition" : null, "Notation" : "CH10/172", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Chlorprothixene" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(Z)-3-(2-Chlorothioxanthen-9-ylidene)-N,N-dimethyl-propan-1-amine" ], "CAS-Nr" : [ "113-59-7" ], "EC-Nr" : [ "204-032-8" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Klorerade aromater/Tioxantener/Aminer" ], "Anvandningsomrade-Egenskaper" : [ "Neuroleptika/Antipsykotika" ] }, { "@id" : "173", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Klortetracyklin", "@language" : "sv" } ], "VocabularyConceptId" : "349335", "VocabularyId" : "73", "Identifier" : "173", "Label" : "Klortetracyklin", "Definition" : null, "Notation" : "CH10/173", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Chlorotetracycline" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(4S,4aS,5aS,6S,12aS)-7-Chloro-4-(dimethylamino)-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-2-tetracenecarboxamide" ], "CAS-Nr" : [ "57-62-5" ], "EC-Nr" : [ "200-341-7" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Tetracykliner" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika" ] }, { "@id" : "174", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Klotrimazol", "@language" : "sv" } ], "VocabularyConceptId" : "349336", "VocabularyId" : "73", "Identifier" : "174", "Label" : "Klotrimazol", "Definition" : null, "Notation" : "CH10/174", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Clotrimazole" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "1-[(2-Chlorophenyl)(diphenyl)methyl]-1H-imidazole" ], "CAS-Nr" : [ "23593-75-1" ], "EC-Nr" : [ "245-764-8" ], "WFD" : [ "Watch" ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Klorfenyler/Imidazoler" ], "Anvandningsomrade-Egenskaper" : [ "Fungicider" ] }, { "@id" : "175", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Kloxacillin", "@language" : "sv" } ], "VocabularyConceptId" : "349337", "VocabularyId" : "73", "Identifier" : "175", "Label" : "Kloxacillin", "Definition" : null, "Notation" : "CH10/175", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Cloxacilline" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(2S,5R,6R)-6-{[3-(2-Chlorophenyl)-5-methyl-oxazole-4-carbonyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid" ], "CAS-Nr" : [ "61-72-3" ], "EC-Nr" : [ "200-514-7" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Beta-laktamer/Penicilliner" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika" ] }, { "@id" : "176", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Klozapin", "@language" : "sv" } ], "VocabularyConceptId" : "349338", "VocabularyId" : "73", "Identifier" : "176", "Label" : "Klozapin", "Definition" : null, "Notation" : "CH10/176", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Clozapine" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "8-Chloro-11-(4-methylpiperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine" ], "CAS-Nr" : [ "5786-21-0" ], "EC-Nr" : [ "227-313-7" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Dibensazepiner" ], "Anvandningsomrade-Egenskaper" : [ "Antipsykotika, mot: Schizofreni, Bipolaritet" ] }, { "@id" : "177", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Kodein", "@language" : "sv" } ], "VocabularyConceptId" : "349339", "VocabularyId" : "73", "Identifier" : "177", "Label" : "Kodein", "Definition" : null, "Notation" : "CH10/177", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Codeine" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(5α,6α)-7,8-Didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol" ], "CAS-Nr" : [ "76-57-3" ], "EC-Nr" : [ "200-969-1" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Opioider/Opiater/Alkaloider" ], "Anvandningsomrade-Egenskaper" : [ "Analgetika/Sedativa/Sömnmedel/Antidepressiva/Mot: Högt blodtryck, Diarré, Hosta, m.fl./Narkotikaklassad" ] }, { "@id" : "178", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Koffein", "@language" : "sv" } ], "VocabularyConceptId" : "349340", "VocabularyId" : "73", "Identifier" : "178", "Label" : "Koffein", "Definition" : null, "Notation" : "CH10/178", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Caffeine" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "1,3,7-Trimethyl-3,7-dihydro-1H-purine-2,6-dione; 1,3,7-Trimethylxanthine" ], "CAS-Nr" : [ "58-08-2" ], "EC-Nr" : [ "200-362-1" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Metylxantiner/Alkaloider" ], "Anvandningsomrade-Egenskaper" : [ "Psykoaktiva/CNS-stimulantia" ] }, { "@id" : "179", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Kokain", "@language" : "sv" } ], "VocabularyConceptId" : "349341", "VocabularyId" : "73", "Identifier" : "179", "Label" : "Kokain", "Definition" : null, "Notation" : "CH10/179", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Cocaine" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "Methyl (1R,2R,3S,5S)-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1] octane-2-carboxylate" ], "CAS-Nr" : [ "50-36-2" ], "EC-Nr" : [ "200-032-7" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Alkaloider/Bensoater/Estrar" ], "Anvandningsomrade-Egenskaper" : [ "Narkotika/Droger/Narkotikaklassad" ] }, { "@id" : "180", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Kotrimoxazol", "@language" : "sv" } ], "VocabularyConceptId" : "349342", "VocabularyId" : "73", "Identifier" : "180", "Label" : "Kotrimoxazol", "Definition" : null, "Notation" : "CH10/180", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Cotrimoxazole; Trimethoprim-Sulfamethoxazole; TMP-SMX; Bactrim; Septra" ], "Synonym_1" : [ "Trimetoprim-Sulfametoxazol" ], "Synonym_2" : [ "TMP-SM" ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "Mixture of Trimethoprim and Sulfamethoxazole, in the ratio of 1 to 5: 5-[(3,4,5-Trimethoxyphenyl)methyl]pyrimidine-2,4-diamine; 4-Amino-N-(5-methyl-1,2-oxazol-3-yl)benzenesulfonamide (1:5)" ], "CAS-Nr" : [ "8064-90-2" ], "EC-Nr" : [ "saknas" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Sulfonamider/Aniliner/Isoxazoler/Aminer/Pyrimider" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika" ] }, { "@id" : "181", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Krotamiton", "@language" : "sv" } ], "VocabularyConceptId" : "349343", "VocabularyId" : "73", "Identifier" : "181", "Label" : "Krotamiton", "Definition" : null, "Notation" : "CH10/181", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Crotamiton" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(2E)-N-Ethyl-N-(2-methylphenyl)-2-butenamide" ], "CAS-Nr" : [ "483-63-6" ], "EC-Nr" : [ "207-596-3" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Amider" ], "Anvandningsomrade-Egenskaper" : [ "Antiparasitika/Skabb-medicin/Klådstillande" ] }, { "@id" : "182", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Lamotrigin", "@language" : "sv" } ], "VocabularyConceptId" : "349344", "VocabularyId" : "73", "Identifier" : "182", "Label" : "Lamotrigin", "Definition" : null, "Notation" : "CH10/182", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Lamotrigine" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "6-(2,3-Dichlorophenyl)-1,2,4-triazine-3,5-diamine" ], "CAS-Nr" : [ "84057-84-1" ], "EC-Nr" : [ "281-901-8" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Klorerade aromater/Fenyltriaziner/Aminer" ], "Anvandningsomrade-Egenskaper" : [ "Antiepileptika/Antipsykotika/Mot: Bipolaritet" ] }, { "@id" : "183", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Lansoprazol", "@language" : "sv" } ], "VocabularyConceptId" : "349345", "VocabularyId" : "73", "Identifier" : "183", "Label" : "Lansoprazol", "Definition" : null, "Notation" : "CH10/183", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Lansoprazole" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(RS)-2-([3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methylsulfinyl)-1H-benzo[d]imidazole" ], "CAS-Nr" : [ "103577-45-3" ], "EC-Nr" : [ "saknas" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Fluororganiska ämnen/Heterocykler/Sulfinyler/Pyridiner" ], "Anvandningsomrade-Egenskaper" : [ "Protonpumpshämmare/Magsårsmediciner" ] }, { "@id" : "184", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Levetiracetam", "@language" : "sv" } ], "VocabularyConceptId" : "349346", "VocabularyId" : "73", "Identifier" : "184", "Label" : "Levetiracetam", "Definition" : null, "Notation" : "CH10/184", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Levetiracetam" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(S)-2-(2-Oxopyrrolidin-1-yl)butanamide" ], "CAS-Nr" : [ "102767-28-2" ], "EC-Nr" : [ "600-348-9" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Amider/Pyrrolidiner" ], "Anvandningsomrade-Egenskaper" : [ "Antiepileptika" ] }, { "@id" : "185", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Levomepromazin", "@language" : "sv" } ], "VocabularyConceptId" : "349347", "VocabularyId" : "73", "Identifier" : "185", "Label" : "Levomepromazin", "Definition" : null, "Notation" : "CH10/185", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Levomepromazine; Nozinan" ], "Synonym_1" : [ "Nozinan" ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(2R)-3-(2-Methoxyphenothiazine-10-yl-)-N,N,2-trimethylpropanamine" ], "CAS-Nr" : [ "60-99-1" ], "EC-Nr" : [ "200-495-5" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Fenotiaziner" ], "Anvandningsomrade-Egenskaper" : [ "Antipsykotika/Analgetika/Sömnmedel/Antiemetika" ] }, { "@id" : "186", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Levonorgestrel", "@language" : "sv" } ], "VocabularyConceptId" : "349348", "VocabularyId" : "73", "Identifier" : "186", "Label" : "Levonorgestrel", "Definition" : null, "Notation" : "CH10/186", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Levonorgestrel" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(8R,9S,10R,13S,14S,17R)-13-Ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-one" ], "CAS-Nr" : [ "797-63-7" ], "EC-Nr" : [ "212-349-8" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Steroidhormoner/Syntetiska progestagener" ], "Anvandningsomrade-Egenskaper" : [ "Hormonella preventivmedel - \"Dagen efter piller\"" ] }, { "@id" : "187", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Lidokain", "@language" : "sv" } ], "VocabularyConceptId" : "349349", "VocabularyId" : "73", "Identifier" : "187", "Label" : "Lidokain", "Definition" : null, "Notation" : "CH10/187", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Lidocaine; Xylocaine" ], "Synonym_1" : [ "Xylocain" ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide" ], "CAS-Nr" : [ "137-58-6" ], "EC-Nr" : [ "205-302-8" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Acetamider/Fenyler" ], "Anvandningsomrade-Egenskaper" : [ "Lokalbedövande medel" ] }, { "@id" : "188", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Linkomycin", "@language" : "sv" } ], "VocabularyConceptId" : "349350", "VocabularyId" : "73", "Identifier" : "188", "Label" : "Linkomycin", "Definition" : null, "Notation" : "CH10/188", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Lincomycin" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(2S,4R)-N-[(1R,2R)-2-Hydroxy-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(methylsulfanyl)oxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide" ], "CAS-Nr" : [ "154-21-2" ], "EC-Nr" : [ "205-824-6" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Linkosamider" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika" ] }, { "@id" : "189", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Litiumkarbonat", "@language" : "sv" } ], "VocabularyConceptId" : "349351", "VocabularyId" : "73", "Identifier" : "189", "Label" : "Litiumkarbonat", "Definition" : null, "Notation" : "CH10/189", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Lithium carbonate" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "Lithium carbonate" ], "CAS-Nr" : [ "554-13-2" ], "EC-Nr" : [ "209-062-5" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Litium-preparat" ], "Anvandningsomrade-Egenskaper" : [ "Antipsykotika/Antidepressiva, spec mot: Bipolaritet" ] }, { "@id" : "190", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Loperamid", "@language" : "sv" } ], "VocabularyConceptId" : "349352", "VocabularyId" : "73", "Identifier" : "190", "Label" : "Loperamid", "Definition" : null, "Notation" : "CH10/190", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Loperamide" ], "Synonym_1" : [ "Imodium" ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "4-[4-(4-Chlorophenyl)-4-hydroxypiperidin-1-yl]-N,N-dimethyl-2,2-diphenylbutanamide" ], "CAS-Nr" : [ "53179-11-6" ], "EC-Nr" : [ "258-416-5" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Opioider/Alkaloider" ], "Anvandningsomrade-Egenskaper" : [ "Mot: Diarré" ] }, { "@id" : "191", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Loratadin", "@language" : "sv" } ], "VocabularyConceptId" : "349353", "VocabularyId" : "73", "Identifier" : "191", "Label" : "Loratadin", "Definition" : null, "Notation" : "CH10/191", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Loratadine" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "Ethyl 4-(8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)-1-piperidinecarboxylate" ], "CAS-Nr" : [ "79794-75-5" ], "EC-Nr" : [ "616-734-5" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Klorerade aromater/Karbamater/Piperidiner/Bensocykloheptapyridiner" ], "Anvandningsomrade-Egenskaper" : [ "Antihistaminer/Antiallergika" ] }, { "@id" : "192", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Lorazepam", "@language" : "sv" } ], "VocabularyConceptId" : "349354", "VocabularyId" : "73", "Identifier" : "192", "Label" : "Lorazepam", "Definition" : null, "Notation" : "CH10/192", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Lorazepam; Temesta; Ativan" ], "Synonym_1" : [ "Temesta" ], "Synonym_2" : [ "Ativan" ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(RS)-7-Chloro-5-(2-chlorophenyl)-3-hydroxy-1,3-dihydro-2H-1,4-benzodiazepin-2-one" ], "CAS-Nr" : [ "846-49-1" ], "EC-Nr" : [ "212-687-6" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Klorerade aromater/Bensodiazepiner/Laktamer" ], "Anvandningsomrade-Egenskaper" : [ "Psykotropa medel/Ångestdämpande/Sedativa/Sömnmedel/Antiemetika/Narkotikaklassad" ] }, { "@id" : "193", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Lovastatin", "@language" : "sv" } ], "VocabularyConceptId" : "349355", "VocabularyId" : "73", "Identifier" : "193", "Label" : "Lovastatin", "Definition" : null, "Notation" : "CH10/193", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Lovastatin" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-Hydroxy-6-oxooxan-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (2S)-2-methylbutanoate" ], "CAS-Nr" : [ "75330-75-5" ], "EC-Nr" : [ "616-212-7" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Laktoner" ], "Anvandningsomrade-Egenskaper" : [ "Blodfettssänkande mediciner/Statiner" ] }, { "@id" : "194", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Lymecyklin", "@language" : "sv" } ], "VocabularyConceptId" : "349356", "VocabularyId" : "73", "Identifier" : "194", "Label" : "Lymecyklin", "Definition" : null, "Notation" : "CH10/194", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Lymecycline" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(2S)-6-[[[(Z)-[(4S,4aS,5aS,6S,12aS) -4-(Dimethylamino)-6,10,11,12a-tetrahydroxy-6-methyl-1,3,12-trioxo-4,4a,5,5a-tetrahydrotetracen-2-ylidene]-hydroxymethyl]amino]methylamino]-2-aminohexanoic acid" ], "CAS-Nr" : [ "992-21-2" ], "EC-Nr" : [ "213-592-2" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Tetracykliner" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika" ] }, { "@id" : "195", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Maprotilin", "@language" : "sv" } ], "VocabularyConceptId" : "349357", "VocabularyId" : "73", "Identifier" : "195", "Label" : "Maprotilin", "Definition" : null, "Notation" : "CH10/195", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Maprotiline" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "N-Methyl-9,10-ethanoanthracene-9(10H)-propanamine" ], "CAS-Nr" : [ "10262-69-8" ], "EC-Nr" : [ "233-599-4" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Aromatiska kolväten" ], "Anvandningsomrade-Egenskaper" : [ "Antidepressiva/TeCA: Tetra-Cykliska Antidepressiva" ] }, { "@id" : "196", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Marbofloxacin", "@language" : "sv" } ], "VocabularyConceptId" : "349358", "VocabularyId" : "73", "Identifier" : "196", "Label" : "Marbofloxacin", "Definition" : null, "Notation" : "CH10/196", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Marbofloxacin" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyridol(3,2,1-ij)(4,2,1)benzoxadiazin-6 carboxylic acid" ], "CAS-Nr" : [ "115550-35-1" ], "EC-Nr" : [ "saknas" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Fluorkinoloner" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika/Veterinärmedicin" ] }, { "@id" : "197", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Mebeverin", "@language" : "sv" } ], "VocabularyConceptId" : "349359", "VocabularyId" : "73", "Identifier" : "197", "Label" : "Mebeverin", "Definition" : null, "Notation" : "CH10/197", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Mebeverine" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(RS)-4-(Ethyl[1-(4-methoxyphenyl)propan-2-yl]amino)butyl 3,4-dimethoxybenzoate" ], "CAS-Nr" : [ "3625-06-7" ], "EC-Nr" : [ "222-830-4" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Metoxibensoater/Aminer" ], "Anvandningsomrade-Egenskaper" : [ "IBS (\"irritable bowl syndrome\")-medicin, Kramplösande, muskelavslappnande/Muskarin-antagonister" ] }, { "@id" : "198", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Medazepam", "@language" : "sv" } ], "VocabularyConceptId" : "349360", "VocabularyId" : "73", "Identifier" : "198", "Label" : "Medazepam", "Definition" : null, "Notation" : "CH10/198", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Medazepam" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "7-Chloro-2,3-dihydro-1-methyl-5-phenyl-1H-1,4-benzodiazepine" ], "CAS-Nr" : [ "2898-12-6" ], "EC-Nr" : [ "220-783-4" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Klororganiska ämnen/Diazepiner" ], "Anvandningsomrade-Egenskaper" : [ "Ångestdämpande/Sedativa/Narkotikaklassad" ] }, { "@id" : "199", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Medroxiprogesteron", "@language" : "sv" } ], "VocabularyConceptId" : "349361", "VocabularyId" : "73", "Identifier" : "199", "Label" : "Medroxiprogesteron", "Definition" : "2026-04-01 Ändrat stavning från Medroxy till Medroxi - ChSp/PubCh/ECHA/WIKI", "Notation" : "CH10/199", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Medroxyprogesterone" ], "Synonym_1" : [ "Medroxyprogesteron" ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "6S,8R,9S,10R,13S,14S,17R)-17-Acetyl-17-hydroxy-6,10,13-trimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one; (6α)-17-Hydroxy-6-methylpregn-4-ene-3,20-dione" ], "CAS-Nr" : [ "520-85-4" ], "EC-Nr" : [ "208-298-6" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Syntetiska progestagener" ], "Anvandningsomrade-Egenskaper" : [ "Hormonella preventivmedel/Mot: Endometriehyperplasi/Medroxiprogesteronacetat-metabolit" ] }, { "@id" : "200", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Mefenaminsyra", "@language" : "sv" } ], "VocabularyConceptId" : "349362", "VocabularyId" : "73", "Identifier" : "200", "Label" : "Mefenaminsyra", "Definition" : null, "Notation" : "CH10/200", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Mefenamic acid" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "2-(2,3-Dimethylphenyl)aminobenzoic acid" ], "CAS-Nr" : [ "61-68-7" ], "EC-Nr" : [ "200-513-1" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Arylaminer/Bensoesyror" ], "Anvandningsomrade-Egenskaper" : [ "Analgetika/Antiinflammatoriska medel/Antipyretika/Mot: Reumatism/NSAID (Non-steroidal anti-inflammatory drugs)" ] }, { "@id" : "201", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Megestrol", "@language" : "sv" } ], "VocabularyConceptId" : "349363", "VocabularyId" : "73", "Identifier" : "201", "Label" : "Megestrol", "Definition" : null, "Notation" : "CH10/201", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Megestrol" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione" ], "CAS-Nr" : [ "3562-63-8" ], "EC-Nr" : [ "222-628-6" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Syntetiska progestagener" ], "Anvandningsomrade-Egenskaper" : [ "Hormonella preventivmedel/Cancermedicin/Mot: Tapp av aptit + vikt i AIDS-patienter/Megestrolacetat-metabolit" ] }, { "@id" : "202", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Meklofenamsyra", "@language" : "sv" } ], "VocabularyConceptId" : "349364", "VocabularyId" : "73", "Identifier" : "202", "Label" : "Meklofenamsyra", "Definition" : null, "Notation" : "CH10/202", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Meclofenamic acid" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "2-[(2,6-Dichloro-3-methylphenyl)amino]benzoic acid" ], "CAS-Nr" : [ "644-62-2" ], "EC-Nr" : [ "211-419-5" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Klorerade aromater/Antranilsyror" ], "Anvandningsomrade-Egenskaper" : [ "Analgetika/Antiinflammatoriska medel/Antipyretika/Mot: Dysmenorré, Artrit/Veterinärmedicin/NSAID (Non-steroidal anti-inflammatory drugs)" ] }, { "@id" : "203", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Meklozin", "@language" : "sv" } ], "VocabularyConceptId" : "349365", "VocabularyId" : "73", "Identifier" : "203", "Label" : "Meklozin", "Definition" : null, "Notation" : "CH10/203", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Meclozine" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(RS)-1-[(4-Chlorophenyl)(phenyl)methyl]-4-(3-methylbenzyl)piperazine" ], "CAS-Nr" : [ "569-65-3" ], "EC-Nr" : [ "209-323-3" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Klorerade aromater/Piperaziner" ], "Anvandningsomrade-Egenskaper" : [ "Antihistaminer/Antiemetika" ] }, { "@id" : "204", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Memantin", "@language" : "sv" } ], "VocabularyConceptId" : "349366", "VocabularyId" : "73", "Identifier" : "204", "Label" : "Memantin", "Definition" : null, "Notation" : "CH10/204", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Memantine" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "3,5-Dimethyltricyclo[3.3.1.13,7]decan-1amine; 3,5-dimethyladamantan-1-amine" ], "CAS-Nr" : [ "19982-08-2" ], "EC-Nr" : [ "saknas" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Adamantan-derivat" ], "Anvandningsomrade-Egenskaper" : [ "Alzheimermedicin" ] }, { "@id" : "205", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Meprobamat", "@language" : "sv" } ], "VocabularyConceptId" : "349367", "VocabularyId" : "73", "Identifier" : "205", "Label" : "Meprobamat", "Definition" : null, "Notation" : "CH10/205", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Meprobamate" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "2-[(Carbamoyloxy)methyl]-2-methylpentyl carbamate" ], "CAS-Nr" : [ "57-53-4" ], "EC-Nr" : [ "200-337-5" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Karbamater" ], "Anvandningsomrade-Egenskaper" : [ "Sömnmedel/Sedativa/Narkotikaklassad" ] }, { "@id" : "206", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Mestranol", "@language" : "sv" } ], "VocabularyConceptId" : "349368", "VocabularyId" : "73", "Identifier" : "206", "Label" : "Mestranol", "Definition" : null, "Notation" : "CH10/206", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Mestranol" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(17α)-3-Methoxy-19-norpregna-1(10),2,4-trien-20-yn-17-ol" ], "CAS-Nr" : [ "72-33-3" ], "EC-Nr" : [ "200-777-8" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Steroidhormoner/Syntetiska östrogener" ], "Anvandningsomrade-Egenskaper" : [ "Hormonella preventivmedel/Hormonersättning" ] }, { "@id" : "207", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Metformin", "@language" : "sv" } ], "VocabularyConceptId" : "349369", "VocabularyId" : "73", "Identifier" : "207", "Label" : "Metformin", "Definition" : null, "Notation" : "CH10/207", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Metformin" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "N,N-Dimethylimidodicarbonimidic diamide" ], "CAS-Nr" : [ "657-24-9" ], "EC-Nr" : [ "211-517-8" ], "WFD" : [ "Watch" ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Biguanider" ], "Anvandningsomrade-Egenskaper" : [ "Antidiabetika/Mot: Hyperglykemi, Polycystiskt ovariesyndrom (PCOS)/Hämmar glukoneogenesen/Minskar insulinresistensen + ökar glukosupptag i skelettmuskelceller/Minskar glukosupptag i tarmarna" ] }, { "@id" : "208", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Meticillin", "@language" : "sv" } ], "VocabularyConceptId" : "349370", "VocabularyId" : "73", "Identifier" : "208", "Label" : "Meticillin", "Definition" : null, "Notation" : "CH10/208", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Methicillin" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(2S,5R,6R)-6-(2,6-Dimethoxybenzamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid" ], "CAS-Nr" : [ "61-32-5" ], "EC-Nr" : [ "200-505-8" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Beta-laktamer/Penicilliner" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika" ] }, { "@id" : "209", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Metoprolol", "@language" : "sv" } ], "VocabularyConceptId" : "349371", "VocabularyId" : "73", "Identifier" : "209", "Label" : "Metoprolol", "Definition" : "ChSp/PubCh/ECHA/WIKI", "Notation" : "CH10/209", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Metoprolol" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "1-[4-(2-methoxyethyl)phenoxy]-3-(propan-2-ylamino)propan-2-ol; 1-(Isopropylamino)-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol" ], "CAS-Nr" : [ "37350-58-6; 51384-51-1" ], "EC-Nr" : [ "253-483-7" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Metoxi-, Fenoxi-alkaner/Aminer/Alkoholer" ], "Anvandningsomrade-Egenskaper" : [ "Mot: Hjärtproblem (Angina, Arytmi, Hjärtklappning), Högt blodtryck, Migrän/Beta-blockerare" ] }, { "@id" : "210", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Metyldietylkarbamoditioat", "@language" : "sv" } ], "VocabularyConceptId" : "349372", "VocabularyId" : "73", "Identifier" : "210", "Label" : "Metyldietylkarbamoditioat", "Definition" : null, "Notation" : "CH10/210", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Methyl diethylcarbamodithioate" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "Methyl diethylcarbamodithioate" ], "CAS-Nr" : [ "686-07-7" ], "EC-Nr" : [ "saknas" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Karbamater" ], "Anvandningsomrade-Egenskaper" : [ "Antabus (Disulfiram)-metabolit" ] }, { "@id" : "211", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Metylfenobarbital", "@language" : "sv" } ], "VocabularyConceptId" : "349373", "VocabularyId" : "73", "Identifier" : "211", "Label" : "Metylfenobarbital", "Definition" : null, "Notation" : "CH10/211", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Methylphenobarbital" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "5-Phenyl-5-ethyl-1-methylbarbituric acid" ], "CAS-Nr" : [ "115-38-8" ], "EC-Nr" : [ "204-085-7" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Barbiturater" ], "Anvandningsomrade-Egenskaper" : [ "Antiepileptika/Sömnmedel/Narkotikaklassad" ] }, { "@id" : "212", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Mevastatin", "@language" : "sv" } ], "VocabularyConceptId" : "349374", "VocabularyId" : "73", "Identifier" : "212", "Label" : "Mevastatin", "Definition" : null, "Notation" : "CH10/212", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Mevastatin" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(1S,7R,8S,8aR)-8-{2-[(2R,4R)-4-Hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-7-methyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (2S)-2-methylbutanoate" ], "CAS-Nr" : [ "73573-88-3" ], "EC-Nr" : [ "700-442-0" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Laktoner" ], "Anvandningsomrade-Egenskaper" : [ "Blodfettssänkande mediciner/Statiner" ] }, { "@id" : "213", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Mianserin", "@language" : "sv" } ], "VocabularyConceptId" : "349375", "VocabularyId" : "73", "Identifier" : "213", "Label" : "Mianserin", "Definition" : null, "Notation" : "CH10/213", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Mianserin" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(±)-2-Methyl-1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine" ], "CAS-Nr" : [ "24219-97-4" ], "EC-Nr" : [ "246-088-6" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Dibensohydrazinoazepiner" ], "Anvandningsomrade-Egenskaper" : [ "Antidepressiva/Sedativa/TeCA: Tetra-Cykliska Antidepressiva" ] }, { "@id" : "214", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Mikonazol", "@language" : "sv" } ], "VocabularyConceptId" : "349376", "VocabularyId" : "73", "Identifier" : "214", "Label" : "Mikonazol", "Definition" : null, "Notation" : "CH10/214", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Miconazole" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(RS)-1-(2-(2,4-Dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl)-1H-imidazole" ], "CAS-Nr" : [ "22916-47-8" ], "EC-Nr" : [ "245-324-5" ], "WFD" : [ "Watch" ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Klorerade aromater/Imidazoler" ], "Anvandningsomrade-Egenskaper" : [ "Fungicider" ] }, { "@id" : "215", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Minocyklin", "@language" : "sv" } ], "VocabularyConceptId" : "349377", "VocabularyId" : "73", "Identifier" : "215", "Label" : "Minocyklin", "Definition" : null, "Notation" : "CH10/215", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Minocycline" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(2E,4S,4aR,5aS,12aR)- 2-(Amino-hydroxy-methylidene)- 4,7-bis(dimethylamino)- 10,11,12a-trihydroxy-4a,5,5a,6- tetrahydro-4H-tetracene- 1,3,12-trione" ], "CAS-Nr" : [ "13614-98-7" ], "EC-Nr" : [ "237-099-7" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Tetracykliner" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika" ] }, { "@id" : "216", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Mirtazapin", "@language" : "sv" } ], "VocabularyConceptId" : "349378", "VocabularyId" : "73", "Identifier" : "216", "Label" : "Mirtazapin", "Definition" : "ChSp/PubCh/ECHA/WIKI", "Notation" : "CH10/216", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Mirtazapine" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "5-Methyl-2,5,19-triazatetracyclo[13.4.0.02,7.08,13]nonadeca-1(15),8,10,12,16,18-hexaene; 2-Methyl-1,2,3,4,10,14b-hexahydropyrazino[2,1-a]pyrido[2,3-c][2]benzazepine" ], "CAS-Nr" : [ "85650-52-8" ], "EC-Nr" : [ "288-060-6" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Bensazepiner" ], "Anvandningsomrade-Egenskaper" : [ "Antidepressiva/Sedativa/TeCA: Tetra-Cykliska Antidepressiva" ] }, { "@id" : "217", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Morantel", "@language" : "sv" } ], "VocabularyConceptId" : "349379", "VocabularyId" : "73", "Identifier" : "217", "Label" : "Morantel", "Definition" : null, "Notation" : "CH10/217", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Morantel" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "1-Methyl-2-[(E)-2-(3-methylthiophen-2-yl)ethenyl]-5,6-dihydro-4H-pyrimidine" ], "CAS-Nr" : [ "20574-50-9" ], "EC-Nr" : [ "243-890-8" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Tiofener/Pyrimidiner" ], "Anvandningsomrade-Egenskaper" : [ "Antiparasitika/Helminticider, \"maskmedel\"/Veterinärmedicin" ] }, { "@id" : "218", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Morfin", "@language" : "sv" } ], "VocabularyConceptId" : "349380", "VocabularyId" : "73", "Identifier" : "218", "Label" : "Morfin", "Definition" : null, "Notation" : "CH10/218", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Morphine" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(5α,6α)-17-Methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol" ], "CAS-Nr" : [ "57-27-2" ], "EC-Nr" : [ "200-320-2" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Alkaloider/Opiater/Fenoler/Alkoholer/Etrar" ], "Anvandningsomrade-Egenskaper" : [ "Droger/Analgetika/Narkotikaklassad" ] }, { "@id" : "219", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Moxidektin", "@language" : "sv" } ], "VocabularyConceptId" : "349381", "VocabularyId" : "73", "Identifier" : "219", "Label" : "Moxidektin", "Definition" : null, "Notation" : "CH10/219", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Moxidectin" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(10E,14E,16E)-(1R,4S,5′S,6R,6′S,8R,13R,20R,21R,24S)-6′-[(1E)-1,3-Dimethylbut-1-enyl]-21,24-dihydroxy-5′,11,13,22-tetramethyl-(3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene)-6-spiro-2′-(tetrahydropyran)-2,4′-dione 4′-(E)-(O-methyloxime)" ], "CAS-Nr" : [ "113507-06-5" ], "EC-Nr" : [ "saknas" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Milbemyciner" ], "Anvandningsomrade-Egenskaper" : [ "Antiparasitika/Helminticider, \"maskmedel\"/Veterinärmedicin/Insekticider/Akaricider" ] }, { "@id" : "220", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Nadolol", "@language" : "sv" } ], "VocabularyConceptId" : "349382", "VocabularyId" : "73", "Identifier" : "220", "Label" : "Nadolol", "Definition" : null, "Notation" : "CH10/220", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Nadolol" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(2R,3S)-5-[2-Hydroxy-3-(tert-butylamino)propoxy]tetralin-2,3-diol" ], "CAS-Nr" : [ "42200-33-9" ], "EC-Nr" : [ "255-706-3" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Hydroxinaftalener" ], "Anvandningsomrade-Egenskaper" : [ "Mot: Hjärtproblem (Angina, Arytmi, Förmaksflimmer), Högt blodtryck, Migrän/Beta-blockerare" ] }, { "@id" : "221", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Nafcillin", "@language" : "sv" } ], "VocabularyConceptId" : "349383", "VocabularyId" : "73", "Identifier" : "221", "Label" : "Nafcillin", "Definition" : null, "Notation" : "CH10/221", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Nafcillin" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(2S,5R,6R)-6-[(2-Ethoxy-1-naphthoyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid" ], "CAS-Nr" : [ "147-52-4" ], "EC-Nr" : [ "205-690-9" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Beta-laktamer" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika/Penicillin" ] }, { "@id" : "222", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Naloxon", "@language" : "sv" } ], "VocabularyConceptId" : "349384", "VocabularyId" : "73", "Identifier" : "222", "Label" : "Naloxon", "Definition" : null, "Notation" : "CH10/222", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Naloxone" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(5α)-17-Allyl-3,14-dihydroxy-4,5-epoxymorphinan-6-one" ], "CAS-Nr" : [ "465-65-6" ], "EC-Nr" : [ "207-365-7" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Opioider/Alkaloider" ], "Anvandningsomrade-Egenskaper" : [ "Mot: Effekterna av opioidöverdosering/Opoid-antagonister" ] }, { "@id" : "223", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Nandrolon", "@language" : "sv" } ], "VocabularyConceptId" : "349385", "VocabularyId" : "73", "Identifier" : "223", "Label" : "Nandrolon", "Definition" : null, "Notation" : "CH10/223", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Nandrolone" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "17β-Hydroxyestra-4-en-3-one" ], "CAS-Nr" : [ "434-22-0" ], "EC-Nr" : [ "207-101-0" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Steroider" ], "Anvandningsomrade-Egenskaper" : [ "Anabola steroider" ] }, { "@id" : "224", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Naproxen", "@language" : "sv" } ], "VocabularyConceptId" : "349386", "VocabularyId" : "73", "Identifier" : "224", "Label" : "Naproxen", "Definition" : null, "Notation" : "CH10/224", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Naproxen" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(+)-(S)-2-(6-Methoxynaphthalen-2-yl)propanoic acid" ], "CAS-Nr" : [ "22204-53-1" ], "EC-Nr" : [ "244-838-7" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Naftalener/Propionsyror" ], "Anvandningsomrade-Egenskaper" : [ "Antiinflammatoriska medel/Analgetika/Antipyretika/NSAID (Non-steroidal anti-inflammatory drugs)" ] }, { "@id" : "225", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Naproxen-(R)-O-desmetyl", "@language" : "sv" } ], "VocabularyConceptId" : "349387", "VocabularyId" : "73", "Identifier" : "225", "Label" : "Naproxen-(R)-O-desmetyl", "Definition" : null, "Notation" : "CH10/225", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Naproxen-(R)-O-desmethyl; (R)-O-Desmethyl-naproxen" ], "Synonym_1" : [ "(R)-O-Desmetyl-naproxen" ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(2R)-2-(6-Hydroxy-2-naphthyl)propanoic acid" ], "CAS-Nr" : [ "123050-98-6" ], "EC-Nr" : [ "saknas" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Hydroxinaftalener/Karboxylsyror" ], "Anvandningsomrade-Egenskaper" : [ "Antiinflammatoriska medel/Naproxen-metabolit" ] }, { "@id" : "226", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "N-Demetylflunitrazepam", "@language" : "sv" } ], "VocabularyConceptId" : "349388", "VocabularyId" : "73", "Identifier" : "226", "Label" : "N-Demetylflunitrazepam", "Definition" : null, "Notation" : "CH10/226", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "N-Demethylflunitrazepam" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "7-Fluoro-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one" ], "CAS-Nr" : [ "2648-00-2" ], "EC-Nr" : [ "saknas" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Bensodiazepiner" ], "Anvandningsomrade-Egenskaper" : [ "Sömnmedel/Sedativa/Muskelavslappnande/Flunitrazepam-metabolit" ] }, { "@id" : "227", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Nefazodon", "@language" : "sv" } ], "VocabularyConceptId" : "349389", "VocabularyId" : "73", "Identifier" : "227", "Label" : "Nefazodon", "Definition" : null, "Notation" : "CH10/227", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Nefazodone" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "1-(3-[4-(3-Chlorophenyl)piperazin-1-yl]propyl)-3-ethyl-4-(2-phenoxyethyl)-1H-1,2,4-triazol-5(4H)-one" ], "CAS-Nr" : [ "83366-66-9" ], "EC-Nr" : [ "saknas" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Klororganiska ämnen/Triazoloner/Piperaziner/Karbamider/Fenoletrar/Ureater" ], "Anvandningsomrade-Egenskaper" : [ "Antidepressiva/SSRI: Selektiva Serotoninåterupptagshämmare" ] }, { "@id" : "228", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Neomycin B", "@language" : "sv" } ], "VocabularyConceptId" : "349390", "VocabularyId" : "73", "Identifier" : "228", "Label" : "Neomycin B", "Definition" : null, "Notation" : "CH10/228", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Neomycin B; Framycetin" ], "Synonym_1" : [ "Framycetin" ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(1R,2R,3S,4R,6S)-4,6-Diamino-2-{[3-O-(2,6-diamino-2,6-dideoxy-β-L-idopyranosyl)- β-D-ribofuranosyl]oxy}-3-hydroxycyclohexyl 2,6-diamino-2,6-dideoxy-α-D-glucopyranoside" ], "CAS-Nr" : [ "1404-04-2; 119-04-0" ], "EC-Nr" : [ "204-292-2" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Aminoglykosider" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika" ] }, { "@id" : "229", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "N-Metylfenacetin", "@language" : "sv" } ], "VocabularyConceptId" : "349391", "VocabularyId" : "73", "Identifier" : "229", "Label" : "N-Metylfenacetin", "Definition" : null, "Notation" : "CH10/229", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "N-Methylphenacetine" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "N-(4-ethoxyphenyl)-N-methylacetamide " ], "CAS-Nr" : [ "7298-73-9" ], "EC-Nr" : [ "saknas" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Acetamider/Etoxyfenoler" ], "Anvandningsomrade-Egenskaper" : [ "Mot: Feber, Migrän, Ledgångsreumatism och Huvudvärk/Fenacitin-metabolit" ] }, { "@id" : "230", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Noretindron", "@language" : "sv" } ], "VocabularyConceptId" : "349392", "VocabularyId" : "73", "Identifier" : "230", "Label" : "Noretindron", "Definition" : null, "Notation" : "CH10/230", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Norethindrone; Norethisterone" ], "Synonym_1" : [ "Noretisteron" ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(8R,9S,10R,13S,14S,17S)-17-Ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one" ], "CAS-Nr" : [ "68-22-4" ], "EC-Nr" : [ "200-681-6" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Steroidhormoner/Progestagener" ], "Anvandningsomrade-Egenskaper" : [ "Hormonella preventivmedel/Mot: PMS, Dysmenorré, m.fl" ] }, { "@id" : "231", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Norfentanyl", "@language" : "sv" } ], "VocabularyConceptId" : "349393", "VocabularyId" : "73", "Identifier" : "231", "Label" : "Norfentanyl", "Definition" : null, "Notation" : "CH10/231", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Norfentanyl" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "N-Phenyl-N-(4-piperidinyl)propanamide" ], "CAS-Nr" : [ "1609-66-1" ], "EC-Nr" : [ "216-543-3" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Opioider/Alkaloider" ], "Anvandningsomrade-Egenskaper" : [ "Analgetika/Anestetika/Fentanyl-metabolit" ] }, { "@id" : "232", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Norfloxacin", "@language" : "sv" } ], "VocabularyConceptId" : "349394", "VocabularyId" : "73", "Identifier" : "232", "Label" : "Norfloxacin", "Definition" : null, "Notation" : "CH10/232", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Norfloxacin" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "1-Ethyl-6-fluoro-4-oxo-7-(1-piperazinyl)-1,4-dihydro-3-quinolinecarboxylic acid" ], "CAS-Nr" : [ "70458-96-7" ], "EC-Nr" : [ "274-614-4" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Fluorkinoloner/Piperaziner" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika" ] }, { "@id" : "233", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Norpropoxifen", "@language" : "sv" } ], "VocabularyConceptId" : "349395", "VocabularyId" : "73", "Identifier" : "233", "Label" : "Norpropoxifen", "Definition" : null, "Notation" : "CH10/233", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Norpropoxyphene" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(2S,3R)-3-Methyl-4-(methylamino)-1,2-diphenyl-2-butanyl propionate" ], "CAS-Nr" : [ "3376-94-1" ], "EC-Nr" : [ "saknas" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Opioider/Alkaloider" ], "Anvandningsomrade-Egenskaper" : [ "Analgetika/Anestetika/Dextropropoxifen-metabolit" ] }, { "@id" : "234", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Novobiocin", "@language" : "sv" } ], "VocabularyConceptId" : "349396", "VocabularyId" : "73", "Identifier" : "234", "Label" : "Novobiocin", "Definition" : null, "Notation" : "CH10/234", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Novobiocin" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "[(3R,4S,5R,6R)-5-Hydroxy-6-[4-hydroxy-3-[[4-hydroxy-3-(3-methylbut-2-enyl)benzoyl]amino]-8-methyl-2-oxochromen-7-yl]oxy-3-methoxy-2,2-dimethyloxan-4-yl] carbamate" ], "CAS-Nr" : [ "1476-53-5" ], "EC-Nr" : [ "303-81-1" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Aminokumariner" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika" ] }, { "@id" : "235", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Ofloxacin", "@language" : "sv" } ], "VocabularyConceptId" : "349397", "VocabularyId" : "73", "Identifier" : "235", "Label" : "Ofloxacin", "Definition" : null, "Notation" : "CH10/235", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Ofloxacin" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(RS)-7-Fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid" ], "CAS-Nr" : [ "82419-36-1" ], "EC-Nr" : [ "617-457-2" ], "WFD" : [ "Watch" ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Fluorkinoloner/Piperaziner" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika" ] }, { "@id" : "236", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Oleandomycin", "@language" : "sv" } ], "VocabularyConceptId" : "349398", "VocabularyId" : "73", "Identifier" : "236", "Label" : "Oleandomycin", "Definition" : null, "Notation" : "CH10/236", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Oleandomycin" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "6-(4-Dimethylamino-3-hydroxy-6-methyl-oxan-2-yl)oxy-14-hydroxy-8-(5-hydroxy-4-methoxy-6-methyl-oxan-2-yl)oxy-5,7,9,12,13,15-hexamethyl-2,11-dioxaspiro[2.13]hexadecane-10,16-dione" ], "CAS-Nr" : [ "3922-90-5" ], "EC-Nr" : [ "223-495-7" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Makrolider" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika" ] }, { "@id" : "237", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Omeprazol", "@language" : "sv" } ], "VocabularyConceptId" : "349399", "VocabularyId" : "73", "Identifier" : "237", "Label" : "Omeprazol", "Definition" : null, "Notation" : "CH10/237", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Omeprazole" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(RS)-5-Methoxy-2-((4-methoxy-3,5-dimethylpyridin-2-yl) methylsulfinyl)-1H-benzo[d]imidazole" ], "CAS-Nr" : [ "73590-58-6" ], "EC-Nr" : [ "615-996-8" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Bensimidazoler/Fenoletrar/Pyridiner/Sulfoxider" ], "Anvandningsomrade-Egenskaper" : [ "Protonpumpshämmare/Mot: Magsår, Dyspepsi, Refluxer, m.fl." ] }, { "@id" : "238", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Orfenadrin", "@language" : "sv" } ], "VocabularyConceptId" : "349400", "VocabularyId" : "73", "Identifier" : "238", "Label" : "Orfenadrin", "Definition" : null, "Notation" : "CH10/238", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Orphenadrine" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "N,N-Dimethyl-2-[(2-methylphenyl)- phenyl-methoxy]-ethanamine" ], "CAS-Nr" : [ "83-98-7" ], "EC-Nr" : [ "201-509-2" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Etanolaminderivat/Etrar" ], "Anvandningsomrade-Egenskaper" : [ "Analgetika/Antispasmolytika/Anti-Parkinson-läkemedel/Muskarin-antagonister" ] }, { "@id" : "239", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Oxacillin", "@language" : "sv" } ], "VocabularyConceptId" : "349401", "VocabularyId" : "73", "Identifier" : "239", "Label" : "Oxacillin", "Definition" : null, "Notation" : "CH10/239", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Oxacillin" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(2S,5R,6R)-6-({[3-(2-Chlorophenyl)-5-methyl-1,2-oxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid" ], "CAS-Nr" : [ "66-79-5" ], "EC-Nr" : [ "200-635-5" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Beta-laktamer/Penicilliner" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika" ] }, { "@id" : "240", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Oxazepam", "@language" : "sv" } ], "VocabularyConceptId" : "349402", "VocabularyId" : "73", "Identifier" : "240", "Label" : "Oxazepam", "Definition" : null, "Notation" : "CH10/240", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Oxazepam; Sobril" ], "Synonym_1" : [ "Sobril" ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "7-Chloro-3-hydroxy-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one" ], "CAS-Nr" : [ "604-75-1" ], "EC-Nr" : [ "210-076-9" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Klorerade aromater/Bensodiazepiner" ], "Anvandningsomrade-Egenskaper" : [ "Ångestdämpande/Sedativa" ] }, { "@id" : "241", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Oxfendazol", "@language" : "sv" } ], "VocabularyConceptId" : "349403", "VocabularyId" : "73", "Identifier" : "241", "Label" : "Oxfendazol", "Definition" : null, "Notation" : "CH10/241", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Oxfendazole" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "Methyl N-[6-(benzenesulfinyl)-1H-1,3-benzodiazol-2-yl]carbamate" ], "CAS-Nr" : [ "53716-50-0" ], "EC-Nr" : [ "258-714-5" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Bensimidazoler/Sulfinyler/Karbamater" ], "Anvandningsomrade-Egenskaper" : [ "Antiparasitika/Helminticider, \"maskmedel\"/Veterinärmedicin" ] }, { "@id" : "242", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Oxikodon", "@language" : "sv" } ], "VocabularyConceptId" : "349404", "VocabularyId" : "73", "Identifier" : "242", "Label" : "Oxikodon", "Definition" : null, "Notation" : "CH10/242", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Oxycodone" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(5α)-14-Hydroxy-3-methoxy-17-methyl-4,5-epoxymorphinan-6-one" ], "CAS-Nr" : [ "76-42-6" ], "EC-Nr" : [ "200-960-2" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Opioider/Morfinaner/Ketoner/Alkoholer/Fenoletrar" ], "Anvandningsomrade-Egenskaper" : [ "Analgetika/Narkotikaklassad" ] }, { "@id" : "243", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Oxolinsyra", "@language" : "sv" } ], "VocabularyConceptId" : "349405", "VocabularyId" : "73", "Identifier" : "243", "Label" : "Oxolinsyra", "Definition" : null, "Notation" : "CH10/243", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Oxalinic acid" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "5-Ethyl-8-oxo-5,8-dihydro[1,3]dioxolo[4,5-g]quinoline-7-carboxylic acid" ], "CAS-Nr" : [ "14698-29-4" ], "EC-Nr" : [ "238-750-8" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Kinoloner" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika" ] }, { "@id" : "244", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Oxprenolol", "@language" : "sv" } ], "VocabularyConceptId" : "349406", "VocabularyId" : "73", "Identifier" : "244", "Label" : "Oxprenolol", "Definition" : null, "Notation" : "CH10/244", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Oxprenolol" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(RS)-1-[2-(Allyloxy)phenoxy]-3-(isopropylamino)propan-2-ol" ], "CAS-Nr" : [ "6452-71-7" ], "EC-Nr" : [ "229-257-9" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Fenoletrar/Alkylaminer/Alkoholer" ], "Anvandningsomrade-Egenskaper" : [ "Sympatomimetika/Vid: Hjärtstopp, Blodtrycksfall, Anafylaxi/Beta-blockerare" ] }, { "@id" : "245", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Oxitetracyklin", "@language" : "sv" } ], "VocabularyConceptId" : "349407", "VocabularyId" : "73", "Identifier" : "245", "Label" : "Oxitetracyklin", "Definition" : "ChSp/PubCh/ECHA/WIKI", "Notation" : "CH10/245", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Oxytetracycline" ], "Synonym_1" : [ "Oxytetracyklin" ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(4S,4aR,5S,5aR,6S,12aS)-4-(Dimethylamino)-3,5,6,10,11,12a-hexahydroxy -6-methyl-1,12-dioxo-1,4,4a,5,5a,6,12,12a-octahydrotetracene -2-carboxamide; (4S,4aR,5S,5aR,6S,12aS)-4-(Dimethylamino)-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-2-tetracenecarboxamide" ], "CAS-Nr" : [ "79-57-2" ], "EC-Nr" : [ "201-212-8" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Tetracykliner" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika" ] }, { "@id" : "246", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Paracetamol", "@language" : "sv" } ], "VocabularyConceptId" : "349408", "VocabularyId" : "73", "Identifier" : "246", "Label" : "Paracetamol", "Definition" : null, "Notation" : "CH10/246", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Paracetamol" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "N-(4-Hydroxyphenyl)acetamide" ], "CAS-Nr" : [ "103-90-2" ], "EC-Nr" : [ "203-157-5" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Fenoler/Amider" ], "Anvandningsomrade-Egenskaper" : [ "Analgetika/Antipyretika" ] }, { "@id" : "247", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Paroxetin", "@language" : "sv" } ], "VocabularyConceptId" : "349409", "VocabularyId" : "73", "Identifier" : "247", "Label" : "Paroxetin", "Definition" : null, "Notation" : "CH10/247", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Paroxetine" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(3S,4R)-3-[(2H-1,3-Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine" ], "CAS-Nr" : [ "61869-08-7" ], "EC-Nr" : [ "600-962-7: Paroxetine, hydrochloride, hydrate (2:2:1)" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Bensodioxoler/Fluorfenyler/Piperidiner/Fenoletrar" ], "Anvandningsomrade-Egenskaper" : [ "Antidepressiva/SSRI: Selektiva Serotoninåterupptagshämmare" ] }, { "@id" : "248", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Penicillin G", "@language" : "sv" } ], "VocabularyConceptId" : "349410", "VocabularyId" : "73", "Identifier" : "248", "Label" : "Penicillin G", "Definition" : null, "Notation" : "CH10/248", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Penicillin G; Benzylpenicillin" ], "Synonym_1" : [ "Bensylpenicillin" ], "Synonym_2" : [ "Kåvepenin" ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(2S,5R,6R)-3,3-Dimethyl-7-oxo-6-(2-phenylacetamido)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid" ], "CAS-Nr" : [ "61-33-6" ], "EC-Nr" : [ "200-506-3" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Beta-laktamer/Penicilliner" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika" ] }, { "@id" : "249", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Penicillin V", "@language" : "sv" } ], "VocabularyConceptId" : "349411", "VocabularyId" : "73", "Identifier" : "249", "Label" : "Penicillin V", "Definition" : null, "Notation" : "CH10/249", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Penicillin V; Phenoxymethylpenicillin" ], "Synonym_1" : [ "Fenoxymetylpenicillin" ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "3,3-Dimethyl-6-oxo-7-(2-phenoxyacetyl)amino-2-thia-5-azabicyclo[3.2.0]heptane-4-carboxylic acid" ], "CAS-Nr" : [ "87-08-1" ], "EC-Nr" : [ "201-722-0" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Beta-laktamer" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika" ] }, { "@id" : "250", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Pentobarbital", "@language" : "sv" } ], "VocabularyConceptId" : "349412", "VocabularyId" : "73", "Identifier" : "250", "Label" : "Pentobarbital", "Definition" : null, "Notation" : "CH10/250", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Pentobarbital; Nembutal" ], "Synonym_1" : [ "Nembutal" ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione" ], "CAS-Nr" : [ "76-74-4" ], "EC-Nr" : [ "200-983-8" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Barbiturater" ], "Anvandningsomrade-Egenskaper" : [ "Anestetika/Sedativa/Sömnmedel/Antikonvulsiva/Narkotikaklassad" ] }, { "@id" : "251", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Pentoxifyllin", "@language" : "sv" } ], "VocabularyConceptId" : "349413", "VocabularyId" : "73", "Identifier" : "251", "Label" : "Pentoxifyllin", "Definition" : null, "Notation" : "CH10/251", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Pentoxifylline" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "3,7-Dimethyl-1-(5-oxohexyl)-3,7-dihydro-1H-purine-2,6-dione" ], "CAS-Nr" : [ "6493-05-6" ], "EC-Nr" : [ "229-374-5" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Xantiner/Ketoner" ], "Anvandningsomrade-Egenskaper" : [ "Vasodilativa/Mot: Fönstertittarsjuka, m.fl." ] }, { "@id" : "252", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Perfenazin", "@language" : "sv" } ], "VocabularyConceptId" : "349414", "VocabularyId" : "73", "Identifier" : "252", "Label" : "Perfenazin", "Definition" : null, "Notation" : "CH10/252", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Perphenazine" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "2-{4-[3-(2-Chloro-10H-phenothiazin-10-yl)propyl]-1-piperazinyl}ethanol" ], "CAS-Nr" : [ "58-39-9" ], "EC-Nr" : [ "200-381-5" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Piperacinyler/Fenotiaziner" ], "Anvandningsomrade-Egenskaper" : [ "Antipsykotika" ] }, { "@id" : "253", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Pindolol", "@language" : "sv" } ], "VocabularyConceptId" : "349415", "VocabularyId" : "73", "Identifier" : "253", "Label" : "Pindolol", "Definition" : null, "Notation" : "CH10/253", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Pindolol" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(RS)-1-(1H-Indol-4-yloxy)-3-(isopropylamino)propan-2-ol" ], "CAS-Nr" : [ "13523-86-9" ], "EC-Nr" : [ "236-867-9" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Indoler/Aminer" ], "Anvandningsomrade-Egenskaper" : [ "Mot: Hypertoni, Angina, Hjärtarytmi/Beta-blockerare" ] }, { "@id" : "254", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Pipamperon", "@language" : "sv" } ], "VocabularyConceptId" : "349416", "VocabularyId" : "73", "Identifier" : "254", "Label" : "Pipamperon", "Definition" : null, "Notation" : "CH10/254", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Pipamperone" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "1'-[4-(4-Fluorophenyl)-4-oxobutyl]-1,4'-bipiperidine-4'-carboxamide" ], "CAS-Nr" : [ "1893-33-0" ], "EC-Nr" : [ "606-172-9" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Butyrofenoner/Fluorfenyler/Piperidiner/Karboximider" ], "Anvandningsomrade-Egenskaper" : [ "Antipsykotika" ] }, { "@id" : "255", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Pizotifen", "@language" : "sv" } ], "VocabularyConceptId" : "349417", "VocabularyId" : "73", "Identifier" : "255", "Label" : "Pizotifen", "Definition" : null, "Notation" : "CH10/255", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Pizotifen" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "4-(1-Methyl-4-piperidylidine)-9,10-dihydro -4H-benzo-[4,5]cyclohepta[1,2]-thiophene" ], "CAS-Nr" : [ "15574-96-6" ], "EC-Nr" : [ "239-632-9" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Bensocykloheptener/Piperidiner/Tiofener" ], "Anvandningsomrade-Egenskaper" : [ "Migränmedicin" ] }, { "@id" : "256", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Pravastatin", "@language" : "sv" } ], "VocabularyConceptId" : "349418", "VocabularyId" : "73", "Identifier" : "256", "Label" : "Pravastatin", "Definition" : null, "Notation" : "CH10/256", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Pravastatin" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(3R,5R)-3,5-Dihydroxy-7-((1R,2S,6S,8R,8aR)-6-hydroxy-2-methyl-8-{[(2S)-2-methylbutanoyl]oxy}-1,2,6,7,8,8a-hexahydronaphthalen-1-yl)-heptanoic acid" ], "CAS-Nr" : [ "81093-37-0" ], "EC-Nr" : [ "saknas" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Karboxylatestrar/Karboxylsyror/Naftalener/Dioler" ], "Anvandningsomrade-Egenskaper" : [ "Blodfettssänkande mediciner/Statiner" ] }, { "@id" : "257", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Prednisolon", "@language" : "sv" } ], "VocabularyConceptId" : "349419", "VocabularyId" : "73", "Identifier" : "257", "Label" : "Prednisolon", "Definition" : null, "Notation" : "CH10/257", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Prednisolone" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(11β)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione" ], "CAS-Nr" : [ "50-24-8" ], "EC-Nr" : [ "200-021-7" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Glukokortikoider" ], "Anvandningsomrade-Egenskaper" : [ "Antiinflammatoriska medel/Mot autoimmuna sjukdomar: Astma, Reumatism, MS, Chrons sjukdom, m.fl./Aktiv Prednison-metabolit" ] }, { "@id" : "258", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Primidon", "@language" : "sv" } ], "VocabularyConceptId" : "349420", "VocabularyId" : "73", "Identifier" : "258", "Label" : "Primidon", "Definition" : null, "Notation" : "CH10/258", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Primidone" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "5-Ethyl-5-phenylperhydropyrimidine-4,6-dione" ], "CAS-Nr" : [ "125-33-7" ], "EC-Nr" : [ "204-737-0" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Pyrimidindioner" ], "Anvandningsomrade-Egenskaper" : [ "Antiepileptika/Kramplösande" ] }, { "@id" : "259", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Progesteron", "@language" : "sv" } ], "VocabularyConceptId" : "349421", "VocabularyId" : "73", "Identifier" : "259", "Label" : "Progesteron", "Definition" : null, "Notation" : "CH10/259", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Progesterone" ], "Synonym_1" : [ "Gulkroppshormon" ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "Pregn-4-ene-3,20-dione" ], "CAS-Nr" : [ "57-83-0" ], "EC-Nr" : [ "200-350-6" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Endogena steroidhormoner/Progestagener" ], "Anvandningsomrade-Egenskaper" : [ "Hormonbehandlingar vid: Graviditeter, IVF, m.fl. " ] }, { "@id" : "260", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Prometazin", "@language" : "sv" } ], "VocabularyConceptId" : "349422", "VocabularyId" : "73", "Identifier" : "260", "Label" : "Prometazin", "Definition" : null, "Notation" : "CH10/260", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Promethazine; Lergigan" ], "Synonym_1" : [ "Lergigan" ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(RS)-N,N-Dimethyl-1-(10H-phenothiazin-10-yl)propan-2-amine" ], "CAS-Nr" : [ "60-87-7" ], "EC-Nr" : [ "200-489-2" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Fenotiaziner" ], "Anvandningsomrade-Egenskaper" : [ "Antipsykotika/Sedativa/Antihistaminer/Antiemetika/Åksjukemedel/Antikolinerg verkan" ] }, { "@id" : "261", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Propofol", "@language" : "sv" } ], "VocabularyConceptId" : "349423", "VocabularyId" : "73", "Identifier" : "261", "Label" : "Propofol", "Definition" : null, "Notation" : "CH10/261", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Propofol; 2,6-Diisopropylphenol" ], "Synonym_1" : [ "2,6-Diisopropylfenol" ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "2,6-Di(propan-2-yl)phenol" ], "CAS-Nr" : [ "2078-54-8" ], "EC-Nr" : [ "218-206-6" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Fenoler" ], "Anvandningsomrade-Egenskaper" : [ "Anestetika/Sedativa" ] }, { "@id" : "262", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Propranolol", "@language" : "sv" } ], "VocabularyConceptId" : "349424", "VocabularyId" : "73", "Identifier" : "262", "Label" : "Propranolol", "Definition" : null, "Notation" : "CH10/262", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Propranolol; Propanolol" ], "Synonym_1" : [ "Propanolol" ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(RS)-1-(1-Methylethylamino)-3-(1-naphthyloxy)propan-2-ol" ], "CAS-Nr" : [ "525-66-6" ], "EC-Nr" : [ "208-378-0" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Arylaminer/Alkoholer" ], "Anvandningsomrade-Egenskaper" : [ "Blodtrycksmediciner/Mot: Kärlkramp, Hjärtarytmi, Migrän, Tremor/Beta-blockerare" ] }, { "@id" : "263", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Propyfenazon", "@language" : "sv" } ], "VocabularyConceptId" : "349425", "VocabularyId" : "73", "Identifier" : "263", "Label" : "Propyfenazon", "Definition" : null, "Notation" : "CH10/263", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Propyphenazone" ], "Synonym_1" : [ "Propifenazon" ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "1,5-Dimethyl-2-phenyl-4-propan-2-yl-pyrazol-3-one" ], "CAS-Nr" : [ "479-92-5" ], "EC-Nr" : [ "207-539-2" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Fenylpyrazoloner" ], "Anvandningsomrade-Egenskaper" : [ "Analgetika/Antipyretika/NSAID (Non-steroidal anti-inflammatory drugs)" ] }, { "@id" : "264", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Pyrantel", "@language" : "sv" } ], "VocabularyConceptId" : "349426", "VocabularyId" : "73", "Identifier" : "264", "Label" : "Pyrantel", "Definition" : null, "Notation" : "CH10/264", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Pyrantel" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "1-Methyl-2-[(E)-2-(2-thienyl)vinyl]-1,4,5,6-tetrahydropyrimidine" ], "CAS-Nr" : [ "15686-83-6" ], "EC-Nr" : [ "239-774-1" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Tiofener/Pyrimidiner" ], "Anvandningsomrade-Egenskaper" : [ "Antiparasitika/Helminticider, \"maskmedel\"/Veterinärmedicin/Nikotinreceptor-antagonister" ] }, { "@id" : "265", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Ranitidin", "@language" : "sv" } ], "VocabularyConceptId" : "349427", "VocabularyId" : "73", "Identifier" : "265", "Label" : "Ranitidin", "Definition" : null, "Notation" : "CH10/265", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Ranitidine" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "N-(2-[(5-[(Dimethylamino)methyl]furan-2-yl)methylthio]ethyl)-N'-methyl-2-nitroethene-1,1-diamine" ], "CAS-Nr" : [ "66357-35-5" ], "EC-Nr" : [ "266-332-5" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Furaner/Aminer/Tioetrar/Nitroetener" ], "Anvandningsomrade-Egenskaper" : [ "Mot: Halsbränna, Reflux" ] }, { "@id" : "266", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Repaglinid", "@language" : "sv" } ], "VocabularyConceptId" : "349428", "VocabularyId" : "73", "Identifier" : "266", "Label" : "Repaglinid", "Definition" : null, "Notation" : "CH10/266", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Repaglinide" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(S)-(+)-2-Ethoxy-4-[2-(3-methyl-1-[2-(piperidin-1-yl)phenyl]butylamino)-2-oxoethyl]benzoic acid" ], "CAS-Nr" : [ "135062-02-1" ], "EC-Nr" : [ "saknas" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Bensoesyror/Piperidiner" ], "Anvandningsomrade-Egenskaper" : [ "Antidiabetika/Blodsockersänkande medel" ] }, { "@id" : "267", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Risperidon", "@language" : "sv" } ], "VocabularyConceptId" : "349429", "VocabularyId" : "73", "Identifier" : "267", "Label" : "Risperidon", "Definition" : null, "Notation" : "CH10/267", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Risperidone" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "4-[2-[4-(6-Fluorobenzo[d]isoxazol-3-yl)-1-piperidyl]ethyl]-3-methyl-2,6-diazabicyclo[4.4.0]deca-1,3-dien-5-one" ], "CAS-Nr" : [ "106266-06-2" ], "EC-Nr" : [ "600-733-1" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Heterocykler" ], "Anvandningsomrade-Egenskaper" : [ "Antipsykotika" ] }, { "@id" : "268", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Rosuvastatin", "@language" : "sv" } ], "VocabularyConceptId" : "349430", "VocabularyId" : "73", "Identifier" : "268", "Label" : "Rosuvastatin", "Definition" : null, "Notation" : "CH10/268", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Rosuvastatin; Crestor" ], "Synonym_1" : [ "Crestor" ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(3R,5S,6E)-7-[4-(4-Fluorophenyl)-2-(N-methylmethanesulfonamido)-6-(propan-2-yl)pyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid" ], "CAS-Nr" : [ "287714-41-4" ], "EC-Nr" : [ "saknas" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Fluorfenyler/Sulfonamider/Pyrimidiner" ], "Anvandningsomrade-Egenskaper" : [ "Blodfettssänkande mediciner/Statiner" ] }, { "@id" : "269", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Roxitromycin", "@language" : "sv" } ], "VocabularyConceptId" : "349431", "VocabularyId" : "73", "Identifier" : "269", "Label" : "Roxitromycin", "Definition" : null, "Notation" : "CH10/269", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Roxithromycin" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(3R,4S,5S,6R,7R,9R,11S,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(Dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy}-3,5,7,9,11,13-hexamethyl-10-(2,4,7-trioxa-1-azaoctan-1-ylidene)-1-oxacyclotetradecan-2-one" ], "CAS-Nr" : [ "80214-83-1" ], "EC-Nr" : [ "617-007-5" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Makrolider/Laktoner/Oximer" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika" ] }, { "@id" : "270", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Salicylsyra", "@language" : "sv" } ], "VocabularyConceptId" : "349432", "VocabularyId" : "73", "Identifier" : "270", "Label" : "Salicylsyra", "Definition" : null, "Notation" : "CH10/270", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Salicylic Acid" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "2-Hydroxybenzoic acid" ], "CAS-Nr" : [ "69-72-7" ], "EC-Nr" : [ "200-712-3" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Hydroxibensoesyror/Fenoler" ], "Anvandningsomrade-Egenskaper" : [ "Analgetika/Antipyretika/Antiinflammatoriska medel/Mot: Akne/Fytohormon i växter" ] }, { "@id" : "271", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Sarafloxacin", "@language" : "sv" } ], "VocabularyConceptId" : "349433", "VocabularyId" : "73", "Identifier" : "271", "Label" : "Sarafloxacin", "Definition" : null, "Notation" : "CH10/271", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Sarafloxacin" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "6-Fluoro-1-(4-fluorophenyl)-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid" ], "CAS-Nr" : [ "98105-99-8" ], "EC-Nr" : [ "saknas" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Fluorerade aromater/Fluorkinoloner/Piperaziner" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika" ] }, { "@id" : "272", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Sekobarbital", "@language" : "sv" } ], "VocabularyConceptId" : "349434", "VocabularyId" : "73", "Identifier" : "272", "Label" : "Sekobarbital", "Definition" : null, "Notation" : "CH10/272", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Secobarbital" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "5-[(2R)-Pentan-2-yl]-5-prop-2-enyl-1,3-diazinane-2,4,6-trione" ], "CAS-Nr" : [ "76-73-3" ], "EC-Nr" : [ "200-982-2" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Barbiturater" ], "Anvandningsomrade-Egenskaper" : [ "Anestetika/Sedativa/Sömnmedel/Antikonvulsiva/Narkotikaklassad" ] }, { "@id" : "273", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Sekobarbital-natrium", "@language" : "sv" } ], "VocabularyConceptId" : "349435", "VocabularyId" : "73", "Identifier" : "273", "Label" : "Sekobarbital-natrium", "Definition" : null, "Notation" : "CH10/273", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Secobarbital-sodium" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "5-Pentan-2-yl-5-prop-2-enyl-1,3-diazinane-2,4,6-trione" ], "CAS-Nr" : [ "309-43-3" ], "EC-Nr" : [ "206-218-4" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Barbiturater" ], "Anvandningsomrade-Egenskaper" : [ "Sömnmedel/Narkotikaklassad" ] }, { "@id" : "274", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Sertralin", "@language" : "sv" } ], "VocabularyConceptId" : "349436", "VocabularyId" : "73", "Identifier" : "274", "Label" : "Sertralin", "Definition" : "ChSp/PubCh/ECHA/WIKI", "Notation" : "CH10/274", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Sertraline; Zoloft" ], "Synonym_1" : [ "Zoloft" ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(1S,4S)-4-(3,4-Dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine" ], "CAS-Nr" : [ "79617-96-2" ], "EC-Nr" : [ "saknas" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Klorerade aromater/Aminer/Tetraliner" ], "Anvandningsomrade-Egenskaper" : [ "Antidepressiva/Ångestdämpande/Mot: MDD, OCD, PD/SSRI: Selektiva Serotoninåterupptagshämmare" ] }, { "@id" : "275", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Simvastatin", "@language" : "sv" } ], "VocabularyConceptId" : "349437", "VocabularyId" : "73", "Identifier" : "275", "Label" : "Simvastatin", "Definition" : null, "Notation" : "CH10/275", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Simvastatin; Zocor" ], "Synonym_1" : [ "Zocord" ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-Hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate" ], "CAS-Nr" : [ "79902-63-9" ], "EC-Nr" : [ "616-751-8" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Laktoner/Karboxylatestrar/Tetrahydropyraner/Alkoholer" ], "Anvandningsomrade-Egenskaper" : [ "Blodfettssänkande mediciner/Statiner" ] }, { "@id" : "276", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Sotalol", "@language" : "sv" } ], "VocabularyConceptId" : "349438", "VocabularyId" : "73", "Identifier" : "276", "Label" : "Sotalol", "Definition" : null, "Notation" : "CH10/276", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Sotalol" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(RS)-N-{4-[1-Hydroxy-2-(propan-2-ylamino)ethyl]phenyl}methanesulfonamid" ], "CAS-Nr" : [ "3930-20-9" ], "EC-Nr" : [ "saknas" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Sulfonamider" ], "Anvandningsomrade-Egenskaper" : [ "Mot: Hjärtarytmi, Högt blodtryck/Beta-blockerare" ] }, { "@id" : "277", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Spektinomycin", "@language" : "sv" } ], "VocabularyConceptId" : "349439", "VocabularyId" : "73", "Identifier" : "277", "Label" : "Spektinomycin", "Definition" : null, "Notation" : "CH10/277", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Spectinomycin" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(1R,3S,5R,8R,10R,11S,12S,13R,14S)-8,12,14-Trihydroxy-5-methyl-11,13-bis(methylamino)-2,4,9-trioxatricyclo[8.4.0.03,8]tetradecan-7-one" ], "CAS-Nr" : [ "1695-77-8" ], "EC-Nr" : [ "216-911-3" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Aminocyklitoler/Aminoglykosider" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika" ] }, { "@id" : "278", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Spiramycin", "@language" : "sv" } ], "VocabularyConceptId" : "349440", "VocabularyId" : "73", "Identifier" : "278", "Label" : "Spiramycin", "Definition" : null, "Notation" : "CH10/278", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Spiramycin" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "[(4R,5R,6S,7R,9R,10R,11E,13Z,16R)-6-{[(2R,3S,4S,5R,6S)-5-{[(2R,4S,5R,6R)-4,5-Dihydroxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-10-{[ (2R,5S,6S)-5-(dimethylamino)-6-methyltetrahydro-2H-pyran-2-yl]oxy}-4-hydroxy-5-methoxy-9,16-dimethyl-2-oxooxacyclohexadeca-11,13-dien-7-yl]acetaldehyde" ], "CAS-Nr" : [ "8025-81-8" ], "EC-Nr" : [ "232-429-6" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Makrolider/Laktoner/Oximer" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika/Mot: Toxoplasmos, m.fl." ] }, { "@id" : "279", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Streptomycin", "@language" : "sv" } ], "VocabularyConceptId" : "349441", "VocabularyId" : "73", "Identifier" : "279", "Label" : "Streptomycin", "Definition" : null, "Notation" : "CH10/279", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Streptomycin" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "1,1'-[(1R,2R,3S,4R,5R,6S)-4-({5-Deoxy-2-O-[2-deoxy-2-(methylamino)-α-L-glucopyranosyl]-3-C-formyl-α-L-lyxofuranosyl}oxy)-2,5,6-trihydroxy-1,3-cyclohexanediyl]diguanidine" ], "CAS-Nr" : [ "57-92-1" ], "EC-Nr" : [ "200-355-3" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Aminoglykosider" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika" ] }, { "@id" : "280", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Sulfabensamid", "@language" : "sv" } ], "VocabularyConceptId" : "349442", "VocabularyId" : "73", "Identifier" : "280", "Label" : "Sulfabensamid", "Definition" : null, "Notation" : "CH10/280", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Sulfabenzamide" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "4-Amino-N-benzoyl-benzenesulfonamide" ], "CAS-Nr" : [ "127-71-9" ], "EC-Nr" : [ "204-859-4" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Bensenulfonamider/Aminer" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika" ] }, { "@id" : "281", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Sulfacetamid", "@language" : "sv" } ], "VocabularyConceptId" : "349443", "VocabularyId" : "73", "Identifier" : "281", "Label" : "Sulfacetamid", "Definition" : null, "Notation" : "CH10/281", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Sulfacetamide" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "N-[(4-Aminophenyl)sulfonyl]acetamide" ], "CAS-Nr" : [ "144-80-9" ], "EC-Nr" : [ "205-640-6" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Sulfonamider" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika" ] }, { "@id" : "282", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Sulfadiazin", "@language" : "sv" } ], "VocabularyConceptId" : "349444", "VocabularyId" : "73", "Identifier" : "282", "Label" : "Sulfadiazin", "Definition" : null, "Notation" : "CH10/282", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Sulfadiazine" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "4-Amino-N-pyrimidin-2-yl-benzenesulfonamide" ], "CAS-Nr" : [ "68-35-9" ], "EC-Nr" : [ "200-685-8" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Sulfonamider/Pyrimidiner/Aniliner" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika" ] }, { "@id" : "283", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Sulfadimetoxin", "@language" : "sv" } ], "VocabularyConceptId" : "349445", "VocabularyId" : "73", "Identifier" : "283", "Label" : "Sulfadimetoxin", "Definition" : null, "Notation" : "CH10/283", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Sulfadimethoxine" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "4-Amino-N-(2,6-dimethoxypyrimidin-4-yl)benzenesulfonamide" ], "CAS-Nr" : [ "122-11-2" ], "EC-Nr" : [ "204-523-7" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Pyrimidiner/Bensensulfonamider/Aminer" ], "Anvandningsomrade-Egenskaper" : [ "Sulfonamid-antibiotika/Bakteriostatika/Veterinärmedicin" ] }, { "@id" : "284", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Sulfadimidin", "@language" : "sv" } ], "VocabularyConceptId" : "349446", "VocabularyId" : "73", "Identifier" : "284", "Label" : "Sulfadimidin", "Definition" : "ChSp/PubCh/ECHA/WIKI", "Notation" : "CH10/284", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Sulfadimidine; Sulfamethazine" ], "Synonym_1" : [ "Sulfametazin" ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "4-Amino-N-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide; 4-Amino-N-(4,6-dimethyl-2-pyrimidinyl)benzenesulfonamide" ], "CAS-Nr" : [ "57-68-1" ], "EC-Nr" : [ "200-346-4" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Sulfonamider" ], "Anvandningsomrade-Egenskaper" : [ "Antibakteriella medel/Antibiotika/Veterinärmedicin" ] }, { "@id" : "285", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Sulfadoxin", "@language" : "sv" } ], "VocabularyConceptId" : "349447", "VocabularyId" : "73", "Identifier" : "285", "Label" : "Sulfadoxin", "Definition" : null, "Notation" : "CH10/285", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Sulfadoxine" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "4-Amino-N-(5,6-dimethoxy-4-pyrimidinyl)benzenesulfonamide" ], "CAS-Nr" : [ "2447-57-6" ], "EC-Nr" : [ "219-504-9" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Sulfonamider" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika/Malariamedicin/Veterinärmedicin" ] }, { "@id" : "286", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Sulfafurazol", "@language" : "sv" } ], "VocabularyConceptId" : "349448", "VocabularyId" : "73", "Identifier" : "286", "Label" : "Sulfafurazol", "Definition" : null, "Notation" : "CH10/286", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Sulfafurazole" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "4-Amino-N-(3,4-dimethyl-1,2-oxazol-5-yl)benzenesulfonamide" ], "CAS-Nr" : [ "127-69-5" ], "EC-Nr" : [ "204-858-9" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Sulfonamider/Oxazoler" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika" ] }, { "@id" : "287", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Sulfaguanidin", "@language" : "sv" } ], "VocabularyConceptId" : "349449", "VocabularyId" : "73", "Identifier" : "287", "Label" : "Sulfaguanidin", "Definition" : null, "Notation" : "CH10/287", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Sulfaguanidine" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "4-Amino-N-carbamimidoylbenzenesulfonamide" ], "CAS-Nr" : [ "57-67-0" ], "EC-Nr" : [ "200-345-9" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Sulfonamider" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika" ] }, { "@id" : "288", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Sulfakinoxalin", "@language" : "sv" } ], "VocabularyConceptId" : "349450", "VocabularyId" : "73", "Identifier" : "288", "Label" : "Sulfakinoxalin", "Definition" : null, "Notation" : "CH10/288", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Sulfaquinoxaline" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "4-Amino-N-2-quinoxalinylbenzenesulfonamide" ], "CAS-Nr" : [ "59-40-5" ], "EC-Nr" : [ "200-423-2" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Bensensulfonamider" ], "Anvandningsomrade-Egenskaper" : [ "Antiparasitika/Mot: Coccidia-amöba/Veterinärmedicin" ] }, { "@id" : "289", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Sulfaklorpyridazin", "@language" : "sv" } ], "VocabularyConceptId" : "349451", "VocabularyId" : "73", "Identifier" : "289", "Label" : "Sulfaklorpyridazin", "Definition" : null, "Notation" : "CH10/289", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Sulfachlorpyridazine" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "4-Amino-N-(6-chloropyridazin-3-yl)benzenesulfonamide" ], "CAS-Nr" : [ "80-32-0" ], "EC-Nr" : [ "201-269-9" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Sulfonamider/Aniliner/Pyridaziner" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika" ] }, { "@id" : "290", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Sulfaklozin", "@language" : "sv" } ], "VocabularyConceptId" : "349452", "VocabularyId" : "73", "Identifier" : "290", "Label" : "Sulfaklozin", "Definition" : null, "Notation" : "CH10/290", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Sulfaclozine" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "4-Amino-N-(6-chloropyrazin-2-yl)benzenesulfonamide" ], "CAS-Nr" : [ "102-65-8" ], "EC-Nr" : [ "203-044-0" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Sulfonamider" ], "Anvandningsomrade-Egenskaper" : [ "Antibakteriella medel/Antiparasitika" ] }, { "@id" : "291", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Sulfamerazin", "@language" : "sv" } ], "VocabularyConceptId" : "349453", "VocabularyId" : "73", "Identifier" : "291", "Label" : "Sulfamerazin", "Definition" : null, "Notation" : "CH10/291", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Sulfamerazine" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "4-Amino-N-(4-methylpyrimidin-2-yl)-benzenesulfonamide" ], "CAS-Nr" : [ "127-79-7" ], "EC-Nr" : [ "204-866-2" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Bensensulfonamider/Pyrimidiner" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika" ] }, { "@id" : "292", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Sulfametizol", "@language" : "sv" } ], "VocabularyConceptId" : "349454", "VocabularyId" : "73", "Identifier" : "292", "Label" : "Sulfametizol", "Definition" : null, "Notation" : "CH10/292", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Sulfamethizole " ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "4-Amino-N-(5-methyl-1,3,4-thiadiazol-2-yl)- benzenesulfonamide" ], "CAS-Nr" : [ "144-82-1" ], "EC-Nr" : [ "205-641-1" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Sulfonamider/Tiadiazoler" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika" ] }, { "@id" : "293", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Sulfametoxazol", "@language" : "sv" } ], "VocabularyConceptId" : "349455", "VocabularyId" : "73", "Identifier" : "293", "Label" : "Sulfametoxazol", "Definition" : null, "Notation" : "CH10/293", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Sulfamethoxazole" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "4-Amino-N-(5-methyloxazol-3-yl)-benzenesulfonamide" ], "CAS-Nr" : [ "723-46-6" ], "EC-Nr" : [ "211-963-3" ], "WFD" : [ "Watch" ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Sulfonamider/Aniliner/Isoxazoler" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika" ] }, { "@id" : "294", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Sulfametoxidiazin", "@language" : "sv" } ], "VocabularyConceptId" : "349456", "VocabularyId" : "73", "Identifier" : "294", "Label" : "Sulfametoxidiazin", "Definition" : null, "Notation" : "CH10/294", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Sulfametoxydiazine" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "4-Amino-N-(5-methoxy-2-pyrimidinyl)benzenesulfonamide" ], "CAS-Nr" : [ "651-06-9" ], "EC-Nr" : [ "211-480-8" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Sulfonamider/Pyrimidiner/Fenoletrar" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika/Mot: Lepra, Urinvägsinfektioner" ] }, { "@id" : "295", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Sulfametoxipyridazin", "@language" : "sv" } ], "VocabularyConceptId" : "349457", "VocabularyId" : "73", "Identifier" : "295", "Label" : "Sulfametoxipyridazin", "Definition" : null, "Notation" : "CH10/295", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Sulfamethoxypyridazine" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "4-Amino-N-(6-methoxypyridazin-3-yl)benzenesulfonamide" ], "CAS-Nr" : [ "80-35-3" ], "EC-Nr" : [ "201-272-5" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Sulfonamider/Aniliner/Pyridaziner" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika" ] }, { "@id" : "296", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Sulfamonometoxin", "@language" : "sv" } ], "VocabularyConceptId" : "349458", "VocabularyId" : "73", "Identifier" : "296", "Label" : "Sulfamonometoxin", "Definition" : null, "Notation" : "CH10/296", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Sulfamonomethoxine" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "4-Amino-N-(6-methoxy-4-pyrimidinyl)benzenesulfonamide" ], "CAS-Nr" : [ "1220-83-3" ], "EC-Nr" : [ "saknas" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Pyrimidiner/Bensensulfonamider/Aminer" ], "Anvandningsomrade-Egenskaper" : [ "Sulfonamid-antibiotika/Bakteriostatika/Veterinärmedicin" ] }, { "@id" : "297", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Sulfamoxol", "@language" : "sv" } ], "VocabularyConceptId" : "349459", "VocabularyId" : "73", "Identifier" : "297", "Label" : "Sulfamoxol", "Definition" : null, "Notation" : "CH10/297", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Sulfamoxole" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "4-Amino-N-(4,5-dimethyl-1,3-oxazol-2-yl)benzenesulfonamide" ], "CAS-Nr" : [ "729-99-7" ], "EC-Nr" : [ "211-982-7" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Sulfonamider/Oxazoler/Aniliner" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika" ] }, { "@id" : "298", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Sulfanilamid", "@language" : "sv" } ], "VocabularyConceptId" : "349460", "VocabularyId" : "73", "Identifier" : "298", "Label" : "Sulfanilamid", "Definition" : null, "Notation" : "CH10/298", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Sulfanilamide" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "4-Aminobenzenesulfonamide" ], "CAS-Nr" : [ "63-74-1" ], "EC-Nr" : [ "200-563-4" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Sulfonamider/Aniliner" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika" ] }, { "@id" : "299", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Sulfapyridin", "@language" : "sv" } ], "VocabularyConceptId" : "349461", "VocabularyId" : "73", "Identifier" : "299", "Label" : "Sulfapyridin", "Definition" : null, "Notation" : "CH10/299", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Sulfapyridine" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "4-Amino-N-pyridin-2-yl-benzenesulfonamide" ], "CAS-Nr" : [ "144-83-2" ], "EC-Nr" : [ "205-642-7" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Sulfonamider/Pyridiner/Aminer" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika" ] }, { "@id" : "300", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Sulfatiazol", "@language" : "sv" } ], "VocabularyConceptId" : "349462", "VocabularyId" : "73", "Identifier" : "300", "Label" : "Sulfatiazol", "Definition" : null, "Notation" : "CH10/300", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Sulfathiazole" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "4-Amino-N-(1,3-thiazol-2-yl)benzenesulfonamide" ], "CAS-Nr" : [ "72-14-0" ], "EC-Nr" : [ "200-771-5" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Sulfonamider/Tiazoler/Fenylaminer" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika" ] }, { "@id" : "301", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Taloxa", "@language" : "sv" } ], "VocabularyConceptId" : "349463", "VocabularyId" : "73", "Identifier" : "301", "Label" : "Taloxa", "Definition" : null, "Notation" : "CH10/301", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Taloxa; Felbamate" ], "Synonym_1" : [ "Felbamat" ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(3-Carbamoyloxy-2-phenyl-propyl) carbamate" ], "CAS-Nr" : [ "25451-15-4" ], "EC-Nr" : [ "247-001-4" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Fenylpropylkarbamater" ], "Anvandningsomrade-Egenskaper" : [ "Antiepileptika" ] }, { "@id" : "302", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Tamoxifen", "@language" : "sv" } ], "VocabularyConceptId" : "349464", "VocabularyId" : "73", "Identifier" : "302", "Label" : "Tamoxifen", "Definition" : null, "Notation" : "CH10/302", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Tamoxifen" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(Z)-2-[4-(1,2-Diphenylbut-1-enyl)phenoxy]-N,N-dimethylethanamine" ], "CAS-Nr" : [ "10540-29-1" ], "EC-Nr" : [ "234-118-0" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Aromatiska kolväten/Aminer" ], "Anvandningsomrade-Egenskaper" : [ "Östrogenreceptor-modulatorer" ] }, { "@id" : "303", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Telmisartan", "@language" : "sv" } ], "VocabularyConceptId" : "349465", "VocabularyId" : "73", "Identifier" : "303", "Label" : "Telmisartan", "Definition" : null, "Notation" : "CH10/303", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Telmisartan" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "2-(4-{[4-Methyl-6-(1-methyl-1H-1,3-benzodiazol-2-yl)-2-propyl-1H-1,3-benzodiazol-1-yl]methyl}phenyl)benzoic acid" ], "CAS-Nr" : [ "144701-48-4" ], "EC-Nr" : [ "saknas" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Bensodiazoler/Bensoesyror" ], "Anvandningsomrade-Egenskaper" : [ "Blodtrycksmediciner/Angiotensin-II-receptor-antagonister" ] }, { "@id" : "304", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Temazepam", "@language" : "sv" } ], "VocabularyConceptId" : "349466", "VocabularyId" : "73", "Identifier" : "304", "Label" : "Temazepam", "Definition" : null, "Notation" : "CH10/304", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Temazepam; Restoril" ], "Synonym_1" : [ "Restoril" ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(RS)-7-Chloro-3-hydroxy-1-methyl-5-phenyl- 1,3-dihydro-2H-1,4-benzodiazepin-2-one" ], "CAS-Nr" : [ "846-50-4" ], "EC-Nr" : [ "212-688-1" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Klorerade aromater/Bensodiazepiner/Laktamer" ], "Anvandningsomrade-Egenskaper" : [ "Psykotropa medel/Ångestdämpande/Sedativa/Sömnmedel/Antikonvulsiva/Muskelavslappnande/Narkotikaklassad" ] }, { "@id" : "305", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Terbutalin", "@language" : "sv" } ], "VocabularyConceptId" : "349467", "VocabularyId" : "73", "Identifier" : "305", "Label" : "Terbutalin", "Definition" : null, "Notation" : "CH10/305", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Terbutaline; Bricanyl" ], "Synonym_1" : [ "Bricanyl" ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(RS)-5-[2-(tert-Butylamino)-1-hydroxyethyl]benzene-1,3-diol" ], "CAS-Nr" : [ "23031-25-6" ], "EC-Nr" : [ "245-385-8" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Fenoler/Aminer" ], "Anvandningsomrade-Egenskaper" : [ "Astmamediciner/Bronkialvidgande/Selektiva beta-2-stimulerare (β2-stimulerare), eller beta-2-agonister" ] }, { "@id" : "306", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Tetracyklin", "@language" : "sv" } ], "VocabularyConceptId" : "349468", "VocabularyId" : "73", "Identifier" : "306", "Label" : "Tetracyklin", "Definition" : null, "Notation" : "CH10/306", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Tetracycline" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(4S,4aS,5aS,6S,12aS)-4-(Dimethylamino)-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-2-tetracenecarboxamide" ], "CAS-Nr" : [ "60-54-8" ], "EC-Nr" : [ "200-481-9" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Tetracykliner" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika/Mot: Akne, Rosacea, Kolera" ] }, { "@id" : "307", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Tiamulin", "@language" : "sv" } ], "VocabularyConceptId" : "349469", "VocabularyId" : "73", "Identifier" : "307", "Label" : "Tiamulin", "Definition" : null, "Notation" : "CH10/307", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Tiamulin" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(4R,5S,6S,8R,9aR,10R)-5-Hydroxy-4,6,9,10-tetramethyl-1-oxo-6-vinyldecahydro-3a,9-propanocyclopenta[8]annulen-8-yl {[2-(diethylamino)ethyl]sulfanyl}acetate" ], "CAS-Nr" : [ "55297-95-5" ], "EC-Nr" : [ "259-580-0" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Sulfanylacetater" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika/Veterinärmedicin" ] }, { "@id" : "308", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Tilmikosin", "@language" : "sv" } ], "VocabularyConceptId" : "349470", "VocabularyId" : "73", "Identifier" : "308", "Label" : "Tilmikosin", "Definition" : null, "Notation" : "CH10/308", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Tilmicosin" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "[(2R,3R,4E,6E,9R,11R,12S,13S,14R)-12-{[3,6-Dideoxy-3-(dimethylamino)-beta-D-glucopyranosyl]oxy}-11-{2-[(3R,5S)-3,5-dimethylpiperidin-1-yl]ethyl}-2-ethyl-14-hydroxy-5,9,13-trimethyl-8,16-dioxooxacycloh exadeca-4,6-dien-3-yl]methyl 6-deoxy-2,3-di-O-methyl-beta-D-allopyranoside " ], "CAS-Nr" : [ "108050-54-0 " ], "EC-Nr" : [ "saknas" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Makrolider" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika/Veterinärmedicin" ] }, { "@id" : "309", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Timolol", "@language" : "sv" } ], "VocabularyConceptId" : "349471", "VocabularyId" : "73", "Identifier" : "309", "Label" : "Timolol", "Definition" : null, "Notation" : "CH10/309", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Timolol" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(2S)-1-[(2-Methyl-2-propanyl)amino]-3-{[4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl]oxy}-2-propanol" ], "CAS-Nr" : [ "91524-16-2" ], "EC-Nr" : [ "248-032-6" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Tiadiazoler/Morfoliner/Etrar/Alkoholer" ], "Anvandningsomrade-Egenskaper" : [ "Blodtrycksmediciner/Mot: Glaukom, Hjärtattack, Migrän/Beta-blockerare" ] }, { "@id" : "310", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Tioridazin", "@language" : "sv" } ], "VocabularyConceptId" : "349472", "VocabularyId" : "73", "Identifier" : "310", "Label" : "Tioridazin", "Definition" : null, "Notation" : "CH10/310", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Thioridazine" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "10-{2-[(RS)-1-Methylpiperidin-2-yl]ethyl}-2-methylsulfanylphenothiazine" ], "CAS-Nr" : [ "50-52-2" ], "EC-Nr" : [ "200-044-2" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Piperidiner/Sulfanylfenotiaziner" ], "Anvandningsomrade-Egenskaper" : [ "Antidepressiva/Antipsykotika" ] }, { "@id" : "311", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Tokoferolacetat", "@language" : "sv" } ], "VocabularyConceptId" : "349473", "VocabularyId" : "73", "Identifier" : "311", "Label" : "Tokoferolacetat", "Definition" : null, "Notation" : "CH10/311", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Tocopherolacetate" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "[2,5,7,8-Tetramethyl-2-(4,8,12-trimethyltridecyl)-3,4-dihydrochromen-6-yl] acetate" ], "CAS-Nr" : [ "7695-91-2" ], "EC-Nr" : [ "231-710-0" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Alkylbensopyraner/Kromener/Acetater" ], "Anvandningsomrade-Egenskaper" : [ "Vitaminer/PCP-produkter" ] }, { "@id" : "312", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Tolfenamsyra", "@language" : "sv" } ], "VocabularyConceptId" : "349474", "VocabularyId" : "73", "Identifier" : "312", "Label" : "Tolfenamsyra", "Definition" : null, "Notation" : "CH10/312", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Tolfenamic acid" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "2-[(3-Chloro-2-methylphenyl)amino]benzoic acid" ], "CAS-Nr" : [ "13710-19-5" ], "EC-Nr" : [ "237-264-3" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Klorerade aromater/Bensoesyror" ], "Anvandningsomrade-Egenskaper" : [ "Antiinflammatoriska medel/Analgetika/Antipyretika/NSAID (Non-steroidal anti-inflammatory drugs)" ] }, { "@id" : "313", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Tramadol", "@language" : "sv" } ], "VocabularyConceptId" : "349475", "VocabularyId" : "73", "Identifier" : "313", "Label" : "Tramadol", "Definition" : null, "Notation" : "CH10/313", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Tramadol" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "2-[(Dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol" ], "CAS-Nr" : [ "27203-92-5" ], "EC-Nr" : [ "248-319-6" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Opioider/Alkaloider" ], "Anvandningsomrade-Egenskaper" : [ "Analgetika/Narkotikaklassad" ] }, { "@id" : "314", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Trihexyfenidyl", "@language" : "sv" } ], "VocabularyConceptId" : "349476", "VocabularyId" : "73", "Identifier" : "314", "Label" : "Trihexyfenidyl", "Definition" : null, "Notation" : "CH10/314", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Trihexyphenidyl" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(RS)-1-Cyclohexyl-1-phenyl-3-(1-piperidyl)propan-1-ol" ], "CAS-Nr" : [ "144-11-6" ], "EC-Nr" : [ "205-614-4" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Fenyler/Piperidiner/Cyklohexyler" ], "Anvandningsomrade-Egenskaper" : [ "Anti-Parkinson-läkemedel/Muskarin-antagonister" ] }, { "@id" : "315", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Trimetoprim", "@language" : "sv" } ], "VocabularyConceptId" : "349477", "VocabularyId" : "73", "Identifier" : "315", "Label" : "Trimetoprim", "Definition" : null, "Notation" : "CH10/315", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Trimethoprim" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "5-(3,4,5-Trimethoxybenzyl)pyrimidine-2,4-diamine" ], "CAS-Nr" : [ "738-70-5" ], "EC-Nr" : [ "212-006-2" ], "WFD" : [ "Watch" ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Pyrimidiner/Arylaminer/Fenyletrar" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika/Folsyre-antagonister" ] }, { "@id" : "316", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Tylosin", "@language" : "sv" } ], "VocabularyConceptId" : "349478", "VocabularyId" : "73", "Identifier" : "316", "Label" : "Tylosin", "Definition" : null, "Notation" : "CH10/316", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Tylosin" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "[(2R,3R,4E,6E,9R,11R,12S,13S,14R) -12- {[3,6-Dideoxy-4-O-(2,6-dideoxy-3-C-methyl-α-L-ribo-hexopyranosyl) -3- (dimethylamino)-β-D-glucopyranosyl]oxy}-2-ethyl-14-hydroxy-5, 9,13-trimethyl-8, 16-dioxo-11-(2-oxoethyl)oxacyclohexadeca-4,6-dien-3-yl]methyl 6-deoxy-2,3-di-O-methyl-β-D-allopyranoside" ], "CAS-Nr" : [ "1401-69-0" ], "EC-Nr" : [ "215-754-8" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Makrolider" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika/Veterinärmedicin" ] }, { "@id" : "317", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Valnemulin", "@language" : "sv" } ], "VocabularyConceptId" : "349479", "VocabularyId" : "73", "Identifier" : "317", "Label" : "Valnemulin", "Definition" : null, "Notation" : "CH10/317", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Valnemulin" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(3aS,4R,5S,6S,8R,9R,9aR,10R)-6-Ethenyl-5-hydroxy-4,6,9,10-tetramethyl-1-oxodecahydro-3a,9-propano-3aH-cyclopenta[8]annulen-8-yl-[(R)-2-(2-amino-3-methylbutanoylamino)-1,1-dimethtylethylsulfanyl]acetate" ], "CAS-Nr" : [ "101312-92-9" ], "EC-Nr" : [ "saknas" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Amider/Pleuromutiliner" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika/Veterinärmedicin" ] }, { "@id" : "318", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Valproinsyra", "@language" : "sv" } ], "VocabularyConceptId" : "349480", "VocabularyId" : "73", "Identifier" : "318", "Label" : "Valproinsyra", "Definition" : null, "Notation" : "CH10/318", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Valproic acid" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "2-Propylpentanoic acid" ], "CAS-Nr" : [ "99-66-1" ], "EC-Nr" : [ "202-777-3" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Karboxylsyror" ], "Anvandningsomrade-Egenskaper" : [ "Antiepileptika/Mot: Bipolaritet" ] }, { "@id" : "319", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Venlafaxin", "@language" : "sv" } ], "VocabularyConceptId" : "349481", "VocabularyId" : "73", "Identifier" : "319", "Label" : "Venlafaxin", "Definition" : null, "Notation" : "CH10/319", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Venlafaxine; Effexor" ], "Synonym_1" : [ "Efexor" ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(RS)-1-[2-Dimethylamino-1-(4-methoxyphenyl)-ethyl]cyclohexanol" ], "CAS-Nr" : [ "93413-69-5" ], "EC-Nr" : [ "618-944-2" ], "WFD" : [ "Watch" ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Fenetylaminer/Fenoletrar/Alkoholer" ], "Anvandningsomrade-Egenskaper" : [ "Antidepressiva/Ångestdämpande/SNRI: Serotonin- och noradrenalinåterupptagshämmare" ] }, { "@id" : "320", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Verapamil", "@language" : "sv" } ], "VocabularyConceptId" : "349482", "VocabularyId" : "73", "Identifier" : "320", "Label" : "Verapamil", "Definition" : null, "Notation" : "CH10/320", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Verapamil" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(RS)-2-(3,4-Dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl]-(methyl)amino}-2-prop-2-ylpentanenitrile" ], "CAS-Nr" : [ "52-53-9" ], "EC-Nr" : [ "200-145-1" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Fenylalkylaminer/Nitriler" ], "Anvandningsomrade-Egenskaper" : [ "Blodtrycksmediciner/Mot: Kärlkramp, Hjärtarytmi, Migrän/Kalcium-antagonister" ] }, { "@id" : "321", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Zolpidem", "@language" : "sv" } ], "VocabularyConceptId" : "349483", "VocabularyId" : "73", "Identifier" : "321", "Label" : "Zolpidem", "Definition" : null, "Notation" : "CH10/321", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Zolpidem" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "N,N-Dimethyl-2-(6-methyl-2-p-tolylimidazo[1,2-a]pyridin-3-yl)acetamide" ], "CAS-Nr" : [ "82626-48-0" ], "EC-Nr" : [ "617-367-3" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Imidazopyridiner/Acetamider" ], "Anvandningsomrade-Egenskaper" : [ "Sömnmedel/Ångestdämpande/Narkotikaklassad" ] }, { "@id" : "322", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Zopiklon", "@language" : "sv" } ], "VocabularyConceptId" : "349484", "VocabularyId" : "73", "Identifier" : "322", "Label" : "Zopiklon", "Definition" : null, "Notation" : "CH10/322", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Zopiclone" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(RS)-6-(5-Chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl 4-methylpiperazine-1-carboxylate" ], "CAS-Nr" : [ "43200-80-2" ], "EC-Nr" : [ "256-138-9" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Klororganiska ämnen/Cyklopyrroloner" ], "Anvandningsomrade-Egenskaper" : [ "Sömnmedel/Sedativa/Ångestdämpande" ] }, { "@id" : "323", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Zopiklon-N-oxid", "@language" : "sv" } ], "VocabularyConceptId" : "349485", "VocabularyId" : "73", "Identifier" : "323", "Label" : "Zopiklon-N-oxid", "Definition" : null, "Notation" : "CH10/323", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Zopiclone-N-oxide" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(5RS)-6-(5-Chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl 4-methylpiperazine-1-carboxylate 4-oxide " ], "CAS-Nr" : [ "43200-96-0" ], "EC-Nr" : [ "saknas" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Klororganiska ämnen/Cyklopyrroloner" ], "Anvandningsomrade-Egenskaper" : [ "Sömnmedel/Sedativa/Ångestdämpande/Zopiklon-metabolit" ] }, { "@id" : "324", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Zuklopentixol", "@language" : "sv" } ], "VocabularyConceptId" : "349486", "VocabularyId" : "73", "Identifier" : "324", "Label" : "Zuklopentixol", "Definition" : null, "Notation" : "CH10/324", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Zuclopenthixol" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "cis-(Z)-2-(4-(3-(2-Chloro-9H-thioxanthen-9-ylidene)propyl)piperazin-1-yl)ethanol" ], "CAS-Nr" : [ "53772-83-1" ], "EC-Nr" : [ "258-758-5" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Tioxantener" ], "Anvandningsomrade-Egenskaper" : [ "Antipsykotika/Dopamin+Serotonin-antagonister" ] }, { "@id" : "325", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Östradiol", "@language" : "sv" } ], "VocabularyConceptId" : "349487", "VocabularyId" : "73", "Identifier" : "325", "Label" : "Östradiol", "Definition" : null, "Notation" : "CH10/325", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Estradiol; 17-beta-Estradiol; 17β-Estradiol" ], "Synonym_1" : [ "17-beta-Östradiol" ], "Synonym_2" : [ "17β-Östradiol" ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(8R,9S,13S,14S,17S)-13-Methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol" ], "CAS-Nr" : [ "50-28-2" ], "EC-Nr" : [ "200-023-8" ], "WFD" : [ "SFÄ" ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Steroidhormoner" ], "Anvandningsomrade-Egenskaper" : [ "Östrogena hormoner" ] }, { "@id" : "326", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Östriol", "@language" : "sv" } ], "VocabularyConceptId" : "349488", "VocabularyId" : "73", "Identifier" : "326", "Label" : "Östriol", "Definition" : null, "Notation" : "CH10/326", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Estriol" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(16α,17β)-Estra-1,3,5(10)-triene-3,16,17-triol" ], "CAS-Nr" : [ "50-27-1" ], "EC-Nr" : [ "200-022-2" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Steroidhormoner" ], "Anvandningsomrade-Egenskaper" : [ "Östrogena hormoner/Produceras i placenta" ] }, { "@id" : "327", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Östron", "@language" : "sv" } ], "VocabularyConceptId" : "349489", "VocabularyId" : "73", "Identifier" : "327", "Label" : "Östron", "Definition" : null, "Notation" : "CH10/327", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Estrone" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(8R,9S,13S,14S)-3-Hydroxy-13-methyl- 6,7,8,9,11,12,13,14,15,16- decahydrocyclopenta[a]phenanthren- 17- one" ], "CAS-Nr" : [ "53-16-7" ], "EC-Nr" : [ "200-164-5" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Steroidhormoner" ], "Anvandningsomrade-Egenskaper" : [ "Östrogena hormoner" ] }, { "@id" : "328", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Östronsulfat", "@language" : "sv" } ], "VocabularyConceptId" : "349490", "VocabularyId" : "73", "Identifier" : "328", "Label" : "Östronsulfat", "Definition" : null, "Notation" : "CH10/328", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Estrone sulfate" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "[(8R,9S,13S,14S)-13-Methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate" ], "CAS-Nr" : [ "481-97-0" ], "EC-Nr" : [ "207-575-9" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Steroidhormoner" ], "Anvandningsomrade-Egenskaper" : [ "Östrogena hormoner/Östron-derivat" ] }, { "@id" : "329", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Amlodipin", "@language" : "sv" } ], "VocabularyConceptId" : "349491", "VocabularyId" : "73", "Identifier" : "329", "Label" : "Amlodipin", "Definition" : null, "Notation" : "CH10/329", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Amlodipine" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "3-O-ethyl 5-O-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate" ], "CAS-Nr" : [ "88150-42-9" ], "EC-Nr" : [ "618-119-7" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Klorerade aromater/Aminer/Karboxylatestrar/Dihydropyridiner" ], "Anvandningsomrade-Egenskaper" : [ "Blodtrycksmediciner/Vasodilativa/Kalcium-kanal-blockerare/Antimineralkortikoid" ] }, { "@id" : "330", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Bikalutamid", "@language" : "sv" } ], "VocabularyConceptId" : "349492", "VocabularyId" : "73", "Identifier" : "330", "Label" : "Bikalutamid", "Definition" : null, "Notation" : "CH10/330", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Bicalutamide; Casodex" ], "Synonym_1" : [ "Casodex" ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "N-[4-Cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methylpropanamide" ], "CAS-Nr" : [ "90357-06-5" ], "EC-Nr" : [ "618-534-3" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Fluorerade aromater/Anilider/Sulfoner/Nitriler/Alkoholer" ], "Anvandningsomrade-Egenskaper" : [ "Antiandrogener/Mot: Prostatacancer" ] }, { "@id" : "331", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Cetirizin", "@language" : "sv" } ], "VocabularyConceptId" : "349493", "VocabularyId" : "73", "Identifier" : "331", "Label" : "Cetirizin", "Definition" : null, "Notation" : "CH10/331", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Cetirizine; Zyrtec" ], "Synonym_1" : [ "Zyrtec" ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(2-{4-[(4-Chlorophenyl)(phenyl)methyl]-1-piperazinyl}ethoxy)acetic acid" ], "CAS-Nr" : [ "83881-51-0" ], "EC-Nr" : [ "NA" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Karboxylsyror/Piperaziner/Etrar" ], "Anvandningsomrade-Egenskaper" : [ "Antihistaminer/Antiallergika" ] }, { "@id" : "332", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Desvenlafaxin", "@language" : "sv" } ], "VocabularyConceptId" : "349494", "VocabularyId" : "73", "Identifier" : "332", "Label" : "Desvenlafaxin", "Definition" : null, "Notation" : "CH10/332", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Desvenlafaxine; O-Desmethylvenlafaxine; Pristiq" ], "Synonym_1" : [ "O-desmetylvenlafaxin" ], "Synonym_2" : [ "Pristiq" ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "4-[2-(Dimethylamino)-1-(1-hydroxycyclohexyl)ethyl]phenol" ], "CAS-Nr" : [ "93413-62-8" ], "EC-Nr" : [ "700-516-2" ], "WFD" : [ "Watch" ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Fenetylaminer/Fenoler/Alkoholer" ], "Anvandningsomrade-Egenskaper" : [ "Antidepressiva/SNRI: Serotonin–noradrenalinåterupptagshämmare" ] }, { "@id" : "333", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Kandesartan", "@language" : "sv" } ], "VocabularyConceptId" : "349495", "VocabularyId" : "73", "Identifier" : "333", "Label" : "Kandesartan", "Definition" : null, "Notation" : "CH10/333", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Candesartan" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)-4-biphenylyl]methyl}-1H-benzimidazole-7-carboxylic acid" ], "CAS-Nr" : [ "139481-59-7" ], "EC-Nr" : [ "604-138-8" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Tetrazoler/Bensimidazoler/Etrar/Karboxylsyror/Bifenyler" ], "Anvandningsomrade-Egenskaper" : [ "Blodtrycksmediciner/Angiotensin-II-receptor-antagonister" ] }, { "@id" : "334", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Klimbazol", "@language" : "sv" } ], "VocabularyConceptId" : "349496", "VocabularyId" : "73", "Identifier" : "334", "Label" : "Klimbazol", "Definition" : null, "Notation" : "CH10/334", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Climbazole" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ ], "CAS-Nr" : [ "38083-17-9" ], "EC-Nr" : [ "253-775-4" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Klorerade aromater/Fenoletrar/Ketoner/Imidazoler" ], "Anvandningsomrade-Egenskaper" : [ "Fungicider/Mot: Mjäll, Eksem" ] }, { "@id" : "335", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "klopidogrel", "@language" : "sv" } ], "VocabularyConceptId" : "349497", "VocabularyId" : "73", "Identifier" : "335", "Label" : "klopidogrel", "Definition" : null, "Notation" : "CH10/335", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Clopidogrel; Plavix" ], "Synonym_1" : [ "Plavix" ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "Methyl (2S)-(2-chlorophenyl)(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetate" ], "CAS-Nr" : [ "113665-84-2" ], "EC-Nr" : [ "601-269-2" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Klorerade aromater/Tienopyridiner/Metyl-estrar/Acetat-estrar" ], "Anvandningsomrade-Egenskaper" : [ "Trombocytaggregationshämmande/Antikoagulationsmedel/Mot: Blodpropp" ] }, { "@id" : "336", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Klorzoxazon", "@language" : "sv" } ], "VocabularyConceptId" : "349498", "VocabularyId" : "73", "Identifier" : "336", "Label" : "Klorzoxazon", "Definition" : null, "Notation" : "CH10/336", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Chlorzoxazone" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "5-Chloro-1,3-benzoxazol-2(3H)-one" ], "CAS-Nr" : [ "95-25-0" ], "EC-Nr" : [ "202-403-9" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Klorerade aromater/Karbamater/Bensoxazoler" ], "Anvandningsomrade-Egenskaper" : [ "Muskelavslappnande medel/Analgetika/Mot: Ryggskott, Spänningshuvudvärk/Hepatotoxiner" ] }, { "@id" : "337", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Losartan", "@language" : "sv" } ], "VocabularyConceptId" : "349499", "VocabularyId" : "73", "Identifier" : "337", "Label" : "Losartan", "Definition" : null, "Notation" : "CH10/337", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Losartan; Cozaar" ], "Synonym_1" : [ "Cozaar" ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(2-Butyl-4-chloro-1-{[2'-(1H-tetrazol-5-yl)-4-biphenylyl]methyl}-1H-imidazol-5-yl)methanol" ], "CAS-Nr" : [ "114798-26-4" ], "EC-Nr" : [ "601-329-8" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Klorerade aromater/Imidazoler/Tetrazoler/Bifenyler/Alkoholer" ], "Anvandningsomrade-Egenskaper" : [ "Blodtrycksmediciner/Angiotensin-II-receptor-antagonister" ] }, { "@id" : "338", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Metronidazol", "@language" : "sv" } ], "VocabularyConceptId" : "349500", "VocabularyId" : "73", "Identifier" : "338", "Label" : "Metronidazol", "Definition" : null, "Notation" : "CH10/338", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Metronidazole; Flagyl" ], "Synonym_1" : [ "Flagyl" ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "2-(2-Methyl-5-nitro-1H-imidazol-1-yl)ethanol" ], "CAS-Nr" : [ "443-48-1" ], "EC-Nr" : [ "207-136-1" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Nitroimidazoler/Alkoholer" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika/Antiprotozo-medel/Mot: PID, salpingit, Bakteriell vaginos, Endokardit" ] }, { "@id" : "339", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Niflumsyra", "@language" : "sv" } ], "VocabularyConceptId" : "349501", "VocabularyId" : "73", "Identifier" : "339", "Label" : "Niflumsyra", "Definition" : null, "Notation" : "CH10/339", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Niflumic acid" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "2-{[3-(Trifluoromethyl)phenyl]amino}nicotinic acid " ], "CAS-Nr" : [ "4394-00-7" ], "EC-Nr" : [ "224-516-2" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Fluorerade aromater/Nikotinsyror/Aniliner/Pyridiner" ], "Anvandningsomrade-Egenskaper" : [ "Antiinflammatoriska medel-NSAID (Non-steroidal anti-inflammatory drugs)/Mot: Reumatism, Led- och muskelvärk" ] }, { "@id" : "340", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Pyrimetamin", "@language" : "sv" } ], "VocabularyConceptId" : "349502", "VocabularyId" : "73", "Identifier" : "340", "Label" : "Pyrimetamin", "Definition" : null, "Notation" : "CH10/340", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Pyrimethamine; Daraprim" ], "Synonym_1" : [ "Daraprim" ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "5-(4-Chlorophenyl)-6-ethyl-2,4-pyrimidinediamine" ], "CAS-Nr" : [ "58-14-0" ], "EC-Nr" : [ "200-364-2" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Klorerade aromater/Pyrimidiner/Aminer" ], "Anvandningsomrade-Egenskaper" : [ "Antiprotozo-medel/Mot: Toxoplasmos, Cystoisosporiasis, Malaria" ] }, { "@id" : "341", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Ramipril", "@language" : "sv" } ], "VocabularyConceptId" : "349503", "VocabularyId" : "73", "Identifier" : "341", "Label" : "Ramipril", "Definition" : null, "Notation" : "CH10/341", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Ramipril; Altace" ], "Synonym_1" : [ "Altace" ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(2S,3aS,6aS)-1-[(2S)-2-{[(2S)-1-Ethoxy-1-oxo-4-phenyl-2-butanyl]amino}propanoyl]octahydrocyclopenta[b]pyrrole-2-carboxylic acid " ], "CAS-Nr" : [ "87333-19-5" ], "EC-Nr" : [ "NA" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Karboxamider/Karboxylsyror/Etylestrar" ], "Anvandningsomrade-Egenskaper" : [ "Blodtrycksmediciner/Mot: Hjärtsvikt/ACE-hämmare" ] }, { "@id" : "342", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Sparfloxacin", "@language" : "sv" } ], "VocabularyConceptId" : "349504", "VocabularyId" : "73", "Identifier" : "342", "Label" : "Sparfloxacin", "Definition" : null, "Notation" : "CH10/342", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Sparfloxacin; Zagam" ], "Synonym_1" : [ "Zagam" ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "5-Amino-1-cyclopropyl-7-[(3R,5S)-3,5-dimethyl-1-piperazinyl]-6,8-difluoro-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid" ], "CAS-Nr" : [ "110871-86-8" ], "EC-Nr" : [ "NA" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Fluorkinoloner/Piperaziner/Cyklopropaner/Karboxylsyror" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika" ] }, { "@id" : "343", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Sulindak", "@language" : "sv" } ], "VocabularyConceptId" : "349505", "VocabularyId" : "73", "Identifier" : "343", "Label" : "Sulindak", "Definition" : null, "Notation" : "CH10/343", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Sulindac" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "{(1Z)-5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid" ], "CAS-Nr" : [ "38194-50-2" ], "EC-Nr" : [ "253-819-2" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Fluorerade aromater/Indener/Karboxylsyror/Sulfoxider" ], "Anvandningsomrade-Egenskaper" : [ "Antiinflammatoriska medel/NSAID (Non-steroidal anti-inflammatory drugs)/Hepatotoxiner" ] }, { "@id" : "344", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Valsartan", "@language" : "sv" } ], "VocabularyConceptId" : "349506", "VocabularyId" : "73", "Identifier" : "344", "Label" : "Valsartan", "Definition" : null, "Notation" : "CH10/344", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Valsartan" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "N-Pentanoyl-N-{[2'-(1H-tetrazol-5-yl)-4-biphenylyl]methyl}-L-valine " ], "CAS-Nr" : [ "137862-53-4" ], "EC-Nr" : [ "604-045-2" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Karboxamider/Karboxylsyror/Tetrazoler/Bifenyler" ], "Anvandningsomrade-Egenskaper" : [ "Blodtrycksmediciner/Mot: Hjärtsvikt/Angiotensin-II-receptor-antagonister" ] }, { "@id" : "345", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "10,11-Dihydro-10-hydroxikarbamazepin", "@language" : "sv" } ], "VocabularyConceptId" : "349507", "VocabularyId" : "73", "Identifier" : "345", "Label" : "10,11-Dihydro-10-hydroxikarbamazepin", "Definition" : null, "Notation" : "CH10/345", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "10,11-Dihydro-10-hydroxycarbamazepine; Licarbazepine" ], "Synonym_1" : [ "Likarbazepin" ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "5-Hydroxy-5,6-dihydrobenzo[b][1]benzazepine-11-carboxamide" ], "CAS-Nr" : [ "29331-92-8" ], "EC-Nr" : [ ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Dibensoazepiner/Karboxamider/Sekundära alkoholer" ], "Anvandningsomrade-Egenskaper" : [ "Antikonvulsiva/stämningsstabiliserare/Natrium-kanal-blockerare/Aktiv oxakarbazin-metabolit" ] }, { "@id" : "346", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "10,11-Dihydrokarbamazepin", "@language" : "sv" } ], "VocabularyConceptId" : "349508", "VocabularyId" : "73", "Identifier" : "346", "Label" : "10,11-Dihydrokarbamazepin", "Definition" : null, "Notation" : "CH10/346", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "10,11-Dihydrocarbamazepine; Dihydrocarbamazepine" ], "Synonym_1" : [ "Dihydrokarbamazepin" ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "5,6-Dihydrobenzo[b][1]benzazepine-11-carboxamide" ], "CAS-Nr" : [ "3564-73-6" ], "EC-Nr" : [ "222-649-0" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Dibensoazepiner/Karboxamider" ], "Anvandningsomrade-Egenskaper" : [ "Förorening i anti-epileptikan karbamazepin" ] }, { "@id" : "347", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Karbamazepin-10,11-epoxid", "@language" : "sv" } ], "VocabularyConceptId" : "349509", "VocabularyId" : "73", "Identifier" : "347", "Label" : "Karbamazepin-10,11-epoxid", "Definition" : null, "Notation" : "CH10/347", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Carbamazepine-10,11-epoxide; Carbamazepine epoxide" ], "Synonym_1" : [ "Karbamazepinepoxid" ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "3-Oxa-11-azatetracyclo[10.4.0.02,4.05,10]hexadeca-1(16),5,7,9,12,14-hexaene-11-carboxamide" ], "CAS-Nr" : [ "36507-30-9" ], "EC-Nr" : [ ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Dibensoazepiner/Epoxider/Ureor" ], "Anvandningsomrade-Egenskaper" : [ "Karbamazepin-metabolit/Allergen" ] }, { "@id" : "348", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Klorokin", "@language" : "sv" } ], "VocabularyConceptId" : "349510", "VocabularyId" : "73", "Identifier" : "348", "Label" : "Klorokin", "Definition" : "ChSp/PubCh/ECHA/WIKI", "Notation" : "CH10/348", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Chloroquine" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "4-N-(7-Chloroquinolin-4-yl)-1-N,1-N-diethylpentane-1,4-diamine; N~4~-(7-Chloro-4-quinolinyl)-N~1~,N~1~-diethyl-1,4-pentanediamine" ], "CAS-Nr" : [ "54-05-7" ], "EC-Nr" : [ "200-191-2" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Heterocykler/Kinoliner/Klorerade aromater" ], "Anvandningsomrade-Egenskaper" : [ "Antiinflammatoriska medel/Malariamedicin" ] }, { "@id" : "349", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Levamisol", "@language" : "sv" } ], "VocabularyConceptId" : "349511", "VocabularyId" : "73", "Identifier" : "349", "Label" : "Levamisol", "Definition" : "ChSp/PubCh/ECHA/WIKI", "Notation" : "CH10/349", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Levamisole; Decaris; Wormicid" ], "Synonym_1" : [ "Dekaris" ], "Synonym_2" : [ "Wormicid" ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(6S)-6-Phenyl-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazole" ], "CAS-Nr" : [ "14769-73-4" ], "EC-Nr" : [ "238-836-5" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "HeterocyklerAzotiazoler/fenyler" ], "Anvandningsomrade-Egenskaper" : [ "Antiparasitika/Helminticider, Maskmedel//Veterinärmedicin/Immunologisk adjuvant cancerbehandling" ] }, { "@id" : "350", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Mebendazol", "@language" : "sv" } ], "VocabularyConceptId" : "349512", "VocabularyId" : "73", "Identifier" : "350", "Label" : "Mebendazol", "Definition" : null, "Notation" : "CH10/350", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Mebendazole; Bantenol; Vermox; Telmin" ], "Synonym_1" : [ "Bantenol" ], "Synonym_2" : [ "Vermox" ], "Synonym_3" : [ "Telmin" ], "Validity" : [ "Valid" ], "IUPAC" : [ "Methyl N-(6-benzoyl-1H-benzimidazol-2-yl)carbamate" ], "CAS-Nr" : [ "31431-39-7" ], "EC-Nr" : [ "250-635-4" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Bensimidasoler/Karbamater/Bensoyler" ], "Anvandningsomrade-Egenskaper" : [ "Antiparasitika/Helminticider, Maskmedel" ] }, { "@id" : "351", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Metotrexat", "@language" : "sv" } ], "VocabularyConceptId" : "349513", "VocabularyId" : "73", "Identifier" : "351", "Label" : "Metotrexat", "Definition" : "ChSp/PubCh/ECHA/WIKI", "Notation" : "CH10/351", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Methotrexate; Amethopterin" ], "Synonym_1" : [ "Ametopterin" ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(2S)-2-[[4-[(2,4-Diaminopteridin-6-yl)methyl-methylamino]benzoyl]amino]pentanedioic acid; N-(4-{[(2,4-Diamino-6-pteridinyl)methyl](methyl)amino}benzoyl)-L-glutamic acid" ], "CAS-Nr" : [ "59-05-2" ], "EC-Nr" : [ "200-413-8" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Heterocykler/Pteridiner/Aminer/Bensoyler/Karboxylsyror" ], "Anvandningsomrade-Egenskaper" : [ "Immunosuppressiva/Cytostatika/ Mot: Reumatoid artrit, Psoriasis, Chrohns sjukdom, Cancer. " ] }, { "@id" : "352", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Citalopram-desmetyl", "@language" : "sv" } ], "VocabularyConceptId" : "349514", "VocabularyId" : "73", "Identifier" : "352", "Label" : "Citalopram-desmetyl", "Definition" : null, "Notation" : "CH10/352", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Citalopram-desmethyl; N-Desmethylcitalopram; Desmethylcitalopram" ], "Synonym_1" : [ "N-Desmetylcitalopram" ], "Synonym_2" : [ "Desmetylcitalopram" ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "1-(4-Fluorophenyl)-1-[3-(methylamino)propyl]-3H-2-benzofuran-5-carbonitrile" ], "CAS-Nr" : [ "62498-67-3" ], "EC-Nr" : [ "263-573-8" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Fluorerade aromater/Aminer/Bensofuraner/Karbonitriler" ], "Anvandningsomrade-Egenskaper" : [ "Citalopram-metabolit (Antidepressiva/Mot: PDS, OCD, PMDD, m.fl./SSRI: Selektiva Serotoninåterupptagshämmare)" ] }, { "@id" : "353", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Nikotinamid", "@language" : "sv" } ], "VocabularyConceptId" : "349515", "VocabularyId" : "73", "Identifier" : "353", "Label" : "Nikotinamid", "Definition" : "ChSp/PubCh/ECHA/WIKI", "Notation" : "CH10/353", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Nicotinamide; Niacinamide" ], "Synonym_1" : [ "Niacinamid" ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "Pyridine-3-carboxamide" ], "CAS-Nr" : [ "98-92-0" ], "EC-Nr" : [ "202-713-4" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Heterocykler/Pyridinkarboxamider" ], "Anvandningsomrade-Egenskaper" : [ "Vitaminer (aktiv form vitamin B3)" ] }, { "@id" : "354", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Fluoxetin-Desmetyl", "@language" : "sv" } ], "VocabularyConceptId" : "349516", "VocabularyId" : "73", "Identifier" : "354", "Label" : "Fluoxetin-Desmetyl", "Definition" : null, "Notation" : "CH10/354", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Fluoxetine-desmethyl; Norfluoxetine; Desmethylfluoxetine" ], "Synonym_1" : [ "Norfluoxetin" ], "Synonym_2" : [ "Desmetylfluoxetin" ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "3-Phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine" ], "CAS-Nr" : [ "83891-03-6; 56161-73-0" ], "EC-Nr" : [ "saknas" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Fluororganiska aromater/Aminer" ], "Anvandningsomrade-Egenskaper" : [ "Fluoxetin-metabolit (Antidepressiva - Mot: MDD, OCD, Bulimia m.fl./SSRI: Selektiva Serotoninåterupptagshämmare)" ] }, { "@id" : "355", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Sertralin-desmetyl", "@language" : "sv" } ], "VocabularyConceptId" : "349517", "VocabularyId" : "73", "Identifier" : "355", "Label" : "Sertralin-desmetyl", "Definition" : "ChSp/PubCh/ECHA/WIKI", "Notation" : "CH10/355", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Sertraline-desmethyl; Norsertraline, Desmethylsertraline" ], "Synonym_1" : [ "Norsertralin" ], "Synonym_2" : [ "Desmetylsertralin" ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(1S,4S)-4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydronaphthalen-1-amine" ], "CAS-Nr" : [ "87857-41-8" ], "EC-Nr" : [ "saknas" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Klorerade aromater/Aminer/Tetraliner" ], "Anvandningsomrade-Egenskaper" : [ "Sertralin-metabolit (Antidepressiva/Ångestdämpande/Mot: MDD, OCD, PD/SSRI: Selektiva Serotoninåterupptagshämmare)" ] }, { "@id" : "356", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Oxkarbazepin", "@language" : "sv" } ], "VocabularyConceptId" : "349518", "VocabularyId" : "73", "Identifier" : "356", "Label" : "Oxkarbazepin", "Definition" : null, "Notation" : "CH10/356", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Oxcarbazepine; Trileptal" ], "Synonym_1" : [ "Trileptal" ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "5-Oxo-6H-benzo[b][1]benzazepine-11-carboxamide" ], "CAS-Nr" : [ "28721-07-5" ], "EC-Nr" : [ "249-188-8" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Dibensoazepiner/Ketoner/Ureor" ], "Anvandningsomrade-Egenskaper" : [ "Antiepileptika/Antikonvulsiva/Stämningsstabiliserare" ] }, { "@id" : "357", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Paraxantin", "@language" : "sv" } ], "VocabularyConceptId" : "349519", "VocabularyId" : "73", "Identifier" : "357", "Label" : "Paraxantin", "Definition" : null, "Notation" : "CH10/357", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Paraxanthine; 1,7-Dimethylxanthine" ], "Synonym_1" : [ "1,7-Dimetylxantin" ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "1,7-Dimethyl-3H-purine-2,6-dione" ], "CAS-Nr" : [ "611-59-6" ], "EC-Nr" : [ "210-271-9" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Metylxantiner/Alkaloider/Puriner" ], "Anvandningsomrade-Egenskaper" : [ "Psykoaktiva/CNS-stimulantia" ] }, { "@id" : "358", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Pyridoxin", "@language" : "sv" } ], "VocabularyConceptId" : "349520", "VocabularyId" : "73", "Identifier" : "358", "Label" : "Pyridoxin", "Definition" : "ChSp/PubCh/ECHA/WIKI", "Notation" : "CH10/358", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Pyridoxine; Pyridoxol" ], "Synonym_1" : [ "Pyridoxol" ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "4,5-Bis(hydroxymethyl)-2-methylpyridin-3-ol; 4,5-Bis(hydroxymethyl)-2-methyl-3-pyridinol" ], "CAS-Nr" : [ "65-23-6" ], "EC-Nr" : [ "200-603-0" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Hydroxipyridiner" ], "Anvandningsomrade-Egenskaper" : [ "B-vitaminer" ] }, { "@id" : "359", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Teofyllin", "@language" : "sv" } ], "VocabularyConceptId" : "349521", "VocabularyId" : "73", "Identifier" : "359", "Label" : "Teofyllin", "Definition" : "ChSp/PubCh/ECHA/WIKI", "Notation" : "CH10/359", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Theophylline; 1,3-Dimethylxanthine; Elixophyllin" ], "Synonym_1" : [ "1,3-Dimetylxantin" ], "Synonym_2" : [ "Elixofyllin" ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "1,3-Dimethyl-7H-purine-2,6-dione; 1,3-Dimethyl-3,7-dihydro-1H-purine-2,6-dione" ], "CAS-Nr" : [ "58-55-9" ], "EC-Nr" : [ "200-385-7" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Metylxantiner" ], "Anvandningsomrade-Egenskaper" : [ "Astmamediciner/Bronkialvidgande" ] }, { "@id" : "360", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Enalapril", "@language" : "sv" } ], "VocabularyConceptId" : "349522", "VocabularyId" : "73", "Identifier" : "360", "Label" : "Enalapril", "Definition" : "Flyttad 2020-05-23 från CH06/273", "Notation" : "CH10/360", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Enalapril; N-[(2S)-1-Ethoxy-1-oxo-4-phenyl-2-butanyl]alanyl-L-proline" ], "Synonym_1" : [ "N-[(2S)-1-Etoxi-1-oxo-4-fenyl-2-butanyl]alanyl-L-prolin" ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "N-[(2S)-1-Ethoxy-1-oxo-4-phenyl-2-butanyl]alanyl-L-proline" ], "CAS-Nr" : [ "75847-73-3" ], "EC-Nr" : [ "616-271-9" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Karboxylatestrar/Pyrrolidiner" ], "Anvandningsomrade-Egenskaper" : [ "Blodtrycksmediciner/Mot: Hjärtsvikt/ACE-hämmare" ] }, { "@id" : "361", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Hydroximetronidazol", "@language" : "sv" } ], "VocabularyConceptId" : "349523", "VocabularyId" : "73", "Identifier" : "361", "Label" : "Hydroximetronidazol", "Definition" : null, "Notation" : "CH10/361", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Hydroxymetronidazole; Metronidazole-OH" ], "Synonym_1" : [ "Metronidazol-OH" ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "2-[2-(Hydroxymethyl)-5-nitro-1H-imidazol-1-yl]ethanol" ], "CAS-Nr" : [ "4812-40-2" ], "EC-Nr" : [ "641-568-5" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Nitroimidazoler/Alkoholer" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika/Antiprotozo-medel/Mot: PID, salpingit, Bakteriell vaginos, Endokardit/Metronidazol-metabolit" ] }, { "@id" : "362", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Ibuprofen-hydroxy, isomer-mix av ibuprofen-1-/2-/3-hydroxy", "@language" : "sv" } ], "VocabularyConceptId" : "349524", "VocabularyId" : "73", "Identifier" : "362", "Label" : "Ibuprofen-hydroxy, isomer-mix av ibuprofen-1-/2-/3-hydroxy", "Definition" : null, "Notation" : "CH10/362", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Ibuprofen-1-/2-/3-hydroxy, isomer mix" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "NA" ], "CAS-Nr" : [ "NA" ], "EC-Nr" : [ "NA" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Arylpropionsyror" ], "Anvandningsomrade-Egenskaper" : [ "Antiinflammatoriska medel-NSAID (Non-steroidal anti-inflammatory drugs)/Analgetika/Antipyretika/Ibuprofen-metabolit" ] }, { "@id" : "363", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Amlodipinbesilat", "@language" : "sv" } ], "VocabularyConceptId" : "349525", "VocabularyId" : "73", "Identifier" : "363", "Label" : "Amlodipinbesilat", "Definition" : null, "Notation" : "CH10/363", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Amlodipine besylate; Amlodipine besilate" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "Benzenesulfonic acid;3-O-Ethyl 5-O-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate" ], "CAS-Nr" : [ "111470-99-6" ], "EC-Nr" : [ "601-097-8" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Klorerade aromater/Aminer/Karboxylatestrar/Dihydropyridiner: Bensensulfonsyror" ], "Anvandningsomrade-Egenskaper" : [ "Blodtrycksmediciner/Vasodilativa/Kalcium-kanal-blockerare/Antimineralkortikoid" ] }, { "@id" : "364", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Enalaprilmaleat", "@language" : "sv" } ], "VocabularyConceptId" : "349526", "VocabularyId" : "73", "Identifier" : "364", "Label" : "Enalaprilmaleat", "Definition" : null, "Notation" : "CH10/364", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Enalapril maleate; Glioten; Renitec; Vasotec" ], "Synonym_1" : [ "Renitec" ], "Synonym_2" : [ "Vasotec" ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(Z)-But-2-enedioic acid;(2S)-1-[(2S)-2-[[(2S)-1-Ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]pyrrolidine-2-carboxylic acid" ], "CAS-Nr" : [ "76095-16-4" ], "EC-Nr" : [ "278-375-7" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Maleinsyror: Karboxylatestrar/Pyrrolidiner" ], "Anvandningsomrade-Egenskaper" : [ "Blodtrycksmediciner/Mot: Hjärtsvikt/ACE-hämmare" ] }, { "@id" : "365", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Gestoden", "@language" : "sv" } ], "VocabularyConceptId" : "349527", "VocabularyId" : "73", "Identifier" : "365", "Label" : "Gestoden", "Definition" : null, "Notation" : "CH10/365", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Gestodene" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(8R,9S,10R,13S,14S,17R)-13-Ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14-decahydrocyclopenta[a]phenanthren-3-one" ], "CAS-Nr" : [ "60282-87-3" ], "EC-Nr" : [ "262-145-8" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Syntetiska progestagener" ], "Anvandningsomrade-Egenskaper" : [ "Hormonella preventivmedel/Mot: Klimakteriebesvär" ] }, { "@id" : "366", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Testosteron", "@language" : "sv" } ], "VocabularyConceptId" : "349528", "VocabularyId" : "73", "Identifier" : "366", "Label" : "Testosteron", "Definition" : null, "Notation" : "CH10/366", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Testosterone; Androst-4-en-17β-ol-3-one" ], "Synonym_1" : [ "Androst-4-en-17β-ol-3-on" ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(8R,9S,10R,13S,14S,17S)-17-Hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one" ], "CAS-Nr" : [ "58-22-0" ], "EC-Nr" : [ "200-370-5" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Steroidhormoner" ], "Anvandningsomrade-Egenskaper" : [ "Androgena hormoner" ] }, { "@id" : "367", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Natamycin", "@language" : "sv" } ], "VocabularyConceptId" : "349529", "VocabularyId" : "73", "Identifier" : "367", "Label" : "Natamycin", "Definition" : null, "Notation" : "CH10/367", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Natamycin; Pimaricin" ], "Synonym_1" : [ "Pimaricin" ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(1R,3S,5R,7R,8E,12R,14E,16E,18E,20E,22R,24S,25R,26S)-22-[(2R,3S,4S,5S,6R)-4-Amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-1,3,26-trihydroxy-12-methyl-10-oxo-6,11,28-trioxatricyclo[22.3.1.05,7]octacosa-8,14,16,18,20-pentaene-25-carboxylic acid" ], "CAS-Nr" : [ "7681-93-8" ], "EC-Nr" : [ "231-683-5" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Makrolider/Polyener/Epoxider" ], "Anvandningsomrade-Egenskaper" : [ "Antimykotika/Antibiotika/Veterinärmedicin/Mot: Ögoninfektion/Konserveringsmedel (E235) hårdost samt saltad och torkad korv" ] }, { "@id" : "368", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Noradrenalin", "@language" : "sv" } ], "VocabularyConceptId" : "349530", "VocabularyId" : "73", "Identifier" : "368", "Label" : "Noradrenalin", "Definition" : null, "Notation" : "CH10/368", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Noradrenaline; Norepinephrine" ], "Synonym_1" : [ "Norepinefrin" ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "4-[(1R)-2-amino-1-hydroxyethyl]benzene-1,2-diol" ], "CAS-Nr" : [ "51-41-2" ], "EC-Nr" : [ "200-096-6" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Fenyletanolaminer/Katekolaminer" ], "Anvandningsomrade-Egenskaper" : [ "Hormoner/Neurotransmittorer/Adrenerga receptormodulatorer" ] }, { "@id" : "369", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Norefedrin", "@language" : "sv" } ], "VocabularyConceptId" : "349531", "VocabularyId" : "73", "Identifier" : "369", "Label" : "Norefedrin", "Definition" : null, "Notation" : "CH10/369", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Norephedrine; Phenylpropanolamine (PPA); beta-Hydroxyamphetamine" ], "Synonym_1" : [ "Fenylpropanolamin (PPA)" ], "Synonym_2" : [ "beta-Hydroxiamfetamin" ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(1S,2R)-2-Amino-1-phenylpropan-1-ol" ], "CAS-Nr" : [ "14838-15-4; 700-65-2" ], "EC-Nr" : [ "211-850-9" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Fenyletylaminer/Substituerade amfetaminer/Alkoholer" ], "Anvandningsomrade-Egenskaper" : [ "Avsvällande nässlemhinnan/Förkylnings- och Hostmedicin/Aptitnedsättare/Alfaadrenerga agonister" ] }, { "@id" : "370", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Amidotrizoinsyra", "@language" : "sv" } ], "VocabularyConceptId" : "349532", "VocabularyId" : "73", "Identifier" : "370", "Label" : "Amidotrizoinsyra", "Definition" : "Dubblett, använd CH10/64", "Notation" : "CH10/370", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Amidotrizoic acid; Diatrizoic acid" ], "Synonym_1" : [ "Diatrizoinsyra" ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Invalid" ], "IUPAC" : [ "3,5-Diacetamido-2,4,6-triiodobenzoic acid" ], "CAS-Nr" : [ "117-96-4" ], "EC-Nr" : [ "204-223-6" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Joderade aromater/Joderade bensoesyror/Acetanilider" ], "Anvandningsomrade-Egenskaper" : [ "Röntgenkontrastmedel/Antiparasitika/Helminticider, \"maskmedel\"" ] }, { "@id" : "371", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Klopidol", "@language" : "sv" } ], "VocabularyConceptId" : "349533", "VocabularyId" : "73", "Identifier" : "371", "Label" : "Klopidol", "Definition" : null, "Notation" : "CH10/371", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Clopidol" ], "Synonym_1" : [ "Clopidol" ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "3,5-Dichloro-2,6-dimethyl-1H-pyridin-4-one" ], "CAS-Nr" : [ "2971-90-6" ], "EC-Nr" : [ "221-008-2" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Klorerade aromater/Pyridiner/Fenoler" ], "Anvandningsomrade-Egenskaper" : [ "Antiparasitika/Mot: Coccidia-amöba/Veterinärmedicin" ] }, { "@id" : "372", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Karprofen", "@language" : "sv" } ], "VocabularyConceptId" : "349534", "VocabularyId" : "73", "Identifier" : "372", "Label" : "Karprofen", "Definition" : null, "Notation" : "CH10/372", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Carprofen" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "2-(6-Chloro-9H-carbazol-2-yl)propanoic acid" ], "CAS-Nr" : [ "53716-49-7" ], "EC-Nr" : [ "258-712-4" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Klorerade aromater/Arylpropionsyror/Karbazoler" ], "Anvandningsomrade-Egenskaper" : [ "Antiinflammatoriska medel/Analgetika/Antipyretika/Veterinärmediciner/NSAID (Non-steroidal anti-inflammatory drugs)" ] }, { "@id" : "373", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Flutikason", "@language" : "sv" } ], "VocabularyConceptId" : "349535", "VocabularyId" : "73", "Identifier" : "373", "Label" : "Flutikason", "Definition" : null, "Notation" : "CH10/373", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Fluticasone" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "S-(Fluoromethyl) (6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate" ], "CAS-Nr" : [ "90566-53-3" ], "EC-Nr" : [ "saknas" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Fluorerade aromater/Kortikosteroider/Diketoner/Dioler/Tioetrar" ], "Anvandningsomrade-Egenskaper" : [ "Astmamediciner/Antiinflammatorisk lungmedicin/Avsvällande nässlemhinnan" ] }, { "@id" : "374", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Gabapentin", "@language" : "sv" } ], "VocabularyConceptId" : "349536", "VocabularyId" : "73", "Identifier" : "374", "Label" : "Gabapentin", "Definition" : null, "Notation" : "CH10/374", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Gabapentin; Neurontin" ], "Synonym_1" : [ "Neurontin" ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "2-[1-(Aminomethyl)cyclohexyl]acetic acid" ], "CAS-Nr" : [ "60142-96-3" ], "EC-Nr" : [ "262-076-3" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Aminosyror/Karboxylsyror/Aminer" ], "Anvandningsomrade-Egenskaper" : [ "Antiepileptika/Neuroleptika/Mot: Neuropati" ] }, { "@id" : "375", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Mometasonfuroat", "@language" : "sv" } ], "VocabularyConceptId" : "349537", "VocabularyId" : "73", "Identifier" : "375", "Label" : "Mometasonfuroat", "Definition" : null, "Notation" : "CH10/375", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Mometasone furoate" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "[(8S,9R,10S,11S,13S,14S,16R,17R)-9-Chloro-17-(2-chloroacetyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] furan-2-carboxylate" ], "CAS-Nr" : [ "83919-23-7" ], "EC-Nr" : [ "saknas" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Klorerade aromater/Glukokortikoider/Steroider/Furoater" ], "Anvandningsomrade-Egenskaper" : [ "Antiallergika/Mot: Allergisk rinit, Astma, Eksem, Psoriasis" ] }, { "@id" : "376", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Nebivolol", "@language" : "sv" } ], "VocabularyConceptId" : "349538", "VocabularyId" : "73", "Identifier" : "376", "Label" : "Nebivolol", "Definition" : null, "Notation" : "CH10/376", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Nebivolol" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "1R)-1-[(2R)-6-Fluoro-3,4-dihydro-2H-chromen-2-yl]-2-[[(2R)-2-[(2S)-6-fluoro-3,4-dihydro-2H-chromen-2-yl]-2-hydroxyethyl]amino]ethanol" ], "CAS-Nr" : [ "118457-14-0" ], "EC-Nr" : [ "601-527-4" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Fluorerade aromater/Kromaner/Dioler/Aminer" ], "Anvandningsomrade-Egenskaper" : [ "AVREGISTRERAT Sverige-Mot: Högt blodtryck, Hjärtsvikt/Beta-blockerare" ] }, { "@id" : "377", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Kvetiapin", "@language" : "sv" } ], "VocabularyConceptId" : "349539", "VocabularyId" : "73", "Identifier" : "377", "Label" : "Kvetiapin", "Definition" : null, "Notation" : "CH10/377", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Quetiapine; Seroquel" ], "Synonym_1" : [ "Quetiapin" ], "Synonym_2" : [ "Seroquel" ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "2-[2-(4-Benzo[b][1,4]benzothiazepin-6-ylpiperazin-1-yl)ethoxy]ethanol" ], "CAS-Nr" : [ "111974-69-7" ], "EC-Nr" : [ "saknas" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Dibensotiazepiner/Piperaziner/Etrar/Alkoholer" ], "Anvandningsomrade-Egenskaper" : [ "Antidepressiva/Antipsykotika/Sedativa/Alfareceptor-blockerare" ] }, { "@id" : "378", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Toltrazuril", "@language" : "sv" } ], "VocabularyConceptId" : "349540", "VocabularyId" : "73", "Identifier" : "378", "Label" : "Toltrazuril", "Definition" : null, "Notation" : "CH10/378", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Toltrazuril" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "1-Methyl-3-[3-methyl-4-[4-(trifluoromethylsulfanyl)phenoxy]phenyl]-1,3,5-triazinane-2,4,6-trione" ], "CAS-Nr" : [ "69004-03-1" ], "EC-Nr" : [ "saknas" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Trifluormetyltio-föreningar/Fenyletrar/Tioetrar/Isocyanursyror/Triaziner" ], "Anvandningsomrade-Egenskaper" : [ "Antiparasitika/Antiprotozo-medel mot: Coccidia-amöba/Veterinärmedicin" ] }, { "@id" : "379", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Xylometazolin", "@language" : "sv" } ], "VocabularyConceptId" : "349541", "VocabularyId" : "73", "Identifier" : "379", "Label" : "Xylometazolin", "Definition" : null, "Notation" : "CH10/379", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Xylometazoline" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "2-[(4-tert-Butyl-2,6-dimethylphenyl)methyl]-4,5-dihydro-1H-imidazole" ], "CAS-Nr" : [ "526-36-3" ], "EC-Nr" : [ "208-390-6" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Imidazoliner/tert-Butylföreningar" ], "Anvandningsomrade-Egenskaper" : [ "Avsvällande nässlemhinnan/Alfaadrenerga agonister" ] }, { "@id" : "380", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Allopurinol", "@language" : "sv" } ], "VocabularyConceptId" : "349542", "VocabularyId" : "73", "Identifier" : "380", "Label" : "Allopurinol", "Definition" : null, "Notation" : "CH10/380", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Allopurinol" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "1,5-Dihydropyrazolo[3,4-d]pyrimidin-4-one" ], "CAS-Nr" : [ "315-30-0" ], "EC-Nr" : [ "206-250-9" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Puriner/Purinoler/Alkoholer" ], "Anvandningsomrade-Egenskaper" : [ "Giktmedicin, sänker urinsyrahalter/Mot: Giktnefropati, Urasten" ] }, { "@id" : "381", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Florfenikol", "@language" : "sv" } ], "VocabularyConceptId" : "349543", "VocabularyId" : "73", "Identifier" : "381", "Label" : "Florfenikol", "Definition" : null, "Notation" : "CH10/381", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Florfenicol" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "2,2-Dichloro-N-[(1R,2S)-3-fluoro-1-hydroxy-1-(4-methylsulfonylphenyl)propan-2-yl]acetamide" ], "CAS-Nr" : [ "73231-34-2; 76639-94-6" ], "EC-Nr" : [ "620-107-1; 642-986-0" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Klororganiska ämnen/Fluororganiska ämnen/Amfenikoler/Bensosulfoner/Fenyletanolaminer/Acetamider" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika/Veterinärmedicin" ] }, { "@id" : "382", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Mesalazin", "@language" : "sv" } ], "VocabularyConceptId" : "349544", "VocabularyId" : "73", "Identifier" : "382", "Label" : "Mesalazin", "Definition" : null, "Notation" : "CH10/382", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Mesalazine; Mesalamine; 5-Aminosalicylic acid" ], "Synonym_1" : [ "Mesalamin" ], "Synonym_2" : [ "5-Aminosalicylsyra " ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "5-Amino-2-hydroxybenzoic acid" ], "CAS-Nr" : [ "89-57-6" ], "EC-Nr" : [ "201-919-1" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Aniliner/Salicylsyror/Aromatiska aminer" ], "Anvandningsomrade-Egenskaper" : [ "Antiinflammatoriskt medel mot tarmsukdomar som: Ulcerös kolit och Crohns sjukdom" ] }, { "@id" : "383", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Pantoprazol", "@language" : "sv" } ], "VocabularyConceptId" : "349545", "VocabularyId" : "73", "Identifier" : "383", "Label" : "Pantoprazol", "Definition" : null, "Notation" : "CH10/383", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Pantoprazole" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "6-(Difluoromethoxy)-2-[(3,4-dimethoxypyridin-2-yl)methylsulfinyl]-1H-benzimidazole" ], "CAS-Nr" : [ "102625-70-7" ], "EC-Nr" : [ "600-331-6" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Bensimidazoler/Fluororganiska ämnen/Fenoletrar/Pyridiner/Sulfoxider" ], "Anvandningsomrade-Egenskaper" : [ "Protonpumpshämmare/Mot: Magsår, Dyspepsi, Refluxer, m.fl." ] }, { "@id" : "384", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Olanzapin", "@language" : "sv" } ], "VocabularyConceptId" : "349546", "VocabularyId" : "73", "Identifier" : "384", "Label" : "Olanzapin", "Definition" : null, "Notation" : "CH10/384", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Olanzapine; Zyprexa" ], "Synonym_1" : [ "Zyprexa" ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "2-Methyl-4-(4-methylpiperazin-1-yl)-10H-thieno[2,3-b][1,5]benzodiazepine" ], "CAS-Nr" : [ "132539-06-1" ], "EC-Nr" : [ "saknas" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Tienobensodiazepiner/Piperaziner" ], "Anvandningsomrade-Egenskaper" : [ "Neuroleptika/Antipsykotika/Mot: Schizofreni, Bipolär sjukdom" ] }, { "@id" : "385", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Guanylurea", "@language" : "sv" } ], "VocabularyConceptId" : "349547", "VocabularyId" : "73", "Identifier" : "385", "Label" : "Guanylurea", "Definition" : "ChSp/PubCh/ECHA/WIKI", "Notation" : "CH10/385", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Guanylurea; Amidinourea; Dicyandiamidine" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "Diaminomethylideneurea" ], "CAS-Nr" : [ "141-83-3" ], "EC-Nr" : [ "205-504-6" ], "WFD" : [ "Watch" ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Biguanider/Guanidiner/Urinämnen" ], "Anvandningsomrade-Egenskaper" : [ "Metformin-metaboliter" ] }, { "@id" : "386", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Läkemedel, summa av 30 (Amidotrizoinsyra, Atenolol, Ciprofloxacin, Citalopram, Diklofenak, Erytromycin, Flukonazol, Furosemid, Ibuprofen, Karbamazepin, Ketokonazol, Klaritromycin, Klopidol, Krotamiton, Losartan, Metoprolol, Metotrexat, Naproxen, Oxazepam, Paracetamol, Primidon, Propranolol, Sertralin, Sotalol, Sulfadiazin, Sulfametoxazol, Tramadol, Trimetoprim, Venlafaxin, Zolpidem)", "@language" : "sv" } ], "VocabularyConceptId" : "349548", "VocabularyId" : "73", "Identifier" : "386", "Label" : "Läkemedel, summa av 30 (Amidotrizoinsyra, Atenolol, Ciprofloxacin, Citalopram, Diklofenak, Erytromycin, Flukonazol, Furosemid, Ibuprofen, Karbamazepin, Ketokonazol, Klaritromycin, Klopidol, Krotamiton, Losartan, Metoprolol, Metotrexat, Naproxen, Oxazepam, Paracetamol, Primidon, Propranolol, Sertralin, Sotalol, Sulfadiazin, Sulfametoxazol, Tramadol, Trimetoprim, Venlafaxin, Zolpidem)", "Definition" : "Summa av 30 läkemedel. Definierade för \"Screening 2023-råvatten\" av Vattenmyndigheten", "Notation" : "CH10/386", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Pharmaceuticals, sum of 30 (Amidotrizoinsyra, Atenolol, Ciprofloxacin, Citalopram, Diklofenak, Erytromycin, Flukonazol, Furosemid, Ibuprofen, Karbamazepin, Ketokonazol, Klaritromycin, Klopidol, Krotamiton, Losartan, Metoprolol, Metotrexat, Naproxen, Oxazepam, Paracetamol, Primidon, Propranolol, Sertralin, Sotalol, Sulfadiazin, Sulfametoxazol, Tramadol, Trimetoprim, Venlafaxin, Zolpidem)" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "NA" ], "CAS-Nr" : [ "NA" ], "EC-Nr" : [ "NA" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ ], "Anvandningsomrade-Egenskaper" : [ ] }, { "@id" : "387", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Dihydrotestosteron", "@language" : "sv" } ], "VocabularyConceptId" : "349549", "VocabularyId" : "73", "Identifier" : "387", "Label" : "Dihydrotestosteron", "Definition" : "ChSp/PubCh/ECHA/WIKI", "Notation" : "CH10/387", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Dihydrotestosterone; 5α-dihydrotestosterone; 5α-DHT; Androstanolone; Stanolone" ], "Synonym_1" : [ "DHT" ], "Synonym_2" : [ "5α-Dihydrotestosteron" ], "Synonym_3" : [ "Stanolon" ], "Validity" : [ "Valid" ], "IUPAC" : [ "(5S,8R,9S,10S,13S,14S,17S)-17-Hydroxy-10,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-one; (5α,17β)-17-Hydroxyandrostan-3-one" ], "CAS-Nr" : [ "521-18-6" ], "EC-Nr" : [ "208-307-3" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Steroidhormoner" ], "Anvandningsomrade-Egenskaper" : [ "Androgena hormoner" ] }, { "@id" : "388", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Amisulprid", "@language" : "sv" } ], "VocabularyConceptId" : "349550", "VocabularyId" : "73", "Identifier" : "388", "Label" : "Amisulprid", "Definition" : "ChSp/PubCh/ECHA/WIKI", "Notation" : "CH10/388", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Amisulpride" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "4-Amino-N-[(1-ethylpyrrolidin-2-yl)methyl]-5-ethylsulfonyl-2-methoxybenzamide; 4-Amino-N-[(1-ethyl-2-pyrrolidinyl)methyl]-5-(ethylsulfonyl)-2-methoxybenzamide" ], "CAS-Nr" : [ "71675-85-9" ], "EC-Nr" : [ "275-831-7" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Bensamider/Pyrrolidiner/Fenoletrar/Sulfoner" ], "Anvandningsomrade-Egenskaper" : [ "Antipsykotika/Antiemetika" ] }, { "@id" : "389", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Fusidinsyra", "@language" : "sv" } ], "VocabularyConceptId" : "349551", "VocabularyId" : "73", "Identifier" : "389", "Label" : "Fusidinsyra", "Definition" : "ChSp/PubCh/ECHA/WIKI", "Notation" : "CH10/389", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Fusidic acid" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(2Z)-2-[(3R,4S,5S,8S,9S,10S,11R,13R,14S,16S)-16-Acetyloxy-3,11-dihydroxy-4,8,10,14-tetramethyl-2,3,4,5,6,7,9,11,12,13,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-ylidene]-6-methylhept-5-enoic acid; (3α,4α,5α,8α,9β,11α,13α,14β,16β,17Z)-16-Acetoxy-3,11-dihydroxy-4,8,14-trimethyl-18-norcholesta-17,24-dien-21-oic acid" ], "CAS-Nr" : [ "69900603" ], "EC-Nr" : [ "230-256-0" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Steroider/Alkensyror/Ättiksyraestrar/Tetracykliska triterpener/Karboxylsyror/Dioler/Diener" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika/Steroid-antibiotika/Bakteriell proteinsyntes-inhibitor" ] }, { "@id" : "390", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Linezolid", "@language" : "sv" } ], "VocabularyConceptId" : "349552", "VocabularyId" : "73", "Identifier" : "390", "Label" : "Linezolid", "Definition" : "ChSp/PubCh/ECHA/WIKI", "Notation" : "CH10/390", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Linezolid" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "N-[[(5S)-3-(3-Fluoro-4-morpholin-4-ylphenyl)-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide; N-({(5S)-3-[3-Fluoro-4-(4-morpholinyl)phenyl]-2-oxo-1,3-oxazolidin-5-yl}methyl)acetamide" ], "CAS-Nr" : [ "165800-03-3" ], "EC-Nr" : [ "605-416-1" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Oxazolidinoner/Fluororganiska aromater/Morfoliner" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika/Bakteriell proteinsyntes-inhibitor/Monoaminoxidashämmare" ] }, { "@id" : "391", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Moxifloxacin", "@language" : "sv" } ], "VocabularyConceptId" : "349553", "VocabularyId" : "73", "Identifier" : "391", "Label" : "Moxifloxacin", "Definition" : "ChSp/PubCh/ECHA/WIKI", "Notation" : "CH10/391", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Moxifloxacin" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "7-[(4aS,7aS)-1,2,3,4,4a,5,7,7a-Octahydropyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6-fluoro-8-methoxy-4-oxoquinoline-3-carboxylic acid; 1-Cyclopropyl-6-fluoro-8-methoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid" ], "CAS-Nr" : [ "151096-09-2" ], "EC-Nr" : [ "604-773-0" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Fluorkinoloner/Cyklopropaner/Fenoletrar/Pyrrolpyridiner/Piperidiner" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika/Blockerar bakteriell DNA-duplikation" ] }, { "@id" : "392", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Rifampicin", "@language" : "sv" } ], "VocabularyConceptId" : "349554", "VocabularyId" : "73", "Identifier" : "392", "Label" : "Rifampicin", "Definition" : "ChSp/PubCh/ECHA/WIKI", "Notation" : "CH10/392", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Rifampicin; Rifampin" ], "Synonym_1" : [ "Rifampin" ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "[(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,27,29-Pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-[(E)-(4-methylpiperazin-1-yl)iminomethyl]-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate; (7S,9E,11S,12R,13S,14R,15R,16R,19Z,21Z)-2,15,17,23,27,29-Hexahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-{(E)-[(4-methyl-1-piperazinyl)imino]methyl}-6-oxo-8,30-dioxa-24-azatetracyclo[23.3.1.1 ~4,7~.0~5,28~]triaconta-1(28),2,4,9,19,21,23,25(29),26-nonaen-13-yl acetate" ], "CAS-Nr" : [ "13292-46-1" ], "EC-Nr" : [ "236-312-0" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Ansamyciner/Naftokinoner/Hydroxinaftalener/Piperaziner" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika/Särskilt mot tuberkolos och lepra/Hämmar bakteriellt DNA -beroende RNA-polymeras" ] }, { "@id" : "393", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Acetanilid", "@language" : "sv" } ], "VocabularyConceptId" : "349555", "VocabularyId" : "73", "Identifier" : "393", "Label" : "Acetanilid", "Definition" : "ChSp/PubCh/ECHA/WIKI", "Notation" : "CH10/393", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Acetanilide; N-Phenylethanamide" ], "Synonym_1" : [ "N-fenylacetamid" ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "N-Phenylacetamide" ], "CAS-Nr" : [ "103-84-4" ], "EC-Nr" : [ "203-150-7; 695-031-5" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Acetanilider/Fenylamider" ], "Anvandningsomrade-Egenskaper" : [ "Analgetika/Antipyretika" ] }, { "@id" : "394", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Amilorid", "@language" : "sv" } ], "VocabularyConceptId" : "349556", "VocabularyId" : "73", "Identifier" : "394", "Label" : "Amilorid", "Definition" : "ChSp/PubCh/ECHA/WIKI", "Notation" : "CH10/394", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Amiloride" ], "Synonym_1" : [ " " ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "3,5-Diamino-6-chloro-N-(diaminomethylidene)pyrazine-2-carboxamide; 3,5-Diamino-N-carbamimidoyl-6-chloro-2-pyrazinecarboxamide" ], "CAS-Nr" : [ "2609-46-3" ], "EC-Nr" : [ "220-024-7" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Guanidiner/Pyraziner/Klorerade heteroaromater/Aminoaziner" ], "Anvandningsomrade-Egenskaper" : [ "Diuretika/Mot: Högt blodtryck, Hjärtsvikt, Ödem" ] }, { "@id" : "395", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Anastrozol", "@language" : "sv" } ], "VocabularyConceptId" : "349557", "VocabularyId" : "73", "Identifier" : "395", "Label" : "Anastrozol", "Definition" : "ChSp/PubCh/ECHA/WIKI", "Notation" : "CH10/395", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Anastrozole" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "2-[3-(2-Cyanopropan-2-yl)-5-(1,2,4-triazol-1-ylmethyl)phenyl]-2-methylpropanenitrile; 2,2′-[5-(1H-1,2,4-Triazol-1-ylmethyl)-1,3-phenylene]bis(2-methylpropanenitrile)" ], "CAS-Nr" : [ "120511-73-1" ], "EC-Nr" : [ "601-715-6" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Nitriler/Triazoler/Bensyler" ], "Anvandningsomrade-Egenskaper" : [ "Antiöstrogen/Mot: Bröstcancer/Aromatashämmare" ] }, { "@id" : "396", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Azatioprin", "@language" : "sv" } ], "VocabularyConceptId" : "349558", "VocabularyId" : "73", "Identifier" : "396", "Label" : "Azatioprin", "Definition" : "ChSp/PubCh/ECHA/WIKI", "Notation" : "CH10/396", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Azathioprine" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "6-(3-Methyl-5-nitroimidazol-4-yl)sulfanyl-7H-purine; 6-[(1-Methyl-4-nitro-1H-imidazol-5-yl)sulfanyl]-1H-purine" ], "CAS-Nr" : [ "446-86-6" ], "EC-Nr" : [ "207-175-4" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Nitroimidazoler/Puriner/Tioetrar" ], "Anvandningsomrade-Egenskaper" : [ "Immunosuppressiva/Mot: Reumatoid artrit, Inflammatoriska tarmsjukfdomar (Crohns sjukdom, ulcerös colit), Andra autoimmuna sjukdomar" ] }, { "@id" : "397", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Bendroflumetiazid", "@language" : "sv" } ], "VocabularyConceptId" : "349559", "VocabularyId" : "73", "Identifier" : "397", "Label" : "Bendroflumetiazid", "Definition" : "ChSp/PubCh/ECHA/WIKI", "Notation" : "CH10/397", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Bendroflumethiazide" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "3-Benzyl-1,1-dioxo-6-(trifluoromethyl)-3,4-dihydro-2H-1λ6,2,4-benzothiadiazine-7-sulfonamide; 3-Benzyl-6-(trifluoromethyl)-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide" ], "CAS-Nr" : [ "73-48-3" ], "EC-Nr" : [ "200-800-1" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Trifluormetyl-föreningar; Bensensulfonamider/Tiazider/Bensyler" ], "Anvandningsomrade-Egenskaper" : [ "Mot: Högt blodtryck, Hjärtsvikt" ] }, { "@id" : "398", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Buspiron", "@language" : "sv" } ], "VocabularyConceptId" : "349560", "VocabularyId" : "73", "Identifier" : "398", "Label" : "Buspiron", "Definition" : "ChSp/PubCh/ECHA/WIKI", "Notation" : "CH10/398", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Buspirone" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "8-[4-(4-Pyrimidin-2-ylpiperazin-1-yl)butyl]-8-azaspiro[4.5]decane-7,9-dione; 8-{4-[4-(2-Pyrimidinyl)-1-piperazinyl]butyl}-8-azaspiro[4.5]decane-7,9-dione" ], "CAS-Nr" : [ "36505-84-7" ], "EC-Nr" : [ "253-072-2" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Imider/Pyrimidiner/Piperaziner/Laktamer" ], "Anvandningsomrade-Egenskaper" : [ "Antidepressiva/Ångestdämpande/Alfa-2-blockerare" ] }, { "@id" : "399", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Butorfanol", "@language" : "sv" } ], "VocabularyConceptId" : "349561", "VocabularyId" : "73", "Identifier" : "399", "Label" : "Butorfanol", "Definition" : "ChSp/PubCh/ECHA/WIKI", "Notation" : "CH10/399", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Butorphanol" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(1S,9R,10S)-17-(Cyclobutylmethyl)-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene-4,10-diol; 17-(Cyclobutylmethyl)morphinan-3,14-diol" ], "CAS-Nr" : [ "42408-82-2" ], "EC-Nr" : [ "255-808-8" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Opioider/Cyklobutaner/Cyklohexener/Cyklohexanoler/Fenoler" ], "Anvandningsomrade-Egenskaper" : [ "Analgesika/Veterinärmedicin" ] }, { "@id" : "400", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Dexmedetomidin", "@language" : "sv" } ], "VocabularyConceptId" : "349562", "VocabularyId" : "73", "Identifier" : "400", "Label" : "Dexmedetomidin", "Definition" : "ChSp/PubCh/ECHA/WIKI", "Notation" : "CH10/400", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Dexmedetomidine" ], "Synonym_1" : [ "Dexmedetomidine" ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "5-[(1S)-1-(2,3-Dimethylphenyl)ethyl]-1H-imidazole; 4-[(1S)-1-(2,3-Dimethylphenyl)ethyl]-1H-imidazole" ], "CAS-Nr" : [ "113775-47-6" ], "EC-Nr" : [ "601-281-8" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Imidazoler/Xylener" ], "Anvandningsomrade-Egenskaper" : [ "Analgetika/Seditativa/Psykoleptika/Veterinärmedicin" ] }, { "@id" : "401", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Entakapon", "@language" : "sv" } ], "VocabularyConceptId" : "349563", "VocabularyId" : "73", "Identifier" : "401", "Label" : "Entakapon", "Definition" : "ChSp/PubCh/ECHA/WIKI", "Notation" : "CH10/401", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Entacapone" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(E)-2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylprop-2-enamide; (2E)-2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylacrylamide" ], "CAS-Nr" : [ "130929-57-6" ], "EC-Nr" : [ "603-449-6" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Karboxamider/Katekoler/Nitriler/Nitrofenoler" ], "Anvandningsomrade-Egenskaper" : [ "Mot: Parkinssons sjukdom" ] }, { "@id" : "402", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Fluvastatin", "@language" : "sv" } ], "VocabularyConceptId" : "349564", "VocabularyId" : "73", "Identifier" : "402", "Label" : "Fluvastatin", "Definition" : "ChSp/PubCh/ECHA/WIKI", "Notation" : "CH10/402", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Fluvastatin" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(E,3R,5S)-7-[3-(4-Fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (3R,5S,6E)-7-[3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid" ], "CAS-Nr" : [ "93957-54-1" ], "EC-Nr" : [ "658-036-3" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Fluorerade aromater/Fluorbensener/Karboxylsyror/Alkensyror/Indoler/Dioler/Sekundära alkoholer/Heteroaromater" ], "Anvandningsomrade-Egenskaper" : [ "Blodfettssänkande mediciner/Statiner" ] }, { "@id" : "403", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Galantamin", "@language" : "sv" } ], "VocabularyConceptId" : "349565", "VocabularyId" : "73", "Identifier" : "403", "Label" : "Galantamin", "Definition" : "ChSp/PubCh/ECHA/WIKI", "Notation" : "CH10/403", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Galantamine; Galanthamine" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(1S,12S,14R)-9-Methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-ol; (4aS,6R,8aS)-3-Methoxy-11-methyl-4a,5,9,10,11,12-hexahydro-6H-benzo[2,3]benzofuro[4,3-cd]azepin-6-ol" ], "CAS-Nr" : [ "357-70-0" ], "EC-Nr" : [ "609-175-3" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Bensazepiner/Dibensofuraner/Fenoletrar/Sekundära alkoholer" ], "Anvandningsomrade-Egenskaper" : [ "Mot: Demens, Alzheimer/Acetylkolinesteras-inhibitorer" ] }, { "@id" : "404", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Hydrokortison", "@language" : "sv" } ], "VocabularyConceptId" : "349566", "VocabularyId" : "73", "Identifier" : "404", "Label" : "Hydrokortison", "Definition" : "ChSp/PubCh/ECHA/WIKI", "Notation" : "CH10/404", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Hydrocortisone; Cortisol" ], "Synonym_1" : [ "Kortisol" ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(8S,9S,10R,11S,13S,14S,17R)-11,17-Dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one; (1R,3aS,3bS,9aR,9bS,10S,11aS)-1,10-dihydroxy-1-(2-hydroxyacetyl)-9a,11a-dimethyl-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-one" ], "CAS-Nr" : [ "50-23-7" ], "EC-Nr" : [ "200-020-1" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Glukokortikosteroider/Ketoner/Dioler" ], "Anvandningsomrade-Egenskaper" : [ "Antiinflammatoriska medel/Immunosuppressiva/Antiklåd-medicin" ] }, { "@id" : "405", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Ipratropium", "@language" : "sv" } ], "VocabularyConceptId" : "349567", "VocabularyId" : "73", "Identifier" : "405", "Label" : "Ipratropium", "Definition" : "PubCh/WIKI", "Notation" : "CH10/405", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Ipratropium" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(1R,3r,5S)-3-[(3-Hydroxy-2-phenylpropanoyl)oxy]-8-methyl-8-(propan-2-yl)-8-azabicyclo[3.2.1]octan-8-ium" ], "CAS-Nr" : [ "60205-81-4" ], "EC-Nr" : [ "saknas" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Karboxylatestrar/Kvarternära ammoniumföreningar/Tropaner/Isopropylaminoföreningar/Alkoholer" ], "Anvandningsomrade-Egenskaper" : [ "Muskarinantagonister/Mot: Andningssvårigheter/Bronkialvidgande/Arytmika" ] }, { "@id" : "406", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Irinotekan", "@language" : "sv" } ], "VocabularyConceptId" : "349568", "VocabularyId" : "73", "Identifier" : "406", "Label" : "Irinotekan", "Definition" : "ChSp/PubCh/ECHA/WIKI", "Notation" : "CH10/406", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Irinotecan" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "[(19S)-10,19-Diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl] 4-piperidin-1-ylpiperidine-1-carboxylate; (4S)-4,11-Diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinolin-9-yl 1,4′-bipiperidine-1′-carboxylate" ], "CAS-Nr" : [ "97682-44-5" ], "EC-Nr" : [ "691-567-9" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Alkaloider/Karbamater/Laktamer/Delta-laktoner/Piperidiner/Pyrroliner/Pyridinoner/Kinoliner/Pyranoindolisokinoliner" ], "Anvandningsomrade-Egenskaper" : [ "Cytostatika/Cancer-medicin/Topoisomerashämmare" ] }, { "@id" : "407", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Kapecitabin", "@language" : "sv" } ], "VocabularyConceptId" : "349569", "VocabularyId" : "73", "Identifier" : "407", "Label" : "Kapecitabin", "Definition" : "ChSp/PubCh/ECHA/WIKI", "Notation" : "CH10/407", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Capecitabine" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "Pentyl N-[1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methyloxolan-2-yl]-5-fluoro-2-oxopyrimidin-4-yl]carbamate; 5′-Deoxy-5-fluoro-N-[(pentyloxy)carbonyl]cytidine" ], "CAS-Nr" : [ "154361-50-9" ], "EC-Nr" : [ "604-948-1" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Flkuorerade aromater/Karbamater/Fluorpyrimidiner/Pyrimidoner/Dihydroxioxolaner" ], "Anvandningsomrade-Egenskaper" : [ "Cytostatika/Cancer-medicin" ] }, { "@id" : "408", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Karvedilol", "@language" : "sv" } ], "VocabularyConceptId" : "349570", "VocabularyId" : "73", "Identifier" : "408", "Label" : "Karvedilol", "Definition" : "ChSp/PubCh/ECHA/WIKI", "Notation" : "CH10/408", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Carvedilol" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "1-(9H-Carbazol-4-yloxy)-3-[2-(2-methoxyphenoxy)ethylamino]propan-2-ol; 1-(9H-Carbazol-4-yloxy)-3-{[2-(2-methoxyphenoxy)ethyl]amino}-2-propanol" ], "CAS-Nr" : [ "72956-09-3" ], "EC-Nr" : [ "615-871-8" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Karbazoler/Fenoxipropanolaminer/Katekoletrar" ], "Anvandningsomrade-Egenskaper" : [ "Betablockerare/Mot: Högt blodtryck, Hjärtsvikt" ] }, { "@id" : "409", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Kolkicin", "@language" : "sv" } ], "VocabularyConceptId" : "349571", "VocabularyId" : "73", "Identifier" : "409", "Label" : "Kolkicin", "Definition" : "ChSp/PubCh/ECHA/WIKI", "Notation" : "CH10/409", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Colchicine; Colchicinum" ], "Synonym_1" : [ "Kolchicin" ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "N-[(7S)-1,2,3,10-Tetramethoxy-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide; N-[(7S)-1,2,3,10-Tetramethoxy-9-oxo-5,6,7,9-tetrahydrobenzo[a]heptalen-7-yl]acetamide" ], "CAS-Nr" : [ "64-86-8" ], "EC-Nr" : [ "200-598-5" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Alkaloider/Acetamider/Bensodihydtoheptalener/Troponer/Pyrgalloletrar" ], "Anvandningsomrade-Egenskaper" : [ "Antiinflammatoriska medel/Gikt-medicin/Mot: Familjär medelhavsfeber, Behcets sjukdom" ] }, { "@id" : "410", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Levosimendan", "@language" : "sv" } ], "VocabularyConceptId" : "349572", "VocabularyId" : "73", "Identifier" : "410", "Label" : "Levosimendan", "Definition" : "ChSp/PubCh/ECHA/WIKI", "Notation" : "CH10/410", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Levosimendan" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "2-[[4-[(4R)-4-Methyl-6-oxo-4,5-dihydro-1H-pyridazin-3-yl]phenyl]hydrazinylidene]propanedinitrile; ({4-[(4R)-4-Methyl-6-oxo-1,4,5,6-tetrahydro-3-pyridazinyl]phenyl}hydrazono)malononitrile" ], "CAS-Nr" : [ "141505-33-1" ], "EC-Nr" : [ "663-528-6" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Laktamer/Nitriler/PyridazinerTetrahydroaziner/Amidiner/Aminobensener" ], "Anvandningsomrade-Egenskaper" : [ "Kalciumsensibilatorer/Inotropa medel/Mot: Akut hjärtsvikt" ] }, { "@id" : "411", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Meloxikam", "@language" : "sv" } ], "VocabularyConceptId" : "349573", "VocabularyId" : "73", "Identifier" : "411", "Label" : "Meloxikam", "Definition" : "ChSp/PubCh/ECHA/WIKI", "Notation" : "CH10/411", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Meloxicam" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "4-Hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-1,1-dioxo-1λ6,2-benzothiazine-3-carboxamide; 4-Hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide" ], "CAS-Nr" : [ "71125-38-7" ], "EC-Nr" : [ "615-253-8" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Bensotiaziner/Karboxamider/Tiazoler" ], "Anvandningsomrade-Egenskaper" : [ "Antiinflammatoriska medel/Analgetika/NSAID (Non-steroidal anti-inflammatory drugs)/COX-2-hämmare/Veterinärmedicin" ] }, { "@id" : "412", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Meropenem", "@language" : "sv" } ], "VocabularyConceptId" : "349574", "VocabularyId" : "73", "Identifier" : "412", "Label" : "Meropenem", "Definition" : "ChSp/PubCh/ECHA/WIKI", "Notation" : "CH10/412", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Meropenem" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(4R,5S,6S)-3-[(3S,5S)-5-(Dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid; (4R,5S,6S)-3-{[(3S,5S)-5-(Dimethylcarbamoyl)-3-pyrrolidinyl]sulfanyl}-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid" ], "CAS-Nr" : [ "96036-03-2" ], "EC-Nr" : [ "641-424-1" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Karboxamider/Pyrrolidiner/Sekundära alkoholer" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika/Bredspektrumantibiotikum mot bl.a. bakteriell meningit/Karbapenemantibiotika" ] }, { "@id" : "413", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Metacyklin", "@language" : "sv" } ], "VocabularyConceptId" : "349575", "VocabularyId" : "73", "Identifier" : "413", "Label" : "Metacyklin", "Definition" : "ChSp/PubCh/ECHA/WIKI", "Notation" : "CH10/413", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Metacycline; Methacycline" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "4S,4aR,5S,5aR,12aR)-4-(Dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methylidene-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide; (2Z,4S,4aR,5S,5aR,12aS)-2-[Amino(hydroxy)methylene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methylene-4a,5a,6,12a-tetrahydro-1,3,12(2H,4H,5H)-tetracenetrione" ], "CAS-Nr" : [ "914-00-1" ], "EC-Nr" : [ "213-017-5" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Tetracykliner/Karboxamider/Dimetylaminer/Fenoler" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika" ] }, { "@id" : "414", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Metylprednisolon", "@language" : "sv" } ], "VocabularyConceptId" : "349576", "VocabularyId" : "73", "Identifier" : "414", "Label" : "Metylprednisolon", "Definition" : "ChSp/PubCh/ECHA/WIKI", "Notation" : "CH10/414", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Methylprednisolone" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-Dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one; (6α,11β)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione" ], "CAS-Nr" : [ "83-43-2" ], "EC-Nr" : [ "201-476-4" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Glukokortikosteroider/Diketoner/Alkoholer (prim./sek./tert.)/Trioler//Cyklopentanoler/Cyklohexanoler" ], "Anvandningsomrade-Egenskaper" : [ "Antiinflammatoriska medel/Immunosuppressiva/Mot: Reumatoid artrit, Astma, Allergi" ] }, { "@id" : "415", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Mykofenolsyra", "@language" : "sv" } ], "VocabularyConceptId" : "349577", "VocabularyId" : "73", "Identifier" : "415", "Label" : "Mykofenolsyra", "Definition" : "ChSp/PubCh/ECHA/WIKI", "Notation" : "CH10/415", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Mycophenolic acid" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(E)-6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-1H-2-benzofuran-5-yl)-4-methylhex-4-enoic acid; (4E)-6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydro-2-benzofuran-5-yl)-4-methylhex-4-enoic acid" ], "CAS-Nr" : [ "24280-93-1" ], "EC-Nr" : [ "246-119-3" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Karboxylsyror/Isobensofuraner/Fenoletrar/Ftalider" ], "Anvandningsomrade-Egenskaper" : [ "Immunosuppressiva/Vid: Organtransplantationer/Mot: Crohns sjukdom" ] }, { "@id" : "416", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Nalidixinsyra", "@language" : "sv" } ], "VocabularyConceptId" : "349578", "VocabularyId" : "73", "Identifier" : "416", "Label" : "Nalidixinsyra", "Definition" : "ChSp/PubCh/ECHA/WIKI", "Notation" : "CH10/416", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Nalidixic acid" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "1-Ethyl-7-methyl-4-oxo-1,8-naphthyridine-3-carboxylic acid; 1-Ethyl-7-methyl-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid" ], "CAS-Nr" : [ "389-08-2" ], "EC-Nr" : [ "206-864-7" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Diazanaftalener/Naftyridoner/Karboxylsyror/Pyridinoner/Alkylpyridiner" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika/Kinolon-antibiotika/Topoisomerasinhibitorer/Gyrashämmare" ] }, { "@id" : "417", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "N-Demetylerytromycin A", "@language" : "sv" } ], "VocabularyConceptId" : "349579", "VocabularyId" : "73", "Identifier" : "417", "Label" : "N-Demetylerytromycin A", "Definition" : "ChSp/PubCh/ECHA", "Notation" : "CH10/417", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "N-Demethylerythromycin A; N-Demethyl erythromycin A; N-Desmethyl Erythromycin" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-Ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-6-[(2S,3R,4S,6R)-3-hydroxy-6-methyl-4-(methylamino)oxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione; (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-Ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-6-{[(2S,3R,4S,6R)-3-hydroxy-6-methyl-4-(methylamino)tetr ahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione; 14-ethyl-7,12,13-trihydroxy-4-(5-hydroxy-4-methoxy- 4,6-dimethyloxan-2-yl)oxy-6-[3-hydroxy-6-methyl-4-(methylamino)oxan- 2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane- 2,10-dione" ], "CAS-Nr" : [ "992-62-1" ], "EC-Nr" : [ "641-787-6" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Makrolider/Alkoholer/Aminer/Etrar/Ketoner" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotikametaboliter/Erytromycin A-metabolit" ] }, { "@id" : "418", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Nelfinavir", "@language" : "sv" } ], "VocabularyConceptId" : "349580", "VocabularyId" : "73", "Identifier" : "418", "Label" : "Nelfinavir", "Definition" : "ChSp/PubCh/WIKI", "Notation" : "CH10/418", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Nelfinavir" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(3S,4aS,8aS)-N-tert-Butyl-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-phenylsulfanylbutyl]-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinoline-3-carboxamide; (3S,4aS,8aS)-2-[(2R,3R)-2-Hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-(phenylsulfanyl)butyl]-N-(2-methyl-2-propanyl)decahydro-3-isoquinolinecarboxamide" ], "CAS-Nr" : [ "159989-64-7" ], "EC-Nr" : [ "saknas" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Dekahydroisokinoloner/Fenoler/Tioetrar/Tert.-butylföreningar" ], "Anvandningsomrade-Egenskaper" : [ "Antiviralt medel/Mot: Retrovirus, HIV-AIDS/Proteashämmare" ] }, { "@id" : "419", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Nimesulid", "@language" : "sv" } ], "VocabularyConceptId" : "349581", "VocabularyId" : "73", "Identifier" : "419", "Label" : "Nimesulid", "Definition" : "ChSp/PubCh/ECHA/WIKI", "Notation" : "CH10/419", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Nimesulide" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "N-(4-Nitro-2-phenoxyphenyl)methanesulfonamide" ], "CAS-Nr" : [ "51803-78-2" ], "EC-Nr" : [ "257-431-4" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Nitrobensener/Metansulfonamider/Difenyletrar/Anilider/" ], "Anvandningsomrade-Egenskaper" : [ "Antiinflammatoriska medel/Analgetika/Antipyretika/NSAID (Non-steroidal anti-inflammatory drugs)/COX-2-hämmare/Veterinärmedicin" ] }, { "@id" : "420", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Ormetoprim", "@language" : "sv" } ], "VocabularyConceptId" : "349582", "VocabularyId" : "73", "Identifier" : "420", "Label" : "Ormetoprim", "Definition" : "ChSp/PubCh/ECHA/WIKI", "Notation" : "CH10/420", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Ormetoprim; Ormethoprim" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "5-[(4,5-Dimethoxy-2-methylphenyl)methyl]pyrimidine-2,4-diamine; 5-(4,5-Dimethoxy-2-methylbenzyl)-2,4(1H,3H)-pyrimidinediimine" ], "CAS-Nr" : [ "6981-18-6" ], "EC-Nr" : [ "230-246-6" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Aminopyridiner/Metoxitoluener" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika/Veterinärmedicin" ] }, { "@id" : "421", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Ornidazol", "@language" : "sv" } ], "VocabularyConceptId" : "349583", "VocabularyId" : "73", "Identifier" : "421", "Label" : "Ornidazol", "Definition" : "ChSp/PubCh/ECHA/WIKI", "Notation" : "CH10/421", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Ornidazole" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "1-Chloro-3-(2-methyl-5-nitroimidazol-1-yl)propan-2-ol; 1-Chloro-3-(2-methyl-5-nitro-1H-imidazol-1-yl)-2-propanol" ], "CAS-Nr" : [ "16773-42-5" ], "EC-Nr" : [ "240-826-0" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Klororganiska ämnen/Nitroimidasoler" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika/Mot: Protozoinfektioner" ] }, { "@id" : "422", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Oximetazolin", "@language" : "sv" } ], "VocabularyConceptId" : "349584", "VocabularyId" : "73", "Identifier" : "422", "Label" : "Oximetazolin", "Definition" : "ChSp/PubCh/ECHA/WIKI", "Notation" : "CH10/422", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Oxymetazoline" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "6-tert-Butyl-3-(4,5-dihydro-1H-imidazol-2-ylmethyl)-2,4-dimethylphenol; 3-(4,5-Dihydro-1H-imidazol-2-ylmethyl)-2,4-dimethyl-6-(2-methyl-2-propanyl)phenol" ], "CAS-Nr" : [ "1491-59-4" ], "EC-Nr" : [ "216-079-1" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Imidazoliner/Fenoler/Tert.-butylföreningar" ], "Anvandningsomrade-Egenskaper" : [ "Topikala avsvällande medel/Kärlsammandragande medel/Mot: Nästäppa, Näsblod" ] }, { "@id" : "423", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Paklitaxel", "@language" : "sv" } ], "VocabularyConceptId" : "349585", "VocabularyId" : "73", "Identifier" : "423", "Label" : "Paklitaxel", "Definition" : "ChSp/PubCh/ECHA/WIKI", "Notation" : "CH10/423", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Paclitaxel; Taxol" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "[(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-Diacetyloxy-15-[(2R,3S)-3-benzamido-2-hydroxy-3-phenylpropanoyl]oxy-1,9-dihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate; (2α,4α,5β,7β,10β,13α)-4,10-Bis(acetyloxy)-13-{[(2R,3S)-3-(benzoylamino)-2-hydroxy-3-phenylpropanoyl]oxy}-1,7-dihydroxy-9-oxo-5,20-epoxytax-11-en-2-yl benzoate" ], "CAS-Nr" : [ "33069-62-4" ], "EC-Nr" : [ "608-826-9" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Bensoatestrar/Karboxylatestrar/Acetatestrar/Bensamider/Alkoholer (sek./tert)/Ketoner/Taxaner" ], "Anvandningsomrade-Egenskaper" : [ "Cytostatika/Kemoterapeutika/Cancer-terapeutika/Växt-toxiner" ] }, { "@id" : "424", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Piperacillin", "@language" : "sv" } ], "VocabularyConceptId" : "349586", "VocabularyId" : "73", "Identifier" : "424", "Label" : "Piperacillin", "Definition" : "ChSp/PubCh/ECHA/WIKI", "Notation" : "CH10/424", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Piperacillin" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(2S,5R,6R)-6-[[(2R)-2-[(4-Ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; 2S,5R,6R)-6-{(E)-[(2R)-2-{(E)-[(4-Ethyl-2,3-dioxo-1-piperazinyl)(hydroxy)methylene]amino}-1-hydroxy-2-phenylethylidene]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid" ], "CAS-Nr" : [ "61477-96-1" ], "EC-Nr" : [ "262-811-8" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Betalaktamer/Aromater/Piperaziner/Acetamider/Karboxylsyror" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika/Bredspektrumpenicillin mot allvarliga infektioner, alltid i kombination med betalaktamashämmaren tazobaktam" ] }, { "@id" : "425", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Piroxikam", "@language" : "sv" } ], "VocabularyConceptId" : "349587", "VocabularyId" : "73", "Identifier" : "425", "Label" : "Piroxikam", "Definition" : "ChSp/PubCh/ECHA/WIKI", "Notation" : "CH10/425", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Piroxicam" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "4-Hydroxy-2-methyl-1,1-dioxo-N-pyridin-2-yl-1λ6,2-benzothiazine-3-carboxamide; 4-Hydroxy-2-methyl-N-(2-pyridinyl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide" ], "CAS-Nr" : [ "36322-90-4" ], "EC-Nr" : [ "252-974-3" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Bensensulfonamider/Karboxamider/Bensotiaziner/Pyridiner/Sultamer" ], "Anvandningsomrade-Egenskaper" : [ "Antiinflammatoriska medel/Analgetika/Antipyretika/NSAID (Non-steroidal anti-inflammatory drugs)/COX-2-hämmare/Veterinärmedicin" ] }, { "@id" : "426", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Prazikvantel", "@language" : "sv" } ], "VocabularyConceptId" : "349588", "VocabularyId" : "73", "Identifier" : "426", "Label" : "Prazikvantel", "Definition" : "ChSp/PubCh/ECHA/WIKI", "Notation" : "CH10/426", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Praziquantel" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "2-(Cyclohexanecarbonyl)-3,6,7,11b-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4-one; 2-(Cyclohexylcarbonyl)-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a]isoquinolin-4-one" ], "CAS-Nr" : [ "55268-74-1" ], "EC-Nr" : [ "259-559-6" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Karboxamider/Laktamer/Piperaziner/Tetrahydroisokinoliner/Kväveheterocykler/Cyklohexyler" ], "Anvandningsomrade-Egenskaper" : [ "Antiparasitika/Helminticider, \"maskmedel\"" ] }, { "@id" : "427", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Propafenon", "@language" : "sv" } ], "VocabularyConceptId" : "349589", "VocabularyId" : "73", "Identifier" : "427", "Label" : "Propafenon", "Definition" : "ChSp/PubCh/ECHA/WIKI", "Notation" : "CH10/427", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Propafenone" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "1-[2-[2-Hydroxy-3-(propylamino)propoxy]phenyl]-3-phenylpropan-1-one; 1-{2-[2-Hydroxy-3-(propylamino)propoxy]phenyl}-3-phenyl-1-propanone" ], "CAS-Nr" : [ "54063-53-5" ], "EC-Nr" : [ "258-955-6" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Aminer/Ketoner/Fenoletrar/Sek. alkoholer" ], "Anvandningsomrade-Egenskaper" : [ "Antiarytmika/Mot: Hjärtarytmi" ] }, { "@id" : "428", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Raloxifen", "@language" : "sv" } ], "VocabularyConceptId" : "349590", "VocabularyId" : "73", "Identifier" : "428", "Label" : "Raloxifen", "Definition" : "ChSp/PubCh/ECHA/WIKI", "Notation" : "CH10/428", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Raloxifene" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "[6-Hydroxy-2-(4-hydroxyphenyl)-1-benzothiophen-3-yl]-[4-(2-piperidin-1-ylethoxy)phenyl]methanone; [6-Hydroxy-2-(4-hydroxyphenyl)-1-benzothiophen-3-yl]{4-[2-(1-piperidinyl)ethoxy]phenyl}methanon" ], "CAS-Nr" : [ "84449-90-1" ], "EC-Nr" : [ "686-786-1" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Bensotiofener/Fenoletrar/Diarylketoner/Piperidiner/Hydroxiaromater" ], "Anvandningsomrade-Egenskaper" : [ "Östrogenreceptormodulatorer/Behandling av osteoporos" ] }, { "@id" : "429", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Salmeterol", "@language" : "sv" } ], "VocabularyConceptId" : "349591", "VocabularyId" : "73", "Identifier" : "429", "Label" : "Salmeterol", "Definition" : "ChSp/PubCh/ECHA/WIKI", "Notation" : "CH10/429", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Salmeterol" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "2-(Hydroxymethyl)-4-[1-hydroxy-2-[6-(4-phenylbutoxy)hexylamino]ethyl]phenol; 2-(Hydroxymethyl)-4-(1-hydroxy-2-{[6-(4-phenylbutoxy)hexyl]amino}ethyl)phenol" ], "CAS-Nr" : [ "89365-50-4" ], "EC-Nr" : [ "618-267-2" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Fenyletylaminer/Etrar/Fenoler/Dioler/Bensylalkoholer" ], "Anvandningsomrade-Egenskaper" : [ "Mot: Astma, KOL/Beta-2 adrenerga receptoragonister/Sympatomimetika" ] }, { "@id" : "430", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Tebain", "@language" : "sv" } ], "VocabularyConceptId" : "349592", "VocabularyId" : "73", "Identifier" : "430", "Label" : "Tebain", "Definition" : "ChSp/PubCh/ECHA/WIKI", "Notation" : "CH10/430", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Thebaine" ], "Synonym_1" : [ "Tebainum" ], "Synonym_2" : [ "Dimetylmorfin" ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(4R,7aR,12bS)-7,9-Dimethoxy-3-methyl-2,4,7a,13-tetrahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline; 3,6-Dimethoxy-17-methyl-6,7,8,14-tetradehydro-4,5-epoxymorphinan" ], "CAS-Nr" : [ "115-37-7" ], "EC-Nr" : [ "204-084-1" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Opiater/Alkaloider/Epoxinorfinaner/Cyklohexadiener/Etrar/Metoxibensener/Kumariner/Cyklohexener/Piperidiner" ], "Anvandningsomrade-Egenskaper" : [ "Psykoaktiva/CNS-stimulantia/Analgetika/Narkotikaklassad" ] }, { "@id" : "431", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Toremifen", "@language" : "sv" } ], "VocabularyConceptId" : "349593", "VocabularyId" : "73", "Identifier" : "431", "Label" : "Toremifen", "Definition" : "ChSp/PubCh/ECHA/WIKI", "Notation" : "CH10/431", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Toremifene" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "2-[4-[(Z)-4-Chloro-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine; 2-{4-[(1Z)-4-Chloro-1,2-diphenyl-1-buten-1-yl]phenoxy}-N,N-dimethylethanamine" ], "CAS-Nr" : [ "89778-26-7" ], "EC-Nr" : [ "618-298-1" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Klororganiska föreningar/Fenoletrar/Trifenyletylener" ], "Anvandningsomrade-Egenskaper" : [ "Östrogenreceptormodulatorer/Behandling av bröstcancer" ] }, { "@id" : "432", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Vankomycin", "@language" : "sv" } ], "VocabularyConceptId" : "349594", "VocabularyId" : "73", "Identifier" : "432", "Label" : "Vankomycin", "Definition" : "ChSp/PubCh/ECHA/WIKI", "Notation" : "CH10/432", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Vancomycin" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(1S,2R,18R,19R,22S,25R,28R,40S)-48-[(2S,3R,4S,5S,6R)-3-[(2S,4S,5S,6S)-4-Amino-5-hydroxy-4,6-dimethyloxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-22-(2-amino-2-oxoethyl)-5,15-dichloro-2,18,32,35,37-pentahydroxy-19-[[(2R)-4-methyl-2-(methylamino)pentanoyl]amino]-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentazaoctacyclo[26.14.2.23,6.214,17.18,12.129,33.010,25.034,39]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34(39),35,37,46,49-pentadecaene-40-carboxylic acid; (1S,2R,18R,19R,22S,25R,28R,40S)-22-(2-Amino-2-oxoethyl)-48-{[2-O-(3-amino-2,3,6-trideoxy-3-methyl-α-L-lyxo-hexopyranosyl)-β-D-glucopyranosyl]oxy}-5,15-dichloro-2,18,32,35,37-pentahydroxy-19-[(N -methyl-D-leucyl)amino]-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentaazaoctacyclo[26.14.2.2~3,6~.2~14,17~.1~8,12~.1~29,33~.0~10,25~.0~34,39~]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34,3 6,38,46,49-pentadecaene-40-carboxylic acid" ], "CAS-Nr" : [ "1404-90-6" ], "EC-Nr" : [ "215-772-6" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Cyklopeptider/Glykosider/Difenyletrar/Polyoler/Fenoler/Fenoletrar/Diaminer/Klorfenyletrar/Bifenyler/Hydroxioxaner" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika/Glykopeptidantibiotika/För behandling av svåra infektioner orsakade av exempelvis stafylokocker som utvecklat resistens mot penicillin och andra antibiotika" ] }, { "@id" : "433", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "4-Acetamidoantipyrin", "@language" : "sv" } ], "VocabularyConceptId" : "349595", "VocabularyId" : "73", "Identifier" : "433", "Label" : "4-Acetamidoantipyrin", "Definition" : "ChSp/PubCh/ECHA", "Notation" : "CH10/433", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "4-Acetamidoantipyrine; 4-Acetylaminoantipyrine; 4-Acetaminoantipyrine; N-Acetylaminoantipyrine; 4-Acetylaminophenazone; ; N-Antipyrinylacetamide" ], "Synonym_1" : [ "4-Acetaminoantipyrin" ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "N-(1,5-Dimethyl-3-oxo-2-phenylpyrazol-4-yl)acetamide; N-(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)acetamide; N-(2,3-Dimethyl-5-oxo-1-phenyl-3-pyrazolin-4-yl)acetamide" ], "CAS-Nr" : [ "83-15-8" ], "EC-Nr" : [ "201-457-0" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Acetamider/Fenylpyrazoloner/Pyrazoler" ], "Anvandningsomrade-Egenskaper" : [ "Analgetika, Antipyretika/Metaboliter från metamizol och aminopyrin, smärtstillande och febernedsättande läkemedel " ] }, { "@id" : "434", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "4-Demetyltrimetoprim", "@language" : "sv" } ], "VocabularyConceptId" : "349596", "VocabularyId" : "73", "Identifier" : "434", "Label" : "4-Demetyltrimetoprim", "Definition" : "ChSp/PubCh", "Notation" : "CH10/434", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "4-Demethyltrimethoprim" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "4-[(2,4-Diaminopyrimidin-5-yl)methyl]-2,6-dimethoxyphenol" ], "CAS-Nr" : [ "21253-58-7" ], "EC-Nr" : [ "saknas" ], "WFD" : [ "Watch" ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Pyrimidiner/Arylaminer/Fenyletrar" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika/Folsyre-antagonister/Trimetoprim-metabolit" ] }, { "@id" : "435", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "4-Formamidoantipyrin", "@language" : "sv" } ], "VocabularyConceptId" : "349597", "VocabularyId" : "73", "Identifier" : "435", "Label" : "4-Formamidoantipyrin", "Definition" : "ChSp/PubCh/ECHA", "Notation" : "CH10/435", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "4-Formamidoantipyrine; 4-Formylaminoantipyrine; 4-(Formylamino)antipyrine" ], "Synonym_1" : [ "4-Formylaminoantipyrin" ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "N-(1,5-Dimethyl-3-oxo-2-phenylpyrazol-4-yl)formamide; (1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)imidoformic acid; N-(2,3-Dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)formamide" ], "CAS-Nr" : [ "1672-58-8" ], "EC-Nr" : [ "216-808-3" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Formamider/Fenylpyrazoloner/Pyrazoler" ], "Anvandningsomrade-Egenskaper" : [ "Analgetika, Antipyretika/Metaboliter från metamizol och aminopyrin, smärtstillande och febernedsättande läkemedel " ] }, { "@id" : "436", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Acetylsulfametoxazol", "@language" : "sv" } ], "VocabularyConceptId" : "349598", "VocabularyId" : "73", "Identifier" : "436", "Label" : "Acetylsulfametoxazol", "Definition" : "ChSp/PubCh/ECHA", "Notation" : "CH10/436", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Acetylsulfamethoxazole" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "N-[4-[(5-Methyl-1,2-oxazol-3-yl)sulfamoyl]phenyl]acetamide; \tN-[4-[[(5-Methylisoxazol-3-yl)amino]sulphonyl]phenyl]acetamide" ], "CAS-Nr" : [ "21312-10-7" ], "EC-Nr" : [ "244-330-5" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Sulfonamider/Aniliner/Isoxazoler" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika-metaboliter/Metabolit av sulfametoxazol" ] }, { "@id" : "437", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Dimetridazol", "@language" : "sv" } ], "VocabularyConceptId" : "349599", "VocabularyId" : "73", "Identifier" : "437", "Label" : "Dimetridazol", "Definition" : "ChSp/PubCh/ECHA/WIKI", "Notation" : "CH10/437", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Dimetridazole" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "1,2-Dimethyl-5-nitroimidazole; 1,2-Dimethyl-5-nitro-1H-imidazole" ], "CAS-Nr" : [ "551-92-8" ], "EC-Nr" : [ "209-001-2" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Nitroimidazoler" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika/Antiprotozo-medel/Veterinärmedicin" ] }, { "@id" : "438", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Pivmecillinam", "@language" : "sv" } ], "VocabularyConceptId" : "349600", "VocabularyId" : "73", "Identifier" : "438", "Label" : "Pivmecillinam", "Definition" : "ChSp/PubCh/ECHA/WIKI", "Notation" : "CH10/438", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Pivmecillinam; \tAmdinocillin pivoxil" ], "Synonym_1" : [ "Amdinocillinpivoxil" ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "2,2-Dimethylpropanoyloxymethyl (2S,5R,6R)-6-(azepan-1-ylmethylideneamino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate" ], "CAS-Nr" : [ "32886-97-8" ], "EC-Nr" : [ "251-276-6" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Azepaner/Karboxylsyraestrar/Propiolaktamer/Amidiner/Tiazolidiner" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika/Penicilliner/Mecillinam-prodrog" ] }, { "@id" : "439", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Bromhexin", "@language" : "sv" } ], "VocabularyConceptId" : "349601", "VocabularyId" : "73", "Identifier" : "439", "Label" : "Bromhexin", "Definition" : "ChSp/PubCh/ECHA/WIKI", "Notation" : "CH10/439", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Bromhexine" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "2,4-Dibromo-6-[[cyclohexyl(methyl)amino]methyl]aniline" ], "CAS-Nr" : [ "3572-43-8" ], "EC-Nr" : [ "222-684-1" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Bromerade aromater/Aromatiska aminer/Brombensener/Aniliner/Cyklohexyler" ], "Anvandningsomrade-Egenskaper" : [ "Hostmediiciner/Slemlösande" ] }, { "@id" : "440", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Buspiron", "@language" : "sv" } ], "VocabularyConceptId" : "349602", "VocabularyId" : "73", "Identifier" : "440", "Label" : "Buspiron", "Definition" : "ChSp/PubCh/ECHA/WIKI", "Notation" : "CH10/440", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Buspirone" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "8-[4-(4-Pyrimidin-2-ylpiperazin-1-yl)butyl]-8-azaspiro[4.5]decane-7,9-dione; 8-{4-[4-(2-Pyrimidinyl)-1-piperazinyl]butyl}-8-azaspiro[4.5]decane-7,9-dione" ], "CAS-Nr" : [ "36505-84-7" ], "EC-Nr" : [ "253-072-2" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Azaspironer/Laktamer/Pyrimidinylpiperaziner/Aminopyrimidiner/Cyklopentaner" ], "Anvandningsomrade-Egenskaper" : [ "Antidepressiva/Ångestdämpande" ] }, { "@id" : "441", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Cefuroxim", "@language" : "sv" } ], "VocabularyConceptId" : "349603", "VocabularyId" : "73", "Identifier" : "441", "Label" : "Cefuroxim", "Definition" : "ChSp/PubCh/ECHA/WIKI", "Notation" : "CH10/441", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Cefuroxime" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(6R,7R)-3-(Carbamoyloxymethyl)-7-[[(2Z)-2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-3-[(Carbamoyloxy)methyl]-7-{[(2Z)-2-(2-furyl)-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid" ], "CAS-Nr" : [ "55268-75-2" ], "EC-Nr" : [ "259-560-1" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Cefalosporiner/Beta-laktamer/Dihydrotiaziner/Vid akuta och kroniska bakterieinfektioner, t.ex. i luftvägar, njurar och hud, används också vid sepsis och hjärnhinneinflammation" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika" ] }, { "@id" : "442", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Isosorbidmononitrat", "@language" : "sv" } ], "VocabularyConceptId" : "349604", "VocabularyId" : "73", "Identifier" : "442", "Label" : "Isosorbidmononitrat", "Definition" : "ChSp/PubCh/ECHA/WIKI", "Notation" : "CH10/442", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Isosorbide Mononitrate" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "[(3S,3aR,6R,6aS)-3-Hydroxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-6-yl] nitrate; 1,4:3,6-Dianhydro-5-O-nitro-D-glucitol" ], "CAS-Nr" : [ "16051-77-7" ], "EC-Nr" : [ "240-197-2" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Nitratestrar/Furofuraner/Sekundära alkoholer" ], "Anvandningsomrade-Egenskaper" : [ "Vasodilativa/Mot: Hjärtproblem (Angina, Hjärtinfarkt)" ] }, { "@id" : "443", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Läkemedel, summa av kvantifierade ämnen", "@language" : "sv" } ], "VocabularyConceptId" : "349605", "VocabularyId" : "73", "Identifier" : "443", "Label" : "Läkemedel, summa av kvantifierade ämnen", "Definition" : "Ej relevant", "Notation" : "CH10/443", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Pharmaceuticals, sum of quantified substances" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "NA" ], "CAS-Nr" : [ "NA" ], "EC-Nr" : [ "NA" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ ], "Anvandningsomrade-Egenskaper" : [ " " ] }, { "@id" : "444", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Norgestrel", "@language" : "sv" } ], "VocabularyConceptId" : "349606", "VocabularyId" : "73", "Identifier" : "444", "Label" : "Norgestrel", "Definition" : "ChSp/PubCh/ECHA/WIKI", "Notation" : "CH10/444", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Norgestrel" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(8R,9S,13S,14S,17R)-13-Ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one" ], "CAS-Nr" : [ "6533-00-2" ], "EC-Nr" : [ "229-433-5" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Steroidhormoner/Syntetiska progestagener" ], "Anvandningsomrade-Egenskaper" : [ "Hormonella preventivmedel - \"Dagen efter piller\"" ] }, { "@id" : "445", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Penicillin G-bensatin", "@language" : "sv" } ], "VocabularyConceptId" : "349607", "VocabularyId" : "73", "Identifier" : "445", "Label" : "Penicillin G-bensatin", "Definition" : "Pubch/ECHA", "Notation" : "CH10/445", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Penicillin G Benzathine; Benzathinepenicillin G; Benzathine benzylpenicilline" ], "Synonym_1" : [ "Bensatinpenicillin G" ], "Synonym_2" : [ "Bensylpenicillinbensatin" ], "Synonym_3" : [ "Bensatin-bensylpenicillin/Bensatinbensylpenicillin" ], "Validity" : [ "Valid" ], "IUPAC" : [ "N,N'-Dibenzylethane-1,2-diamine;(2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid" ], "CAS-Nr" : [ "1538-09-6; 41372-02-5 (tetrahydrate)" ], "EC-Nr" : [ "804-898-2 (tetrahydrate)" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Beta-laktamer/Penicilliner" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika" ] }, { "@id" : "446", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Piperacillin/Tazobaktam, beräknad summa", "@language" : "sv" } ], "VocabularyConceptId" : "349608", "VocabularyId" : "73", "Identifier" : "446", "Label" : "Piperacillin/Tazobaktam, beräknad summa", "Definition" : "ChSp/PubCh/ECHA/WIKI", "Notation" : "CH10/446", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Piperacillin/Tazobactam, calculated sum" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "NA" ], "CAS-Nr" : [ "61477-96-1" ], "EC-Nr" : [ "262-811-8" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "(Betalaktamer/Aromater/Piperaziner/Acetamider/Karboxylsyror)/(Tiazolidinkarboxylsyror/Propiolaktamer/Triazoler/Sulfoner)" ], "Anvandningsomrade-Egenskaper" : [ "(Antibiotika/Bredspektrumpenicillin mot allvarliga infektioner, alltid i kombination med betalaktamashämmaren tazobaktam)/(Antibiotika/Beta-laktamashämmare)" ] }, { "@id" : "447", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Tazobaktam", "@language" : "sv" } ], "VocabularyConceptId" : "349609", "VocabularyId" : "73", "Identifier" : "447", "Label" : "Tazobaktam", "Definition" : "ChSp/PubCh/ECHA/WIKI", "Notation" : "CH10/447", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Tazobactam" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(2S,3S,5R)-3-methyl-4,4,7-trioxo-3-(triazol-1-ylmethyl)-4λ6-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; (2S,3S,5R)-3-methyl-7-oxo-3-(1H-1,2,3-triazol-1-ylmethyl)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 4,4-dioxide" ], "CAS-Nr" : [ "89786-04-9" ], "EC-Nr" : [ "618-303-7" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Tiazolidinkarboxylsyror/Propiolaktamer/Triazoler/Sulfoner" ], "Anvandningsomrade-Egenskaper" : [ "Antibiotika/Beta-laktamashämmare" ] }, { "@id" : "448", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Sertralin/Norsertralin, beräknad summa", "@language" : "sv" } ], "VocabularyConceptId" : "349610", "VocabularyId" : "73", "Identifier" : "448", "Label" : "Sertralin/Norsertralin, beräknad summa", "Definition" : "ChSp/PubCh/ECHA/WIKI", "Notation" : "CH10/448", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Sertralin/Norsertralin, calculated sum; Sertralin/Sertralin-desmethyl, calculated sum" ], "Synonym_1" : [ "Sertralin/Sertralin-desmetyl, beräknad summa" ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "(1S,4S)-4-(3,4-Dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine/(1S,4S)-4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydronaphthalen-1-amine" ], "CAS-Nr" : [ "79617-96-2/87857-41-8" ], "EC-Nr" : [ "saknas" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Klorerade aromater/Aminer/Tetraliner" ], "Anvandningsomrade-Egenskaper" : [ "Antidepressiva/Ångestdämpande/Mot: MDD, OCD, PD/SSRI: Selektiva Serotoninåterupptagshämmare" ] }, { "@id" : "449", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Cyklobensaprin", "@language" : "sv" } ], "VocabularyConceptId" : "349611", "VocabularyId" : "73", "Identifier" : "449", "Label" : "Cyklobensaprin", "Definition" : "ChSp/PubCh/ECHA/WIKI", "Notation" : "CH10/449", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Cyclobenzaprine" ], "Synonym_1" : [ "Cyklobenzaprin" ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "N,N-Dimethyl-3-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenylidene)propan-1-amine; 3-(5H-Dibenzo[a,d][7]annulen-5-ylidene)-N,N-dimethyl-1-propanamine" ], "CAS-Nr" : [ "303-53-7" ], "EC-Nr" : [ "206-145-8" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Dibensocykloheptener/Dimetylpropanaminer" ], "Anvandningsomrade-Egenskaper" : [ "Muskelavslappnande medel/Antidepressiva" ] }, { "@id" : "450", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "2-Hydroxikarbamazepin", "@language" : "sv" } ], "VocabularyConceptId" : "349612", "VocabularyId" : "73", "Identifier" : "450", "Label" : "2-Hydroxikarbamazepin", "Definition" : "ChSp/PubCh/ECHA", "Notation" : "CH10/450", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "2-Hydroxycarbamazepine; Carbamazepine-10,11-diol" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "3-Hydroxybenzo[b][1]benzazepine-11-carboxamide; 2-Hydroxy-5H-dibenzo[b,f]azepine-5-carboxamide" ], "CAS-Nr" : [ "68011-66-5" ], "EC-Nr" : [ "809-752-1" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Dibensoazepiner/Karboxamider/Sekundära alkoholer" ], "Anvandningsomrade-Egenskaper" : [ "Karbamazepin-metabolit/Antiepileptika/Neuroleptika/Mot: Neuropati" ] }, { "@id" : "451", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "10,11-Dihydroxikarbamazepin", "@language" : "sv" } ], "VocabularyConceptId" : "349613", "VocabularyId" : "73", "Identifier" : "451", "Label" : "10,11-Dihydroxikarbamazepin", "Definition" : "ChSp/PubCh/ECHA", "Notation" : "CH10/451", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "10,11-Dihydroxycarbamazepine" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "5,6-Dihydroxy-5,6-dihydrobenzo[b][1]benzazepine-11-carboxamide; 10,11-Dihydroxy-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide" ], "CAS-Nr" : [ "35079-97-1" ], "EC-Nr" : [ "saknas" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Dibensoazepiner/Karboxamider" ], "Anvandningsomrade-Egenskaper" : [ "Karbamazepin-metabolit/Antiepileptika/Neuroleptika/Mot: Neuropati" ] }, { "@id" : "452", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "4-Hydroxidiklofenak", "@language" : "sv" } ], "VocabularyConceptId" : "349614", "VocabularyId" : "73", "Identifier" : "452", "Label" : "4-Hydroxidiklofenak", "Definition" : "ChSp/PubCh/ECHA", "Notation" : "CH10/452", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "4-Hydroxydiclofenac" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "2-[2-(2,6-Dichloro-4-hydroxyanilino)phenyl]acetic acid" ], "CAS-Nr" : [ "64118-84-9" ], "EC-Nr" : [ "626-698-2" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Klorerade aromater/Aniliner/Karboxylsyror/Alkoholer" ], "Anvandningsomrade-Egenskaper" : [ "Diklofenak-metabolit/Antiinflammatoriska medel/Analgetika/Antipyretika/NSAID (Non-steroidal anti-inflammatory drugs)" ] }, { "@id" : "453", "@type" : "skos:Concept", "prefLabel" : [ { "@value" : "Lomefloxacin", "@language" : "sv" } ], "VocabularyConceptId" : "349615", "VocabularyId" : "73", "Identifier" : "453", "Label" : "Lomefloxacin", "Definition" : "ChSp/PubCh/ECHA/WIKI", "Notation" : "CH10/453", "Status" : "Valid", "StatusModifiedDate" : "2026-04-04", "AcceptedDate" : "2026-04-04", "NotAcceptedDate" : null, "broader" : [ ], "narrower" : [ ], "skos:altLabel" : [ "Lomefloxacin" ], "Synonym_1" : [ ], "Synonym_2" : [ ], "Synonym_3" : [ ], "Validity" : [ "Valid" ], "IUPAC" : [ "1-Ethyl-6,8-difluoro-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid; 1-Ethyl-6,8-difluoro-7-(3-methyl-1-piperazinyl)-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid" ], "CAS-Nr" : [ "98079-51-7" ], "EC-Nr" : [ "619-317-6" ], "WFD" : [ ], "Huvud-grupper" : [ "Läkemedel" ], "Sub-grupper" : [ "Fluorerade aromater/Fluorkinoloner/Piperaziner" ], "Anvandningsomrade-Egenskaper" : [ "Antibakteriella medel" ] } ] }